CONCENTRIX CORP, 10-K filed on 1/28/2026
Annual Report
v3.25.4
Cover - USD ($)
12 Months Ended
Nov. 30, 2025
Jan. 16, 2026
May 31, 2025
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Nov. 30, 2025    
Current Fiscal Year End Date --11-30    
Document Transition Report false    
Entity File Number 001-39494    
Entity Registrant Name CONCENTRIX CORPORATION    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 27-1605762    
Entity Address, Address Line One 39899 Balentine Drive    
Entity Address, City or Town Newark    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 94560    
City Area Code 800    
Local Phone Number 747-0583    
Title of 12(b) Security Common Stock, par value $0.0001 per share    
Trading Symbol CNXC    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 2,948,926,137
Entity Common Stock, Shares Outstanding (in shares)   61,597,304  
Documents Incorporated by Reference
Items 10, 11, 12, 13 and 14 of Part III of this Annual Report on Form 10-K incorporate by reference portions of the Registrant’s definitive proxy statement relating to its 2026 Annual Meeting of Stockholders (the “2026 Proxy Statement”) where indicated. The 2026 Proxy Statement will be filed with the U.S. Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.
   
Amendment Flag false    
Document Fiscal Year Focus 2025    
Document Fiscal Period Focus FY    
Entity Central Index Key 0001803599    
Entity Address, Address Line Two Suite 235    
v3.25.4
Audit Information
12 Months Ended
Nov. 30, 2025
Nov. 30, 2024
Auditor Information [Abstract]    
Auditor Name Ernst & Young LLP KPMG LLP
Auditor Location Cincinnati, Ohio Cincinnati, Ohio
Auditor Firm ID 42 185
v3.25.4
CONSOLIDATED BALANCE SHEETS - USD ($)
Nov. 30, 2025
Nov. 30, 2024
Current assets:    
Cash and cash equivalents $ 327,347,000 $ 240,571,000
Accounts receivable, net 1,999,021,000 1,926,737,000
Other current assets 758,135,000 675,116,000
Total current assets 3,084,503,000 2,842,424,000
Property and equipment, net 735,550,000 714,517,000
Goodwill 3,671,746,000 4,986,967,000
Intangible assets, net 1,960,338,000 2,286,940,000
Deferred tax assets 317,453,000 218,396,000
Other assets 991,496,000 942,194,000
Total assets 10,761,086,000 11,991,438,000
Current liabilities:    
Accounts payable 244,771,000 209,812,000
Current portion of long-term debt 65,625,000 2,522,000
Accrued compensation and benefits 764,962,000 706,619,000
Other accrued liabilities 997,198,000 977,314,000
Income taxes payable 123,794,000 99,546,000
Total current liabilities 2,196,350,000 1,995,813,000
Long-term debt, net 4,572,889,000 4,733,056,000
Other long-term liabilities 950,983,000 910,271,000
Deferred tax liabilities 296,519,000 312,574,000
Total liabilities 8,016,741,000 7,951,714,000
Commitments and contingencies (Note 13)
Stockholders’ equity:    
Preferred stock, $0.0001 par value, 10,000 shares authorized and no shares issued and outstanding as of November 30, 2025 and 2024, respectively 0 0
Common stock, $0.0001 par value, 250,000 shares authorized; 70,316 and 68,849 shares issued as of November 30, 2025 and 2024, respectively, and 61,739 and 64,238 shares outstanding as of November 30, 2025 and 2024, respectively 7,000 7,000
Additional paid-in capital 3,783,972,000 3,683,608,000
Treasury stock, 8,577 and 4,611 shares as of November 30, 2025 and 2024, respectively (610,162,000) (421,449,000)
Retained earnings (deficit) (177,010,000) 1,191,871,000
Accumulated other comprehensive loss (252,462,000) (414,313,000)
Total stockholders’ equity 2,744,345,000 4,039,724,000
Total liabilities and stockholders’ equity $ 10,761,086,000 $ 11,991,438,000
v3.25.4
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Nov. 30, 2025
Nov. 30, 2024
Statement of Financial Position [Abstract]    
Preferred stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized (in shares) 10,000,000 10,000,000
Preferred stock, shares outstanding (in shares) 0 0
Preferred stock, shares issued (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 250,000,000 250,000,000
Common stock, shares issued (in shares) 70,316,000 68,849,000
Common stock, shares outstanding (in shares) 61,739,000 64,238,000
Treasury stock (in shares) 8,577,000 4,611,000
v3.25.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Nov. 30, 2025
Nov. 30, 2024
Nov. 30, 2023
Income Statement [Abstract]      
Revenue $ 9,825,771 $ 9,618,900 $ 7,114,706
Cost of revenue 6,390,760 6,170,013 4,536,771
Gross profit 3,435,011 3,448,887 2,577,935
Selling, general and administrative expenses 2,825,468 2,852,500 1,916,608
Impairment charges 1,527,726 0 0
Operating income (loss) (918,183) 596,387 661,327
Interest expense and finance charges, net 290,349 321,828 201,004
Other income, net (26,310) (24,715) 52,095
Income (loss) before income taxes (1,182,222) 299,274 408,228
Provision for income taxes 96,702 48,057 94,386
Net income (loss) $ (1,278,924) $ 251,217 $ 313,842
Earnings (loss) per common share:      
Basic (in dollars per share) $ (20.36) $ 3.72 $ 5.72
Diluted (in dollars per share) $ (20.36) $ 3.71 $ 5.70
Weighted-average common shares outstanding:      
Basic (in shares) 63,012 64,977 53,801
Diluted (in shares) 63,012 65,074 54,010
v3.25.4
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)
$ in Thousands
12 Months Ended
Nov. 30, 2025
Nov. 30, 2024
Nov. 30, 2023
Statement of Comprehensive Income [Abstract]      
Net income (loss) $ (1,278,924) $ 251,217 $ 313,842
Other comprehensive income (loss):      
Unrealized gains (losses) of defined benefit plans, net of taxes of $(1,003), $(2,078), and $(894) for fiscal years ended November 30, 2025, 2024 and 2023, respectively 3,702 5,988 (2,800)
Unrealized gains (losses) on hedges during the period, net of taxes of $2,051, $9,514, and $(4,938) for fiscal years ended November 30, 2025, 2024 and 2023, respectively (3,578) (34,029) 10,610
Reclassification of net losses on hedges to net income (loss), net of taxes of $(2,322), $(1,230), and $(4,594) for fiscal years ended November 30, 2025, 2024 and 2023, respectively 6,818 3,659 13,793
Total change in unrealized gains (losses) on hedges, net of taxes 3,240 (30,370) 24,403
Foreign currency translation adjustments for fiscal years ended November 30, 2025, 2024 and 2023 154,909 (198,204) 102,419
Other comprehensive income (loss) 161,851 (222,586) 124,022
Comprehensive income (loss) $ (1,117,073) $ 28,631 $ 437,864
v3.25.4
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parenthetical) - USD ($)
$ in Thousands
12 Months Ended
Nov. 30, 2025
Nov. 30, 2024
Nov. 30, 2023
Statement of Comprehensive Income [Abstract]      
Unrealized gains (losses) of defined benefit plans, net of taxes of $(1,003), $(2,078), and $(894) for fiscal years ended November 30, 2025, 2024 and 2023, respectively $ (1,003) $ (2,078) $ (894)
Unrealized gains (losses) on cash flow hedges during the period, net of taxes of $2,051, $9,514, $(4,938) for fiscal years ended November 30, 2025, 2024, and 2013, respectively 2,051 9,514 (4,938)
Reclassification of net losses on hedges to net income (loss), net of taxes of $(2,322), $(1,230), and $(4,594) for fiscal years ended November 30, 2025, 2024 and 2023, respectively $ (2,322) $ (1,230) $ (4,594)
v3.25.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional paid-in capital
Treasury stock
Retained earnings (deficit)
Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Nov. 30, 2022   52,367,000        
Beginning Balance at Nov. 30, 2022 $ 2,695,904 $ 5 $ 2,428,313 $ (190,779) $ 774,114 $ (315,749)
Treasury Stock, Common, Shares at Nov. 30, 2022       1,271,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Other comprehensive income (loss) 124,022         124,022
Stock Issued During Period, Shares, Acquisitions   14,862,000        
Common stock issued as acquisition purchase consideration 1,084,896 $ 2 1,084,894      
Share-based compensation activity (in shares)   654,000        
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition 69,314   69,314      
Repurchase of common stock for tax withholdings on equity awards (in shares)       169,000    
Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation (17,231)     $ (17,231)    
Repurchase of common stock (in shares)       709,000    
Treasury Stock, Value, Acquired, Par Value Method (63,958)     $ (63,958)    
Dividends (63,495)       (63,495)  
Net income (loss) 313,842       313,842  
Ending balance (in shares) at Nov. 30, 2023   67,883,000        
Ending Balance at Nov. 30, 2023 4,143,294 $ 7 3,582,521 $ (271,968) 1,024,461 (191,727)
Treasury Stock, Common, Shares at Nov. 30, 2023       2,149,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Other comprehensive income (loss) (222,586)         (222,586)
Share-based compensation activity (in shares)   966,000        
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition 101,087   101,087      
Repurchase of common stock for tax withholdings on equity awards (in shares)       261,000    
Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation (13,385)     $ (13,385)    
Repurchase of common stock (in shares)       2,201,000    
Treasury Stock, Value, Acquired, Par Value Method (136,096)     $ (136,096)    
Dividends (83,807)       (83,807)  
Net income (loss) $ 251,217       251,217  
Ending balance (in shares) at Nov. 30, 2024 64,238,000 68,849,000        
Ending Balance at Nov. 30, 2024 $ 4,039,724 $ 7 3,683,608 $ (421,449) 1,191,871 (414,313)
Treasury Stock, Common, Shares at Nov. 30, 2024 4,611,000     4,611,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Other comprehensive income (loss) $ 161,851         161,851
Share-based compensation activity (in shares)   1,467,000        
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition 100,364   100,364      
Repurchase of common stock for tax withholdings on equity awards (in shares)       409,000    
Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation (20,005)     $ (20,005)    
Repurchase of common stock (in shares)       3,557,000    
Treasury Stock, Value, Acquired, Par Value Method (168,708)     $ (168,708)    
Dividends (89,957)       (89,957)  
Net income (loss) $ (1,278,924)       (1,278,924)  
Ending balance (in shares) at Nov. 30, 2025 61,739,000 70,316,000        
Ending Balance at Nov. 30, 2025 $ 2,744,345 $ 7 $ 3,783,972 $ (610,162) $ (177,010) $ (252,462)
Treasury Stock, Common, Shares at Nov. 30, 2025 8,577,000     8,577,000    
v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Nov. 30, 2025
Nov. 30, 2024
Nov. 30, 2023
Cash flows from operating activities:      
Net income (loss) $ (1,278,924) $ 251,217 $ 313,842
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Impairment charges 1,527,726 0 0
Depreciation 226,101 246,920 173,463
Amortization 434,332 458,925 214,832
Non-cash share-based compensation 96,386 96,057 62,113
Provision for credit losses 5,738 7,057 10,236
Deferred income taxes (154,877) (235,248) (121,711)
Loss on call options 0 0 14,629
Amortization of debt discount and issuance costs 23,548 25,276 6,089
Pension and other post-retirement benefit costs 16,565 16,097 11,328
Pension and other post-retirement plan contributions (4,058) (4,442) (12,143)
Change in acquisition contingent consideration (1,958) (29,268) 15,681
Other 2,152 1,791 306
Changes in operating assets and liabilities:      
Accounts receivable, net (23,078) (63,851) (45,895)
Accounts payable 28,474 (25,819) 9,341
Other operating assets and liabilities (91,160) (77,220) 25,897
Net cash provided by operating activities 806,967 667,492 678,008
Cash flows from investing activities:      
Purchases of property and equipment (234,496) (238,762) (180,532)
Premiums paid for call options 0 0 (14,629)
Acquisitions of business, net of cash and restricted cash acquired (15,887) (5,504) (1,914,079)
Net cash used in investing activities (250,383) (244,266) (2,109,240)
Cash flows from financing activities:      
Proceeds from the Securitization Facility 2,347,700 2,191,000 1,964,000
Repayments of the Securitization Facility (2,181,700) (1,948,500) (2,192,000)
Proceeds from the issuance of Senior Notes 0 0 2,136,987
Other debt proceeds 0 6,369 0
Other debt repayments (828,315) (7,558) 0
Cash paid for debt issuance costs (4,755) (600) (30,519)
Acquisition deferred consideration payment (6,454) 0 0
Cash paid for acquired earnout liabilities 0 (22,737) (13,309)
Proceeds from exercise of stock options 3,978 5,030 7,201
Repurchase of common stock for tax withholdings on equity awards (20,005) (13,385) (17,231)
Repurchase of common stock (168,708) (136,096) (63,958)
Dividends paid (89,618) (83,807) (63,495)
Net Change in Client Fund Obligation (9,191) (32,248) 0
Net cash provided by (used in) financing activities (491,443) (492,532) 1,802,676
Effect of exchange rate changes on cash, cash equivalents, cash held for sale and restricted cash 26,382 (17,577) (12,420)
Net increase (decrease) in cash, cash equivalents, cash held for sale and restricted cash 91,523 (86,883) 359,024
Cash, cash equivalents, cash held for sale and restricted cash at beginning of year 429,604 516,487 157,463
Cash, cash equivalents, cash held for sale and restricted cash at end of year 521,127 429,604 516,487
Supplemental disclosures of cash flow information:      
Interest paid on borrowings 299,615 282,270 142,598
Income taxes paid 270,328 298,445 217,252
Supplemental disclosure of non-cash investing activities:      
Accrued costs for property and equipment purchases 28,781 24,856 26,374
Restated Term Loan      
Cash flows from financing activities:      
Proceeds from the Restated Credit Facility - Term Loan 1,500,000 0 294,702
Repayments of the Prior Credit Facility - Term Loan (1,034,375) (450,000) (194,702)
Term Loan      
Cash flows from financing activities:      
Repayments of the Prior Credit Facility - Term Loan 0 0 (25,000)
Revolver      
Cash flows from financing activities:      
Proceeds from the Restated Credit Facility - Term Loan 238,500 0 0
Repayments of the Prior Credit Facility - Term Loan $ (238,500) $ 0 $ 0
v3.25.4
BACKGROUND AND BASIS OF PRESENTATION
12 Months Ended
Nov. 30, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
BACKGROUND AND BASIS OF PRESENTATION
NOTE 1—BACKGROUND AND BASIS OF PRESENTATION:
Background
Concentrix Corporation (“Concentrix” or the “Company”), is a global technology and services leader that powers exceptional brand experiences and digital operations for more than 2,000 clients across the globe. The Company designs, builds, and runs fully integrated, end-to-end solutions, including customer experience (“CX”) process optimization, technology innovation and design engineering, front- and back-office automation, analytics and business transformation services to clients in five primary industry verticals: technology and consumer electronics; retail, travel and e-commerce; communications and media; banking, financial services and insurance; and healthcare.
Basis of presentation (including principles of consolidation)
The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and include the accounts of the Company, its majority-owned subsidiaries and entities over which the Company has control. All intercompany balances and transactions have been eliminated in consolidation.
On September 25, 2023, the Company completed its acquisition (the “Webhelp Combination”) of all of the issued and outstanding capital stock of Marnix Lux SA (“Webhelp”), from the holders thereof (the “Sellers”). The total purchase price consideration, net of cash and restricted cash acquired, for the acquisition of Webhelp was $3.8 billion, which was funded by proceeds from the Company’s August 2023 offering and sale of senior notes, term loan borrowings under the Company’s senior credit facility, the issuance of a promissory note by Concentrix Corporation to certain Sellers (the “Sellers’ Note”), the issuance of shares of common stock, par value $0.0001 per share, of Concentrix Corporation, and cash on hand. The total cash consideration paid for Webhelp was $2.4 billion, less cash and restricted cash acquired of $0.5 billion. Subsequent to September 25, 2023, the results of Webhelp have been included in the consolidated results of the Company for all periods presented.
v3.25.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
12 Months Ended
Nov. 30, 2025
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
NOTE 2—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:
Use of estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expense during the reporting period. The Company evaluates these estimates on a regular basis and bases them on historical experience and on various assumptions that the Company believes are reasonable. Actual results could differ from the estimates.

Segment reporting
Concentrix’ operations are based on an integrated global delivery model whereby services under a client contract in one location may be provided from delivery centers located in one or more different countries, with a significant portion of the Company’s workforce located in the Philippines and India. Given the homogeneity of end-to-end solutions and technology and the integrated delivery model, the Company operates in a single operating segment, based on how the chief operating decision maker (“CODM”) views and evaluates the Company’s operations in making operational and strategic decisions and assessments of financial performance (including for purposes of allocating resources and assessing performance). The Company’s President and Chief Executive Officer has been identified as the CODM.
Cash equivalents
The Company considers all highly liquid debt instruments purchased with an original maturity or remaining maturity at the date of purchase of three months or less to be cash equivalents. Cash equivalents consist principally of money market deposit accounts that are stated at cost, which approximates fair value. The Company is exposed to
credit risk in the event of default by financial institutions to the extent that cash balances with financial institutions are in excess of amounts that are insured.
Accounts receivable and allowance for credit losses
Accounts receivable are comprised primarily of amounts owed to the Company by clients and are presented net of an allowance for credit losses. The allowance for credit losses is an estimate to cover the losses resulting from uncertainty regarding collections from customers to make payments for outstanding balances. In estimating the required allowance, the Company considers the overall quality and aging of the accounts receivable and credit evaluations of its clients’ financial condition. The Company also evaluates the collectability of accounts receivable based on specific client circumstances, current economic trends, historical experience with collections and the value and adequacy of any collateral received from clients.
Unbilled receivables
For the majority of service contracts, the Company performs the services prior to billing the client, and this amount is captured as an unbilled receivable included in accounts receivable, net on the consolidated balance sheet. Billing usually occurs in the month after the Company performs the services or in accordance with the specific contractual provisions.
Accounts receivable factoring
The Company has factoring programs with certain clients to sell accounts receivable to financial institutions under non-recourse agreements in exchange for cash proceeds. These trade receivable financing agreements are accounted for as a true sale of assets under the provisions of Accounting Standards Codification 860, Transfer and Servicing (“ASC 860”). In accordance with ASC 860, the trade receivable financing arrangements are deemed a true sale as the Company retains no rights or interest and has no obligations with respect to the trade receivables. In some instances, the Company may continue to service the transferred receivables after factoring has occurred. However, any servicing of the trade receivable does not constitute significant continuing involvement. As defined in the trade receivable financing arrangements, the financial institution is responsible for any credit risk associated with the sold trade receivables.

Sales of trade receivables under the various factoring programs were $1.3 billion, $1.4 billion, and $0.3 billion during the years ended November 30, 2025, 2024 and 2023, respectively, which also approximates cash collections on trade receivables during each fiscal year. As noted above, the Company acts as a servicer (collects customer cash on behalf of the financial institution) for certain of its trade receivables factoring arrangements. The servicing fees associated with these trade receivables factoring arrangements were not material to the Company for the years ended November 30, 2025, 2024, and 2023. The loss on the sale of trade receivables under the various trade receivables factoring arrangements was not material to the Company for the years ended November 30, 2025, 2024, and 2023. As of November 30, 2025 and 2024, trade receivables in the amount of $119,000 and $162,000, respectively, were sold to the financial institutions and not included in trade receivables in the consolidated balance sheets.

Derivative financial instruments
The Company accounts for its derivative instruments as either assets or liabilities and carries them at fair value.
For derivative instruments that hedge the exposure to variability in expected future cash flows that are designated as cash flow hedges, the gain or loss on the derivative instrument is reported as a component of “Accumulated other comprehensive income (loss),” in stockholders’ equity and reclassified into earnings in the same line associated with the forecasted transactions, in the same period or periods during which the hedged transaction affects earnings. To receive hedge accounting treatment, cash flow hedges must be highly effective in offsetting changes to expected future cash flows on hedged transactions.
For derivative instruments that are not designated as cash flow hedges, gains and losses on derivative instruments are reported in the consolidated statements of operations in the current period.
Software costs
The Company develops software platforms for internal use. The Company capitalizes costs incurred to develop software subsequent to the software product reaching the application development stage. The Company also
capitalizes the costs incurred to extend the life of existing software, or the cost of significant enhancements that are added to the features of existing software. The capitalized development costs primarily comprise payroll costs and related software costs. Capitalized costs are amortized over the economic life of the software using the straight-line method.
Property and equipment
Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method based upon the shorter of the estimated useful lives of the assets, or the lease term of the respective assets, if applicable. Maintenance and repairs are charged to expense as incurred, and improvements are capitalized. When assets are retired or otherwise disposed of, the cost and accumulated depreciation and amortization are removed from the accounts and any resulting gain or loss is reflected in operations in the period realized. The ranges of estimated useful lives for property and equipment categories are as follows:
Equipment and furniture
3 - 10 years
Software
3 - 7 years
Leasehold improvements
2 - 15 years
Buildings and building improvements
10 - 39 years
Leases
The Company enters into leases as a lessee for property and equipment in the ordinary course of business. When procuring services, or upon entering into a contract with its clients, the Company determines whether an arrangement contains a lease at its inception. As part of that evaluation, the Company considers whether there is an implicitly or explicitly identified asset in the arrangement and whether the Company, as the lessee, or the client, if the Company is the lessor, has the right to control the use of that asset. When the Company is the lessee, all leases with a term of more than 12 months are recognized as right-of-use (“ROU”) assets and associated lease liabilities in the consolidated balance sheet. Lease liabilities are measured at the lease commencement date and determined using the present value of the lease payments not yet paid, at the Company’s incremental borrowing rate, which approximates the rate at which the Company would borrow on a secured basis in the country where the lease was executed. The interest rate implicit in the lease is generally not determinable in the transactions where the Company is the lessee. The ROU asset equals the lease liability adjusted for any initial direct costs, prepaid rent and lease incentives. The Company’s variable lease payments generally relate to payments tied to various indexes, non-lease components and payments above a contractual minimum fixed amount.
Operating leases are included in other assets, net, other accrued liabilities and other long-term liabilities in the consolidated balance sheet. Substantially all of the Company’s leases are classified as operating leases, and lease expense is recorded on a straight-line basis over the lease term. The Company recognizes options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. The Company made a policy election to not recognize leases with a lease term of 12 months or less in the consolidated balance sheet. Lease expenses are recorded within selling, general, and administrative expenses in the consolidated statements of operations. Operating lease payments are presented within “Cash flows from operating activities” in the consolidated statements of cash flows.
For all asset classes, the Company has elected the lessee practical expedient to combine lease and non-lease components (e.g., maintenance services) and account for the consolidated unit as a single lease component. Variable lease payments are recognized in the periods in which the obligations for those payments are incurred. The Company’s lease agreements do not contain any material residual guarantees or material restrictive covenants.
Goodwill and intangible assets
The Company tests goodwill for impairment annually at the reporting unit level on the first day of the fiscal fourth quarter or more frequently if events or changes in circumstances indicate that it may be impaired. For purposes of the goodwill impairment test, the Company can elect to perform a quantitative or qualitative analysis. If the qualitative analysis is elected, goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less
than its carrying value. The factors that are considered in the qualitative analysis include: macroeconomic conditions; industry and market considerations; cost factors such as increases in labor, or other costs that would have a negative effect on earnings and cash flows; and other relevant entity-specific events and information.
If the Company elects to perform or is required to perform a quantitative analysis, then the reporting unit’s carrying value is compared to its fair value. As part of this analysis, the Company reconciles the fair value of its reporting unit to its market capitalization. Additionally, under a quantitative assessment, the fair value of the Company’s single reporting unit is estimated using an income approach and a market approach with equal weighting. The income approach applies a fair value methodology to the Company’s reporting unit based on a discounted cash flow analysis. A number of significant judgments are involved in the application of the discounted cash flow analysis, including estimation of future cash flows, which is dependent on internally developed forecasts, including future levels of revenue and earnings growth, estimation of the long-term rate of growth for the Company’s business, and determination of a discount rate. The market approach is performed using the guideline public company method which involves calculating valuation multiples based on financial data from comparable publicly traded companies and considerations of recent transactions in the market and industry. Goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value and the excess is recognized as an impairment loss. See Note 5—Goodwill and Intangible Assets for more information.
Intangible assets consist of customer relationships, technology, trade names and non-compete agreements. Amortization is based on the pattern over which the economic benefits of the intangible assets will be consumed or, when the consumption pattern is not apparent, by using the straight-line method over the following useful lives:
Customer relationships
10 - 15 years
Technology5 years
Trade names
3 - 5 years
Non-compete agreements3 years
Impairment of long-lived assets
The Company reviews the recoverability of its long-lived assets, such as intangible assets subject to amortization, property and equipment and certain other assets, including lease right-of-use assets, when events or changes in circumstances occur that indicate the carrying value of the asset or asset group may not be recoverable. The assessment of possible impairment is based on the Company’s ability to recover the carrying value of the asset or asset group from the expected future pre-tax cash flows, undiscounted and without interest charges, of the related operations. If these cash flows are less than the carrying value of such assets, an impairment loss is recognized for the difference between estimated fair value and carrying value.
Held for sale
In November 2025, the Company entered into a definitive agreement to sell one of its subsidiaries. The Company completed the sale in December 2025. The Company appropriately classified assets and liabilities related to the subsidiary as current assets and liabilities held for sale on its consolidated balance sheet as of November 30, 2025. The assets and liabilities and related transaction were not material. The loss on the sale was not material.
Concentration of credit risk
Financial instruments that potentially subject the Company to significant concentration of credit risk consist principally of cash and cash equivalents, accounts receivable and derivative instruments.
The Company’s cash and cash equivalents and derivative instruments are transacted and maintained with financial institutions with high credit standing, and their compositions and maturities are regularly monitored by management. Through November 30, 2025, the Company has not experienced any credit losses on such deposits and derivative instruments.
Accounts receivable comprise amounts due from clients. The Company performs ongoing credit evaluations of its clients’ financial condition and limits the amount of credit extended when deemed necessary, but generally requires no collateral. The Company also maintains allowances for credit losses. In estimating the required
allowances, the Company takes into consideration the overall quality and aging of its receivable portfolio and specifically identified client risks.
In fiscal years 2025, 2024, and 2023, no client accounted for more than 10% of the Company’s consolidated revenue.
As of November 30, 2025 and 2024, no client comprised more than 10% of the Company’s total accounts receivable balance.
Revenue recognition
The Company generates revenue primarily from the provision of integrated, end-to-end solutions and technology, including CX process optimization to its clients. The Company recognizes revenue from services contracts over time as the promised services are delivered to clients for an amount that reflects the consideration to which the Company is entitled in exchange for those services. The Company recognizes revenue over time as the client simultaneously receives and consumes the benefits provided by the Company as the Company performs the services. The Company accounts for a contract with a client when it has written approval, the contract is committed, the rights of the parties, including payment terms, are identified, the contract has commercial substance and consideration is probable of collection. Revenue is presented net of taxes collected from clients and remitted to government authorities. The Company generally invoices a client after performance of services, or in accordance with specific contractual provisions. Payments are due as per contract terms and do not contain a significant financing component.
The Company determines whether the services performed during the initial phases of an arrangement, such as setup activities, are distinct. In most cases, the arrangement is a single performance obligation comprised of a series of distinct services that are substantially the same and that have the same pattern of transfer (i.e., distinct days of service).
Service contracts are most significantly based on a fixed unit-price per transaction or other objective measure of output. Revenue on unit-price transactions is recognized over time using an objective measure of output such as staffing hours or the number of transactions processed by service advisors. Client contract terms can range from less than one year to more than five years.
Certain client contracts include incentive payments from the client upon achieving certain agreed-upon service levels and performance metrics or service level agreements that could result in credits or refunds to the client. Revenue relating to such arrangements is accounted for as variable consideration when the likely amount of revenue to be recognized can be estimated to the extent that it is probable that a significant reversal of any incremental revenue will not occur.
Cost of revenue
Recurring direct operating costs for services are recognized as incurred. Cost of services revenue consists primarily of personnel costs and transition and initial set-up costs.
Selling, general and administrative expenses
Selling, general and administrative expenses are charged to income as incurred. Expenses of promoting and selling products and services are classified as selling expense and include such items as compensation, sales commissions and travel. General and administrative expenses include such items as compensation, cost of delivery centers, legal and professional costs, office supplies, non-income taxes, insurance and utility expenses. In addition, selling, general and administrative expenses include other operating items such as allowances for credit losses, depreciation and amortization of intangible assets.
Advertising
Costs related to advertising and service promotion expenditures are charged to “Selling, general and administrative expenses” as incurred. To date, net costs related to advertising and promotion expenditures have not been material.
Income taxes
The asset and liability method is used in accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for the expected tax consequences of temporary differences between the tax bases of assets and liabilities and their reported amounts in the financial statements using enacted tax rates and laws that will be in effect when the difference is expected to reverse. Tax on global low-taxed intangible income is accounted for as a current expense in the period in which the income is includable in a tax return using the “period cost” method. Valuation allowances are provided against deferred tax assets that are not likely to be realized.
The Company recognizes tax benefits from uncertain tax positions only if that tax position is more likely than not to be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. The Company recognizes interest and penalties related to unrecognized tax benefits in the provisions for income taxes.
Foreign currency translations
The functional currencies of the legal entities’ financial statements included in these consolidated financial statements are the local currencies of the legal entities and are translated into United States (“U.S.”) dollars for consolidation as follows: assets and liabilities at the exchange rate as of the balance sheet date, equity at the historical rates of exchange, and income and expense amounts at the average exchange rate for the month. Translation adjustments resulting from the translation of the legal entities’ accounts are included in “Accumulated other comprehensive income (loss).” Transactions denominated in currencies other than the applicable functional currency are converted to the functional currency at the exchange rate on the transaction date. At period end, monetary assets and liabilities are remeasured to the functional currency using exchange rates in effect at the balance sheet date. Non-monetary assets and liabilities are remeasured at historical exchange rates. Gains and losses resulting from foreign currency transactions are included within “Other expense (income), net.”
Other comprehensive income (loss)
The primary components of other comprehensive income (loss) for the Company include foreign currency translation adjustments arising from the Company’s foreign legal entities, unrealized gains and losses on qualifying hedges, and changes in unrecognized pension and post-retirement benefits.
Share-based compensation
Share-based compensation cost for stock options, restricted stock awards and restricted stock units is determined based on the fair value at the measurement date. The Company recognizes share-based compensation cost as expense for these awards ratably on a straight-line basis over the requisite service period. Share-based compensation for performance-based restricted stock units is measured based on fair value at the initial measurement date and is adjusted each reporting period, as necessary, to reflect changes in management’s assessment of the probability that performance conditions will be satisfied. The Company recognizes share-based compensation cost associated with its performance-based restricted stock units over the requisite service period if it is probable that the performance conditions will be satisfied. Share-based compensation cost for equity awards that include a market performance condition are determined using a Monte Carlo simulation valuation model and expense is recognized for these awards ratably on a straight-line basis over the requisite service period. The Company accounts for expense reductions that result from the forfeiture of unvested awards in the period that the forfeitures occur.
Pension and post-retirement benefits
The funded status of the Company’s pension and other post-retirement benefit plans is recognized in the consolidated balance sheets. The funded status is measured as the difference between the fair value of plan assets and the benefit obligation at November 30, the measurement date. For defined benefit pension plans, the benefit obligation is the projected benefit obligation (“PBO”) and, for the other post-retirement benefit plans, the benefit obligation is the accumulated post-retirement benefit obligation (“APBO”). The PBO represents the actuarial present value of benefits expected to be paid upon retirement. For active plans, the present value reflects estimated future compensation levels. The APBO represents the actuarial present value of post-retirement benefits attributed to employee services already rendered. The fair value of plan assets represents the current market value of assets held by an irrevocable trust fund for the sole benefit of participants. The measurement of the benefit obligation is based
on the Company’s estimates and actuarial valuations. These valuations reflect the terms of the plans and use participant-specific information such as compensation, age and years of service, as well as certain key assumptions that require significant judgment, including, but not limited to, estimates of discount rates, expected return on plan assets, inflation, rate of compensation increases, interest crediting rates and mortality rates. The assumptions used are reviewed on an annual basis.
Earnings (loss) per common share
Basic and diluted earnings (loss) per common share are calculated using the two-class method. The two-class method is an earnings allocation proportional to the respective ownership among holders of common stock and participating securities. The Company’s restricted stock awards and, effective in the fourth quarter of fiscal year 2023, restricted stock units are considered participating securities because holders have a non-forfeitable right to receive dividends. Basic earnings per common share is computed by dividing net income attributable to the Company’s common stockholders by the weighted-average common shares outstanding during the period. Diluted earnings per common share also considers the dilutive effect of in-the-money stock options and non-participating securities, calculated using the treasury stock method.
Treasury stock
Repurchases of shares of common stock are accounted for at cost and are included as a component of stockholders’ equity in the consolidated balance sheets.
Accounting pronouncements recently issued
In November 2023, the Financial Accounting Standards Board (the “FASB”) issued accounting standards update (“ASU”) 2023-07, which enhances the disclosures required for reportable segments in annual and interim consolidated financial statements. The Company adopted this ASU during the fiscal year ended November 30, 2025. See Note 16—Segment Reporting for more information.
In December 2023, the FASB issued ASU 2023-09, which requires enhanced income tax disclosures, including disaggregation of information in the rate reconciliation table and disaggregated information related to income taxes paid. The amendments in ASU 2023-09 are effective for the Company for the fiscal year ending November 30, 2026. The Company is currently evaluating the impact that this update will have on its disclosures in the consolidated financial statements.
In November 2024, the FASB issued ASU 2024-03, which requires the disaggregation of certain expenses in the notes to the financial statements, to provide enhanced transparency into the expense captions presented on the face of the income statement. ASU 2024-03 is effective for the Company for annual reporting periods beginning with the fiscal year ending November 30, 2028 and for interim periods beginning in fiscal year 2029. Early adoption is permitted. The amendments in this ASU may be applied either prospectively or retrospectively. The Company is currently evaluating the impact that this update will have on its disclosures in the consolidated financial statements.
In September 2025, the FASB issued ASU 2025-06, which amends the guidance in ASC 350-40, Intangibles -Goodwill and Other - Internal-Use Software. The amendments modernize the recognition and disclosure framework for internal-use software costs, removing the previous “development stage” model and introducing a more judgment-based approach. ASU 2025-06 is effective for the Company for annual reporting periods beginning with the fiscal year ending November 30, 2029 and for interim reporting periods beginning in that fiscal year. The Company is currently evaluating the impact that this update will have on the consolidated financial statements.

No other new accounting pronouncements recently adopted or issued had or are expected to have a material impact on the consolidated financial statements.
v3.25.4
SHARE-BASED COMPENSATION
12 Months Ended
Nov. 30, 2025
Share-Based Payment Arrangement [Abstract]  
SHARE-BASED COMPENSATION
NOTE 3—SHARE-BASED COMPENSATION:
In November 2020, TD SYNNEX Corporation (“TD SYNNEX”), as the former sole stockholder of Concentrix, approved the Concentrix Corporation 2020 Stock Incentive Plan (the “Concentrix Stock Incentive Plan”) and the Concentrix Corporation 2020 Employee Stock Purchase Plan (the “Concentrix ESPP”), each to be effective upon completion of Concentrix’ spin-off from TD SYNNEX, which occurred on December 1, 2020. 4,000 shares of Concentrix common stock were reserved for issuance under the Concentrix Stock Incentive Plan, and 1,000 shares of Concentrix common stock were authorized for issuance under the Concentrix ESPP. In December 2021, 2022 and
2023, respectively, 523, 520, and 664 additional shares of Concentrix common stock were reserved for issuance under the Concentrix Stock Incentive Plan resulting from an automatic annual increase pursuant to the terms of the plan (the “Evergreen Provision”).
On October 28, 2024, the stockholders of Concentrix approved an amendment and restatement of the Concentrix Stock Incentive Plan (the “2020 Plan”) at a Special Meeting of Stockholders that (i) increased the number of authorized shares thereunder by 3,000 shares and (ii) removed the Evergreen Provision, among other amendments. The amendment and restatement of the Concentrix Stock Incentive Plan was previously approved by the Company’s board of directors.
The Company recorded share-based compensation expense of $97,875, $95,922, and $62,493 for the fiscal years ended November 30, 2025, 2024 and 2023, respectively. Share-based compensation expense is included in selling, general and administrative expenses in the consolidated statements of operations.
Employee Stock Options
The Company uses the Black-Scholes valuation model to estimate the fair value of stock options. The Black-Scholes option-pricing model was developed for use in estimating the fair value of short-lived exchange traded options that have no vesting restrictions and are fully transferable. In addition, option-pricing models require the input of subjective assumptions, including the option’s expected life and the price volatility of the underlying stock. The stock options have ten-year terms and vesting terms of five years. The Company did not grant any stock options during the fiscal years 2025, 2024 and 2023.
A summary of the changes in the employee stock options during fiscal years 2023, 2024, and 2025 is presented below.
Options Outstanding
Number of shares
(in thousands)
Weighted-
average exercise
price per share
Balance as of November 30, 2022395$52.60 
Options granted— — 
Options exercised(100)45.50 
Options cancelled
(1)30.70 
Balance as of November 30, 202329454.45 
Options granted— — 
Options exercised(56)42.60
Balance as of November 30, 202423857.21 
Options granted— — 
Options exercised(18)44.58
Options cancelled
(2)55.12
Balance as of November 30, 2025218$58.28 

As of November 30, 2025, 218 options were outstanding with a weighted-average life of 3.02 years and an aggregate pre-tax intrinsic value of $0. As of November 30, 2025, all of the options were fully vested and exercisable.
Restricted Stock Awards, Restricted Stock Units and Performance-Based Restricted Stock Units
The fair value of restricted stock awards and restricted stock units granted under the Concentrix Stock Incentive Plan in fiscal years 2025, 2024 and 2023 were determined based on the trading price of Concentrix common stock on the date of grant. The awards are expensed on a straight-line basis over the vesting term, typically three or four years. The holders of restricted stock awards are entitled to the same voting, dividend and other rights as holders of Concentrix common stock.
In fiscal years 2025, 2024, and 2023, the Company granted performance-based restricted stock units to the Company’s senior executive team. The performance-based restricted stock units will vest, if at all, upon the achievement of certain annual financial targets during the three-year periods ending November 30, 2027, November 30, 2026 and November 30, 2025, respectively. For the awards with a final performance period ending on November 30, 2025, approximately 12% of the awards vested.
In April 2024, the Company granted performance-based restricted stock units under the Concentrix Stock Incentive Plan. The performance-based restricted stock units will vest, if at all, upon the achievement of certain financial targets during the three-year period ending November 30, 2026.
A summary of the changes in the non-vested restricted stock awards, restricted stock units, and performance-based stock units (exclusive of performance-based awards with market conditions as described further below) during fiscal years 2023, 2024 and 2025 is presented below.
Number of shares
(in thousands)
Weighted-average,
grant-date
fair value per share
Non-vested as of November 30, 20221,395 $124.69 
Awards granted60 135.01 
Units granted (1)
1,828 74.64 
Performance-based units vested in excess of target (2)
17 159.97 
Awards and units vested(513)122.76 
Awards and units cancelled/forfeited(114)138.88 
Non-vested as of November 30, 20232,673 92.80 
Units granted (1)
2,824 52.94 
Awards and units vested(849)92.02 
Awards and units cancelled/forfeited(337)84.94 
Non-vested as of November 30, 20244,311 68.35 
Units granted (1)
1,817 47.81 
Awards and units vested(1,374)72.75 
Awards and units cancelled/forfeited(474)68.82 
Non-vested as of November 30, 20254,280 $58.18 
(1)For performance-based restricted stock units, the target number of shares that can be awarded upon full vesting of the grants is included.
(2)Amounts represent performance-based awards that vested in excess of the target number of shares for the fiscal year 2021 performance-based grants.
In January 2025, the Company granted performance-based restricted stock units under the 2020 Plan that will vest, if at all, upon the achievement of certain total shareholder return goals during the three-year period ending January 25, 2028. These performance-based restricted stock units are market condition awards and had a grant date
weighted-average fair value of $41.28 per share, valued using a Monte-Carlo simulation model. Below is a summary of the changes in these awards during fiscal year 2025.
Number of shares
(in thousands)
Weighted-average,
grant-date
fair value per share
Non-vested as of November 30, 2024
— $— 
Units granted
326 41.28 
Units cancelled/forfeited
(21)41.28 
Non-vested as of November 30, 2025
305 $41.28 
In October 2025, the Company granted cash-settled restricted stock units under the Concentrix Stock Incentive Plan. These units will be settled in cash and are accounted for as liability-type awards. The expense is recognized over the requisite service period with remeasurement at the end of each reporting period at fair value until settlement. The requisite service period is based on the vesting provisions of the awards which generally occur in three equal annual installments beginning one year after the grant date. Below is a summary of the changes in these units during fiscal year 2025.
Number of shares
(in thousands)
Weighted-average,
grant-date
fair value per share
Non-vested as of November 30, 2024— $— 
Units granted 622 46.93 
Units cancelled/forfeited(2)46.93 
Non-vested as of November 30, 2025
620 $46.93 
As of November 30, 2025, there was $191,887 of total unamortized share-based compensation expense related to non-vested restricted stock awards, restricted stock units and performance-based restricted stock units granted under the Concentrix Stock Incentive Plan. That cost is expected to be recognized over an estimated weighted-average amortization period of 2.14 years.
v3.25.4
BALANCE SHEET COMPONENTS
12 Months Ended
Nov. 30, 2025
Balance Sheet Related Disclosures [Abstract]  
BALANCE SHEET COMPONENTS
NOTE 4—BALANCE SHEET COMPONENTS:
Cash, cash equivalents, cash held for sale and restricted cash:
The following table provides a reconciliation of cash, cash equivalents, cash held for sale and restricted cash reported within the consolidated balance sheets that sum to the total of the same amounts shown in the consolidated statements of cash flows:
As of November 30,
20252024
Cash and cash equivalents$327,347 $240,571 
Cash held for sale
2,057 — 
Restricted cash included in other current assets191,723 189,033 
Cash, cash equivalents, cash held for sale and restricted cash
$521,127 $429,604 
Restricted cash balances relate primarily to funds held for clients, restrictions placed on cash deposits by banks as collateral for the issuance of bank guarantees and the terms of a government grant, and letters of credit for leases. Of the restricted cash balance, $187,139 and $179,949 related to funds held for clients as of November 30, 2025 and 2024, respectively. As of November 30, 2025 and 2024, the Company has a corresponding current liability recorded in other accrued liabilities on the consolidated balance sheet related to these funds.
Accounts receivable, net:
Accounts receivable, net is comprised of the following as of November 30, 2025 and 2024:
As of November 30,
20252024
Billed accounts receivable$1,102,601 $1,080,778 
Unbilled accounts receivable913,863 860,266 
Less: Allowance for credit losses
(17,443)(14,307)
Accounts receivable, net$1,999,021 $1,926,737 
Allowance for credit losses:
Presented below is a progression of the allowance for credit losses:
Fiscal Years Ended November 30,
202520242023
Balance at beginning of period$14,307 $12,533 $4,797 
Net additions
5,738 7,057 10,236 
Write-offs
(2,602)(5,283)(2,500)
Balance at end of period$17,443 $14,307 $12,533 
Property and equipment, net:
The following table summarizes the carrying amounts and related accumulated depreciation for property and equipment as of November 30, 2025 and 2024:
As of November 30,
20252024
Land$28,391 $28,235 
Equipment, computers, and software
969,841 853,558 
Furniture and fixtures172,154 151,477 
Buildings, building improvements, and leasehold improvements
704,074 617,880 
Construction-in-progress39,098 44,566 
Total property and equipment, gross$1,913,558 $1,695,716 
Less: Accumulated depreciation(1,178,008)(981,199)
Property and equipment, net$735,550 $714,517 
Shown below are the countries where 10% or more and other significant concentrations of the Company’s property and equipment, net are located as of November 30, 2025 and 2024:
As of November 30,
20252024
Property and equipment, net:
Philippines$105,475 $82,864 
United States
93,773 118,732 
India
57,585 49,339 
France
56,386 59,645 
Others422,331 403,937 
Total$735,550 $714,517 
Accumulated other comprehensive loss:
The components of accumulated other comprehensive loss (“AOCL”), net of taxes, were as follows:
Unrecognized
gains (losses) on
defined benefit
plan, net
of taxes
Unrealized gains
(losses)
on
hedges, net of
taxes
Foreign currency
translation
adjustment and other,
net of taxes
Total
Balances at November 30, 2023$(11,271)$4,489 $(184,945)$(191,727)
Other comprehensive income (loss) before reclassification5,988 (34,029)(198,204)(226,245)
Reclassification of losses from other comprehensive income (loss)
— 3,659 — 3,659 
Balances at November 30, 2024$(5,283)$(25,881)$(383,149)$(414,313)
Other comprehensive income (loss) before reclassification3,702 (3,578)154,909 155,033 
Reclassification of losses from other comprehensive income (loss)
— 6,818 — 6,818 
Balances at November 30, 2025$(1,581)$(22,641)$(228,240)$(252,462)
Refer to Note 6—Derivative Instruments for the location of gains and losses on cash flow hedges reclassified from other comprehensive income (loss) to the consolidated statements of operations. Reclassifications of amortization of actuarial (gains) losses of defined benefit plans is recorded in “Other expense (income), net” in the consolidated statement of operations.
v3.25.4
GOODWILL AND INTANGIBLE ASSETS
12 Months Ended
Nov. 30, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND INTANGIBLE ASSETS
NOTE 5—GOODWILL AND INTANGIBLE ASSETS:
Goodwill
The Company tests goodwill for impairment annually on the first day of its fourth fiscal quarter and at other times if events have occurred or circumstances exist that indicate the carrying value of goodwill may no longer be recoverable. Goodwill impairment testing is performed at the reporting unit level. Based on the current year assessment, the Company concluded that no impairment charges were necessary for the Company’s reporting unit as of its annual impairment testing date of September 1, 2025. Subsequent to September 1, 2025, the Company experienced a sustained decrease in the market price of its common stock resulting in the market capitalization being significantly less than the carrying value of the reporting unit. After considering all available evidence in the evaluation of goodwill impairment indicators, the Company determined it appropriate to perform an interim quantitative assessment as of November 1, 2025. The quantitative impairment testing performed consisted of the income and market approach and was reconciled to the Company’s market capitalization. The income approach applied a fair value methodology to our reporting unit based on discounted cash flows. This analysis requires significant judgments and assumptions, including estimation of our future cash flows, which is dependent on internally developed forecasts, including future levels of revenue growth, and adjusted earnings before interest, taxes, depreciation, and amortization (“EBITDA”) margin, and determination of a weighted average cost of capital. We also applied a market approach. Under the market approach, we utilized a guideline public company method, which involves calculating valuation multiples based on financial data from comparable publicly traded companies and considerations of recent transactions in the technology industry. Multiples derived from these companies and transactions provide an indication of how much a knowledgeable investor in the marketplace would be willing to pay for a company. These multiples are then applied to the financial data for our reporting unit to arrive at an indication of fair value. The market multiple was applied to adjusted EBITDA.
As a result of the quantitative analysis performed, the carrying value of the Company’s reporting unit exceeded its fair value, resulting in a non-cash goodwill impairment charge of $1,523,266. This charge was recorded within the impairment charges caption of the consolidated statement of operations for the fiscal year ended November 30, 2025. No subsequent impairment indicators were identified. The Company did not have any impairment charges related to goodwill during the fiscal years ended November 30, 2024 or prior.
Below is a progression of goodwill for fiscal years 2025 and 2024:
Fiscal Years Ended November 30,
20252024
Balance at beginning of year$4,986,967 $5,078,668 
Acquisitions17,370 2,000 
Acquisition measurement period adjustments— 60,630 
Assets held for sale(2,570)— 
Impairment charge(1,523,266)— 
Foreign currency translation193,245 (154,331)
Balance at end of year$3,671,746 $4,986,967 

The Company is required to provide additional disclosures about fair value measurements as part of the consolidated financial statements for each major category of assets and liabilities measured at fair value on a non-recurring basis (including impairment assessments). Goodwill was valued using Level 3 inputs, which are unobservable by nature, and included internal estimates of future cash flows (income approach). Significant increases (decreases) in any of those unobservable inputs in isolation would result in a significantly higher (lower) fair value measurement.

Other Intangible Assets
The Company’s other intangible assets, primarily acquired through business combinations, are subject to amortization and are evaluated periodically if events or circumstances indicate a possible inability to recover their carrying amounts. Impairment charges, related to a subsidiary that met held for sale criteria as of November 30, 2025, were not material for the fiscal year end November 30, 2025. There were no impairment charges recorded for the fiscal years ended November 30, 2024 and 2023. As of November 30, 2025 and 2024, the Company’s other intangible assets consisted of the following:
As of November 30, 2025As of November 30, 2024
Gross
amounts
Accumulated
amortization
Net
amounts
Gross
amounts
Accumulated
amortization
Net
amounts
Customer relationships$3,736,591 $(1,822,119)$1,914,472 $3,594,694 $(1,399,588)$2,195,106 
Technology79,603 (64,089)15,514 79,645 (50,119)29,526 
Trade names123,484 (93,132)30,352 113,758 (51,503)62,255 
Non-compete agreements2,200 (2,200)— 2,200 (2,147)53 
$3,941,878 $(1,981,540)$1,960,338 $3,790,297 $(1,503,357)$2,286,940 
Amortization expense for intangible assets was $434,332, $458,925, and $214,832 for the fiscal years ended November 30, 2025, 2024 and 2023, respectively, and the related estimated expense for the five subsequent fiscal years and thereafter is as follows:
Fiscal Years Ending November 30,Amortization Expense
2026$393,559 
2027297,133 
2028251,871 
2029209,650 
2030177,687 
Thereafter630,438 
Total$1,960,338 
The remaining weighted average amortization period for customer relationships and other intangible assets is approximately 12 years.
v3.25.4
DERIVATIVE INSTRUMENTS
12 Months Ended
Nov. 30, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE INSTRUMENTS
NOTE 6—DERIVATIVE INSTRUMENTS:
In the ordinary course of business, the Company is exposed to foreign currency risk and credit risk. The Company enters into transactions, and owns monetary assets and liabilities, that are denominated in currencies other than the legal entity’s functional currency. The Company may enter into forward contracts, option contracts, or other derivative instruments to offset a portion of the risk on expected future cash flows, earnings, net investments in certain non-U.S. legal entities and certain existing assets and liabilities. However, the Company may choose not to hedge certain exposures for a variety of reasons including, but not limited to, accounting considerations and the economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange or interest rates. Generally, the Company does not use derivative instruments to cover equity risk and credit risk. The Company’s hedging program is not used for trading or speculative purposes.
All derivatives are recognized on the consolidated balance sheets at their fair values. Changes in the fair value of derivatives are recorded in the consolidated statements of operations, or as a component of AOCL in the consolidated balance sheets, as discussed below. The cash flow effects of the Company’s cash flow and fair value derivative instruments are reflected in operating activities on the consolidated statements of cash flows.
Cash Flow Hedges
To mitigate the impact on gross margins from fluctuations in foreign currency exchange rates, certain of the Company’s legal entities with functional currencies that are not U.S. dollars may hedge a portion of forecasted revenue or costs not denominated in the entities’ functional currencies. These instruments mature at various dates through November 2027. Gains and losses on cash flow hedges are recorded in AOCL until the hedged item is recognized in earnings. Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of “Revenue” in the same period as the related revenue is recognized, and deferred gains and losses related to cash flow hedges of foreign currency costs are recognized as a component of “Cost of revenue” or “Selling, general and administrative expenses” in the same period as the related costs are recognized. Derivative instruments designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and losses in AOCL associated with such derivative instruments are reclassified into earnings in the period of de-designation. Any subsequent changes in fair value of such derivative instruments are recorded in earnings unless they are re-designated as hedges of other transactions.
Non-Designated Derivatives
The Company uses short-term forward contracts to offset the foreign exchange risk of assets and liabilities denominated in currencies other than the functional currencies of the Company’s legal entities that own the assets or liabilities. These contracts, which are not designated as hedging instruments, mature or settle within twelve months. Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item to which the derivative relates.
Interest rate swaps and cross-currency interest rate swaps
In connection with the closing of the Webhelp Combination, the Company entered into cross-currency swap arrangements with certain financial institutions for a total notional amount of $500,000 of the Company’s senior notes. In addition to aligning the currency of a portion of the Company’s interest payments to the Company’s euro-denominated cash flows, the arrangements, together with intercompany loans and additional intercompany cross-currency interest rate swap arrangements described below, effectively converted $250,000 aggregate principal amount of the Company’s 6.650% Senior Notes due 2026 and $250,000 aggregate principal amount of the Company’s 6.660% Senior Notes due 2028 into synthetic fixed euro-based debt at weighted average interest rates of 5.12% and 5.18%, respectively.
Concurrent with entering into the cross-currency interest rate swaps with certain financial institutions, Marnix SAS, an indirect wholly owned subsidiary of Concentrix, entered into corresponding U.S. dollar denominated intercompany loan agreements with certain other subsidiaries of Concentrix with identical terms and notional
amounts as the underlying $500,000 U.S. dollar denominated senior notes, with reciprocal cross-currency interest rate swaps.
The cross-currency interest rate swaps are designated as fair value hedges.
In September 2025, in connection with the issuance of the delayed draw term loans of total principal of $750,000, the Company entered into an interest rate swap to fix the interest component associated with this debt, creating synthetic fixed-rate debt. Concurrent with entering the interest rate swaps, the Company entered into cross-currency swap arrangements with certain financial institutions for a total notional amount equivalent to $750,000. In addition to aligning the currency of the Company’s interest payments to the Company’s euro-denominated cash flows, the arrangements, together with intercompany loans and additional intercompany cross-currency interest rate swap arrangements, effectively converted the delayed draw term loans into synthetic fixed euro-based debt at weighted average interest rates of 3.43% for the three-year term and 3.69% for the five-year term.
The interest rate swap is designated as a cash flow hedge and the cross-currency swaps are designated as fair value hedges.
Fair Values of Derivative Instruments in the Consolidated Balance Sheets
The fair values of the Company’s derivative instruments are disclosed in Note 7—Fair Value Measurements and summarized in the table below:
Value as of
Balance Sheet Line ItemNovember 30, 2025November 30, 2024
Derivative instruments not designated as hedging instruments:
Foreign exchange forward contracts (notional value)$— $458,482 
Other current assets
— 13,935 
Other accrued liabilities
— 167 
Derivative instruments designated as fair value hedges:
Cross-currency interest rate swaps (notional value)
$1,112,706 $471,604 
Other assets5,343 — 
Other current liabilities and other long-term liabilities
49,319 7,468 
Derivative instruments designated as cash flow hedges:
Interest rate swaps (notional value)
$750,000 $— 
Other long-term liabilities
3,357 — 
Foreign exchange forward contracts (notional value)$1,049,896 $1,049,787 
Other current assets and other assets
914 578 
Other accrued liabilities and other long-term liabilities
21,424 22,155 
Volume of activity
The notional amounts of foreign exchange forward contracts represent the gross amounts of foreign currency, including, principally, the Philippine peso and the Indian rupee, that will be bought or sold at maturity. The notional amounts for outstanding derivative instruments provide one measure of the transaction volume outstanding and do not represent the amount of the Company’s exposure to credit or market loss. The Company’s exposure to credit loss and market risk will vary over time as currency exchange rates change.
The Effect of Derivative Instruments on AOCL and the Consolidated Statements of Operations
The following table shows the location of the gains and losses, before taxes, of the Company’s derivative instruments designated as cash flow hedges, fair value hedges, and not designated as hedging instruments in other comprehensive income (“OCI”), and the consolidated statements of operations for the periods presented:
Fiscal Years Ended November 30,
Locations of gain (loss) in statement of operations
202520242023
Derivative instruments designated as cash flow and fair value hedges:
Gains (losses) recognized in OCI:
Foreign exchange forward contracts
$(8,072)$(38,459)$19,199 
Cross-currency interest rate swaps
5,800 (5,084)(3,651)
Interest rate swaps
(3,357)— — 
Total$(5,629)$(43,543)$15,548 
Gains (losses) reclassified from AOCL into income:
Foreign exchange forward contracts
Gain (loss) reclassified from AOCL into income
Revenue for services
$— $— $222 
Gain (loss) reclassified from AOCL into income
Cost of revenue
(6,484)(4,028)(13,864)
Gain (loss) reclassified from AOCL into income
Selling, general and administrative expenses
(2,656)(861)(4,745)
Total$(9,140)$(4,889)$(18,387)
Derivative instruments not designated as hedging instruments:
Gain (loss) recognized from foreign exchange forward contracts, net(1)
Other expense (income), net
$6,429 $9,940 $(13,007)
Gain (loss) recognized from foreign exchange call options contracts, net
Other expense (income), net— — (14,629)
Total
$6,429 $9,940 $(27,636)
(1)    The gains and losses largely offset the currency gains and losses that resulted from changes in the assets and liabilities denominated in nonfunctional currencies.
There were no material gain or loss amounts excluded from the assessment of effectiveness. Existing net losses in AOCL that are expected to be reclassified into earnings in the normal course of business within the next twelve months are $14,504.
Offsetting of Derivatives
In the consolidated balance sheets, the Company does not offset derivative assets against liabilities in master netting arrangements.
Credit exposure for derivative financial instruments is limited to the amounts, if any, by which the counterparties’ obligations under the contracts exceed the Company’s obligations to the counterparties. The Company manages the potential risk of credit losses by selecting counterparties from a limited group of financial institutions with high credit standing.
v3.25.4
FAIR VALUE MEASUREMENTS
12 Months Ended
Nov. 30, 2025
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS
NOTE 7—FAIR VALUE MEASUREMENTS:
Fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. The authoritative guidance establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are from sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about the factors market participants would use in valuing the asset or liability developed based upon the best information available in the circumstances. The categorization of financial assets and liabilities within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The hierarchy is broken down into three levels:
Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;
Level 2: Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and
Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).
The following table summarizes the valuation of the Company’s investments and financial instruments that are measured at fair value on a recurring basis:
As of November 30, 2025As of November 30, 2024
Fair value measurement categoryFair value measurement category
TotalLevel 1Level 2Level 3TotalLevel 1Level 2Level 3
Assets measured at fair value:
Cash and cash equivalents, including cash held for sale
$329,404 $329,404 $— $— $240,571 $240,571 $— $— 
Restricted cash
191,723 191,723 — — 189,033 189,033 — — 
Forward foreign currency exchange contracts914 — 914 — 14,513 — 14,513 — 
Cross-currency interest rate swaps5,343 — 5,343 — — — — — 
Liabilities measured at fair value:
Forward foreign currency exchange contracts21,424 — 21,424 — 22,322 — 22,322 — 
Cross-currency interest rate swaps
49,319 — 49,319 — 7,468 — 7,468 — 
Interest rate swaps
3,357 — 3,357 — — — — — 
Acquisition contingent consideration
7,866 — — 7,866 13,373 — — 13,373 
Liabilities measured at other than fair value:
Long term debt (senior notes)
Fair value
2,184,727 — 2,184,727 — 2,202,221 — 2,202,221 — 
Carrying amount
2,139,537 — — — 2,135,576 — — — 
The Company’s cash and cash equivalents, including cash held for sale, consist primarily of cash on hand, including bank deposits, money market fund securities, and term deposits with maturity periods of three months or less. The carrying values of cash equivalents approximate fair value since they are near their maturity. Restricted cash balances relate primarily to funds held for clients. The carrying values of restricted cash balances approximate
fair value since they are highly liquid and short-term in nature. The Company does not adjust the quoted market price for such financial instruments. The fair values of forward exchange contracts are measured based on the foreign currency spots, forward rates, and volatility. Fair values of long-term foreign currency exchange contracts are measured using valuations based upon quoted prices for similar assets and liabilities in active markets and are valued by reference to similar financial instruments, adjusted for terms specific to the contracts. The fair values of the cross-currency interest rate swaps are determined using a market approach that is based on observable inputs other than quoted market prices, including contract terms, interest rates, currency rates, and other market factors. The estimated fair value of the acquisition contingent consideration entered into in connection with the Webhelp Combination is determined using a Monte-Carlo simulation model. The inputs include the closing price of Concentrix common stock as of the reporting period end date, Concentrix-specific historical equity volatility, and the risk-free rate. The inputs for this liability are unobservable, and therefore, are classified within Level 3 of the fair value hierarchy. Changes in the fair value of this liability are recorded in other expense (income), net on the consolidated statement of operations.
The effect of nonperformance risk on the fair value of derivative instruments was not material as of November 30, 2025 and 2024.
The carrying values of term deposits with maturities less than one year, accounts receivable and accounts payable approximate fair value due to their short maturities and interest rates that are variable in nature. The carrying values of the outstanding balance on the term loans under the Company’s senior credit facility and the outstanding balance on the Company’s accounts receivable securitization facility (the “Securitization Facility”) approximate their fair values since they bear interest rates that are similar to existing market rates. The fair values of the 2026 Notes, 2028 Notes, and 2033 Notes (as defined in Note 8) are based on quoted prices in active markets and are classified within Level 2 of the fair value hierarchy. The Company does not adjust the quoted market prices for such financial instruments.
During fiscal years 2025, 2024 and 2023, there were no transfers between the fair value measurement category levels.
v3.25.4
BORROWINGS
12 Months Ended
Nov. 30, 2025
Debt Disclosure [Abstract]  
BORROWINGS
NOTE 8—BORROWINGS:
Borrowings consist of the following:
As of November 30,
20252024
Credit Facility - current portion of term loans component$65,625 $— 
Other loans— 2,522 
Current portion of long-term debt$65,625 $2,522 
6.650% Senior Notes due 2026
$800,000 $800,000 
6.600% Senior Notes due 2028
800,000 800,000 
6.850% Senior Notes due 2033
550,000 550,000 
Credit Facility - term loans component1,900,000 1,500,000 
Securitization Facility537,000 371,000 
Sellers’ Note— 740,466 
Other loans— 3,643 
Long-term debt, before unamortized debt discount and issuance costs4,587,000 4,765,109 
Less: unamortized debt discount and issuance costs(14,111)(32,053)
Long-term debt, net$4,572,889 $4,733,056 
Senior Notes
On August 2, 2023, the Company issued and sold (i) $800,000 aggregate principal amount of 6.650% Senior Notes due 2026 (the “2026 Notes”), (ii) $800,000 aggregate principal amount of 6.600% Senior Notes due 2028 (the
“2028 Notes”) and (iii) $550,000 aggregate principal amount of 6.850% Senior Notes due 2033 (the “2033 Notes” and, together with the 2026 Notes and 2028 Notes, the “Senior Notes”). The Senior Notes were sold in a registered public offering pursuant to the Company’s Registration Statement on Form S-3, which became effective upon filing, and a Prospectus Supplement dated July 19, 2023, to a Prospectus dated July 17, 2023.
The Senior Notes were issued pursuant to, and are governed by, an indenture, dated as of August 2, 2023 (the “Base Indenture”), between Concentrix and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”), as supplemented by a first supplemental indenture dated as of August 2, 2023 between Concentrix and the Trustee relating to the 2026 Notes, a second supplemental indenture dated as of August 2, 2023 between Concentrix and the Trustee relating to the 2028 Notes, and a third supplemental indenture dated as of August 2, 2023 between Concentrix and the Trustee relating to the 2033 Notes (such supplemental indentures, together with the Base Indenture, the “Indenture”). The Indenture contains customary covenants and restrictions, including covenants that limit Concentrix Corporation’s and certain of its subsidiaries’ ability to create or incur liens on shares of stock of certain subsidiaries or on principal properties, engage in sale/leaseback transactions or, with respect to Concentrix Corporation, consolidate or merge with, or sell or lease substantially all its assets to, another person. The Indenture also provides for customary events of default.
The principal amount outstanding on the 2026 Notes as of November 30, 2025 was classified as long-term debt within the consolidated balance sheet based on the Company’s ability and intent to refinance on a long-term basis.
Restated Credit Agreement
On April 11, 2025, Concentrix Corporation entered into an Amendment and Restatement Agreement (the “Amendment Agreement”) with the lenders party thereto, Bank of America, N.A., as the administrative agent, the L/C issuer and the swing line lender, and JPMorgan Chase Bank, N.A., as the existing administrative agent, the existing L/C issuer and the existing swing line lender, to amend and restate the Company’s Amended and Restated Credit Agreement dated as of April 21, 2023 (the “Existing Credit Agreement” and, as so amended and restated by the Amendment Agreement, the “Restated Credit Agreement”). The Amendment Agreement appoints Bank of America, N.A. as the Administrative Agent under the Restated Credit Agreement, as successor to JPMorgan Chase Bank, N.A.
The Restated Credit Agreement provides for (i) an unsecured three-year term loan facility in an aggregate principal amount not to exceed $750,000 (the “New Term Loan Facility”), (ii) an unsecured three-year delayed draw term loan facility in an aggregate principal amount not to exceed $250,000 (the “3-Year DD Term Loan Facility”), which was drawn in full in September 2025, (iii) an unsecured five-year delayed draw term loan facility in an aggregate principal amount not to exceed $500,000 (the “5-Year DD Term Loan Facility”, and together with the 3-Year DD Term Loan Facility, the “Delayed Draw Term Loans”), which was drawn in full in September 2025, and (iv) a senior unsecured revolving credit facility not to exceed an aggregate principal amount of $1.1 billion (the “Revolving Credit Facility”). The Restated Credit Agreement also provided for the conversion and continuation of loans in an aggregate principal amount of $750,000 under the Company’s prior unsecured term loan facility into loans under an unsecured term loan facility with the same maturity as such converted and continued loans (the “Continued Term Loan Facility”). Aggregate borrowing capacity under the Restated Credit Agreement may be increased by up to an additional $500,000 by increasing the amount of the revolving credit facility commitments or by incurring additional term loans, in each case subject to the satisfaction of certain conditions set forth in the Restated Credit Agreement, including the receipt of additional commitments for such increase(s).

The maturity date of the New Term Loan Facility and the 3-Year DD Term Loan Facility is September 30, 2028. The maturity date of the 5-Year DD Term Loan Facility and the Revolving Credit Facility is April 11, 2030, subject, in the case of the Revolving Credit Facility, to two one-year extensions upon Concentrix’ prior notice to the lenders and the agreement of the lenders to extend such maturity date. The maturity date of the Continued Term Loan Facility remains December 27, 2026.
The outstanding principal amount of each of the New Term Loan Facility and the Delayed Draw Term Loans is payable in quarterly installments in an amount equal to 1.25% of the existing principal balance of the applicable term loan, commencing on September 30, 2025, in the case of the New Term Loan Facility, and on March 31, 2026,
in the case of the Delayed Draw Term Loans, with the outstanding principal amount of the New Term Loan Facility, the Delayed Draw Term Loans, and the Continued Term Loan Facility due in full on the applicable maturity date.
Borrowings under the Restated Credit Agreement bear interest, in the case of SOFR rate loans, at a per annum rate equal to the applicable SOFR rate (but not less than 0.00%), plus an applicable margin, based on the credit ratings of Concentrix’ senior unsecured non-credit enhanced long-term indebtedness for borrowed money plus a credit spread adjustment to the SOFR rate of 0.10%. The applicable margin ranges from 1.000% to 1.500% for the New Term Loan Facility and the 3-Year DD Term Loan Facility, 1.100% to 1.600% for the 5-Year DD Term Loan Facility, 1.125% to 2.000% for the Continued Term Loan Facility, and 0.875% to 1.500% for the Revolving Credit Facility. Borrowings under the Restated Credit Agreement that are base rate loans bear interest at a per annum rate (but not less than 1.0%) equal to (i) the greatest of (A) the “prime rate” (as defined in the Restated Credit Agreement) in effect on such day, (B) the Federal Funds Rate (as defined in the Restated Credit Agreement) in effect on such day plus 0.500%, and (C) the adjusted one-month term SOFR rate plus 1.0% per annum, plus (ii) an applicable margin, based on the credit ratings of Concentrix’ senior unsecured non-credit enhanced long-term indebtedness for borrowed money. The applicable margin ranges from 0.000% to 0.500% for the New Term Loan Facility, the 3-Year DD Term Loan Facility, and the Revolving Credit Facility, 0.100% to 0.600% for the 5-Year DD Term Loan Facility, and 0.125% to 1.000% for the Continued Term Loan Facility.
The Restated Credit Agreement contains certain loan covenants that are customary for credit facilities of this type and that restrict the ability of Concentrix and its subsidiaries to take certain actions, including the creation of liens, mergers, consolidations or other fundamental changes to the nature of their business, and, solely with respect to subsidiaries of Concentrix, incurrence of indebtedness. In addition, the Restated Credit Agreement contains financial covenants that require Concentrix to maintain at the end of each fiscal quarter, (i) a consolidated leverage ratio (as defined in the Restated Credit Agreement) not to exceed 3.75 to 1.00 (or for certain periods following certain qualified acquisitions, 4.25 to 1.00) and (ii) a consolidated interest coverage ratio (as defined in the Restated Credit Agreement) no less than 3.00 to 1.00. The Restated Credit Agreement also contains various customary events of default, including payment defaults, defaults under certain other indebtedness, and a change of control of Concentrix.
As of November 30, 2025 and 2024, the outstanding principal balance on the Company’s term loans was $1,965,625 and $1,500,000, respectively. During the fiscal year ended November 30, 2025, the Company voluntarily prepaid $275,000 of the principal balance on the Company’s term loans, without penalty. The Company also made a required quarterly principal payment of $9,375 during the fourth quarter of fiscal year 2025.
None of Concentrix’ subsidiaries guarantee the obligations under the Restated Credit Agreement.
As of November 30, 2025 and 2024, no amounts were outstanding under the Company’s revolving credit facility.
Securitization Facility
Under the Securitization Facility, Concentrix Corporation and certain of its U.S. based subsidiaries (the “Originators”) sell or otherwise transfer all of their accounts receivable to a special purpose bankruptcy-remote subsidiary of the Company (the “Borrower”) that grants a security interest in the receivables to the lenders in exchange for available borrowings. On January 14, 2025, the Company entered into an amendment to the Securitization Facility to increase the commitment of the lenders to provide available borrowings from up to $600,000 to up to $700,000 and extend the termination date of the Securitization Facility from April 24, 2026 to January 14, 2027. For borrowings that are funded by certain lenders through the issuance of commercial paper, the amendment also reduced the spread to the applicable commercial paper rate from 0.80% to 0.75%. Other borrowings bear interest at a per annum rate equal to the applicable SOFR rate (subject to a SOFR related adjustment of 0.10%), plus a spread of 0.90%.

The amount received under the Securitization Facility is recorded as debt on the Company’s consolidated balance sheets. Borrowing availability under the Securitization Facility may be limited by the Company’s accounts receivable balances, changes in the credit ratings of the clients comprising the receivables, client concentration
levels in the receivables, and certain characteristics of the accounts receivable being transferred (including factors tracking performance of the accounts receivable over time).

The Securitization Facility contains various affirmative and negative covenants, including a consolidated leverage ratio covenant that is consistent with the Restated Credit Agreement and customary events of default, including payment defaults, defaults under certain other indebtedness, a change in control of Concentrix Corporation, and certain events negatively affecting the overall credit quality of the transferred accounts receivable.
The Borrower’s sole business consists of the purchase or acceptance through capital contributions of the receivables and related security from the Originators and the subsequent retransfer of or granting of a security interest in such receivables and related security to the administrative agent under the Securitization Facility for the benefit of the lenders. The Borrower is a separate legal entity with its own separate creditors who will be entitled, upon its liquidation, to be satisfied out of the Borrower’s assets prior to any assets or value in the Borrower becoming available to the Borrower’s equity holders, and the assets of the Borrower are not available to pay creditors of the Company and its subsidiaries.
Sellers’ Note
On September 25, 2023, as part of the consideration for the Webhelp Combination, Concentrix Corporation issued the Sellers’ Note in the aggregate principal amount of €700,000 to certain Sellers. The stated rate of interest associated with the Sellers’ Note was two percent (2.00%) per annum, which was below the Company’s expected borrowing rate. As a result, the Company discounted the Sellers’ Note by €31,500 using an approximate 4.36% imputed annual interest rate. This discounting resulted in an initial value of €668,500 or $711,830. The discounted value was amortized into interest expense over the two-year term.
On September 25, 2025, the Company used the proceeds of the Delayed Draw Term Loans and cash on hand to repay the principal balance and accrued interest on the Sellers’ Note. The principal amount outstanding on the Sellers’ Note as of November 30, 2024 was classified as long-term debt within the consolidated balance sheet based on the Company’s ability and intent to refinance on a long-term basis.

Covenant compliance
As of November 30, 2025 and 2024, Concentrix was in compliance with all covenants for the above arrangements.
Future principal payments
As of November 30, 2025, future principal payments under the above loans for the subsequent fiscal years are as follows:
Amount
Fiscal Years Ending November 30,
2026 (1)
$865,625 
20271,087,000 
20281,718,750 
202925,000 
2030406,250 
Thereafter550,000 
Total$4,652,625 
v3.25.4
REVENUE
12 Months Ended
Nov. 30, 2025
Revenue from Contract with Customer [Abstract]  
REVENUE
NOTE 9—REVENUE:
Disaggregated revenue
The following table presents the Company’s revenue disaggregated by primary industry verticals:
Fiscal Years Ended November 30,
202520242023
Industry vertical:
Technology and consumer electronics$2,666,072 $2,674,040 $2,205,834 
Retail, travel and e-commerce
2,433,885 2,361,866 1,448,666 
Communications and media1,592,373 1,527,922 1,117,694 
Banking, financial services and insurance1,536,223 1,455,641 1,091,853 
Healthcare725,283 727,389 696,266 
Other871,935 872,042 554,393 
Total$9,825,771 $9,618,900 $7,114,706 
The following table presents the Company’s revenue by geographical locations where the Company’s services are delivered. Shown below are the countries that account for the Company’s revenue for the periods presented:
Fiscal Years Ended November 30,
202520242023
Revenue by geography:
Philippines$1,594,559 $1,596,578 $1,585,878 
India
1,126,061 1,054,460 898,250 
United States
1,051,700 1,110,763 1,304,797 
Great Britain356,490 394,945 205,437 
Germany334,293 388,005 232,729 
Canada302,085 307,590 317,410 
Others5,060,583 4,766,559 2,570,205 
Total$9,825,771 $9,618,900 $7,114,706 
Deferred revenue contract liabilities and deferred costs to obtain or fulfill a contract are not material.
v3.25.4
PENSION AND EMPLOYEE BENEFITS PLANS
12 Months Ended
Nov. 30, 2025
Retirement Benefits [Abstract]  
PENSION AND EMPLOYEE BENEFITS PLANS
NOTE 10—PENSION AND EMPLOYEE BENEFITS PLANS:
The Company has a 401(k) plan in the United States under which eligible employees may contribute up to the maximum amount as provided by law. Employees become eligible to participate in the 401(k) plan on the first day of the month after their employment date. The Company may make discretionary contributions under the plan. Employees in most of the Company’s non-U.S. legal entities are covered by government mandated defined contribution plans. During fiscal years 2025, 2024 and 2023, the Company contributed $127,611, $105,087 and $89,767, respectively, to defined contribution plans.
Defined Benefit Plans
For eligible employees in the United States, the Company maintains a frozen defined benefit pension plan (“the cash balance plan”), which includes both a qualified and non-qualified portion. The pension benefit formula for the cash balance plan is determined by a combination of compensation, age-based credits and annual guaranteed interest credits. The qualified portion of the cash balance plan has been funded through contributions made to a trust fund.
The Company maintains funded or unfunded defined benefit pension or retirement plans for certain eligible employees in the Philippines, Malaysia, India, and France. Benefits under these plans are primarily based on years
of service and compensation during the years immediately preceding retirement or termination of participation in the plans.
The Company’s measurement date for all defined benefit plans and other post-retirement benefits is November 30. The plan assumptions for both the U.S. and non-U.S. defined benefit pension plans are evaluated annually and are updated as deemed necessary. Net benefit costs related to defined benefit plans were $16,565, $16,097 and $11,328, during fiscal years 2025, 2024 and 2023, respectively.
Components of pension cost for the Company’s defined benefit plans are as follows:
Fiscal Years Ended November 30,
202520242023
Service costs$12,289 $9,033 $6,937 
Interest costs on projected benefit obligation10,379 10,893 10,306 
Expected return on plan assets(6,918)(5,295)(6,208)
Amortization and deferrals, net1,696 1,457 98 
Settlement charges— 9 195 
Curtailment gain
(881)— — 
Total pension costs$16,565 $16,097 $11,328 
Service costs are recorded in cost of services and selling, general and administrative expenses while the remaining components of total pension costs are recorded within other expense (income), net in the consolidated statements of operations.
 
The funded status of the Company’s defined benefit plans is summarized below:
Fiscal Years Ended November 30,
20252024
Change in Benefit Obligation:
Benefit obligation at beginning of year$213,865 $208,565 
Service costs
12,289 9,033 
Interest costs
10,379 10,893 
Actuarial losses
584 6,017 
Benefits paid
(20,094)(17,161)
Settlements
— (490)
Curtailments
(1,784)— 
Foreign currency adjustments
(1,284)(2,992)
Projected obligation at end of year$213,955 $213,865 
Change in Plan Assets:
Fair value of plan assets at beginning of year$135,923 $126,752 
Actual return on assets
8,395 17,251 
Settlements
— (83)
Employer contributions
4,058 4,442 
Benefits paid
(14,815)(12,279)
Foreign currency adjustments
(670)(160)
Fair value of plan assets at end of year$132,891 $135,923 
Funded Status of Plans:
Unfunded status$81,064 $77,942 
Amounts recognized in the consolidated balance sheet and recorded within other accrued liabilities and other long-term liabilities as of November 30, 2025 and 2024 consist of the following:
As of November 30,
20252024
Current liability$16,623 $16,694 
Non-current liability64,441 61,248 
Total$81,064 $77,942 
The accumulated benefit obligation for all defined benefit pension plans was $192,950 and $213,461 at November 30, 2025 and 2024, respectively.
The following weighted-average rates were used in determining the benefit obligations as of November 30, 2025 and 2024:
As of November 30,
20252024
Discount rate
3.6% - 6.1%
3.2% - 6.7%
Interest crediting rate for cash balance plan4.0 %4.0 %
Expected rate of future compensation growth
1.5% - 8.0%
2.5% - 7.0%
The following weighted-average rates were used in determining the pension costs for the fiscal years ended November 30, 2025 and 2024:
Fiscal Years Ended November 30,
20252024
Discount rate
3.2% - 6.7%
4.0% - 7.5%
Interest crediting rate for cash balance plan4.0 %4.0 %
Expected return on plan assets
1.0% - 7.0%
3.6% - 7.1%
Expected rate of future compensation growth
2.5% - 7.5%
1.8% - 8.0%
For the cash balance plan, the discount rate reflects the rate at which benefits could effectively be settled and is based on current investment yields of high-quality corporate bonds. The Company uses an actuarially-developed yield curve approach to match the timing of cash flows of expected future benefit payments by applying specific spot rates along the yield curve to determine the assumed discount rate.
The range of discount rates utilized in determining the pension cost and projected benefit obligation of the Company’s defined benefit plans reflects a lower prevalent rate applicable to the frozen cash balance plan for eligible employees in U.S. and a higher applicable rate for the unfunded defined benefit plan for certain eligible employees in the Philippines, France and Malaysia. The plans outside the U.S. represented approximately 42% and 40% of the Company’s total projected benefit obligation for all defined benefit plans as of November 30, 2025 and 2024, respectively.
Plan Assets
As of November 30, 2025 and 2024, plan assets for the cash balance plan consisted of common/collective trusts (of which approximately 26% are invested in equity backed funds and approximately 74% are invested in funds in fixed income instruments) and a private equity fund. The Company’s targeted allocation was 25% equity and 75% fixed income. The investment objectives for the plan assets are to generate returns that will enable the plan to meet its future obligations. The Company’s expected long-term rate of return was determined based on the asset mix of the plan, projected returns, past performance and other factors. The following table sets forth by level within the fair value hierarchy, total plan assets at fair value as of November 30, 2025 and 2024, including the cash balance plan and other funded benefit plans:
InvestmentsAs of November 30, 2025As of Quoted Prices in Active Markets for Identical Assets
(Level 1)
As of Significant Other Observable Inputs (Level 2)As of Significant Unobservable Inputs (Level 3)
Cash and cash equivalents$3,682 $3,682 $— $— 
Common/collective trusts:
Fixed income86,623 — 86,623 — 
U.S. large cap13,642 — 13,642 — 
U.S. small cap3,489 — 3,489 — 
International equity13,825 — 13,825 — 
Governmental bonds6,873 — 6,873 — 
Corporate bonds4,757 — 4,757 — 
Total investments$132,891 $3,682 $129,209 $— 
InvestmentsAs of November 30, 2024As of Quoted Prices in Active Markets for Identical Assets
(Level 1)
As of Significant Other Observable Inputs (Level 2)As of Significant Unobservable Inputs (Level 3)
Cash and cash equivalents$3,606 $3,606 $— $— 
Common/collective trusts:
Fixed income59,928 — 59,928 — 
U.S. large cap25,924 — 25,924 — 
U.S. small cap7,662 — 7,662 — 
International equity27,168 — 27,168 — 
Governmental bonds8,501 — 8,501 — 
Corporate bonds3,134 — 3,134 — 
Total investments$135,923 $3,606 $132,317 $— 
The Company’s cash balance plan holds level 2 investments in common/collective trust funds that are public investment vehicles valued using a net asset value (“NAV”) provided by the manager of each fund. The NAV is based on the underlying net assets owned by the fund, divided by the number of shares outstanding. The NAV’s unit price is quoted on a private market that may not be active. However, the NAV is based on the fair value of the underlying securities within the fund, which are traded on an active market, and valued at the closing price reported on the active market on which those individual securities are traded. The significant investment strategies of the funds are as described in the financial statements provided by each fund. There are no restrictions on redemptions from these funds. Level 3 investments are equity based funds that primarily invest in domestic early stage capital funds.
Benefit Payments
The following table details expected benefit payments for the cash balance plan and other defined benefit plans:
Fiscal Years Ending November 30,
2026$30,790 
202727,236 
202825,420 
202923,419 
203022,260 
Thereafter98,213 
Total$227,338 
The Company expects to make approximately $3,877 in contributions during fiscal year 2026.
v3.25.4
LEASES
12 Months Ended
Nov. 30, 2025
Leases [Abstract]  
LEASES
NOTE 11—LEASES:
The Company leases certain of its facilities and equipment under operating lease agreements, which expire in various periods through 2036. The Company’s finance leases are not material.
The following table presents the various components of operating lease costs:
Fiscal Years Ended November 30,
202520242023
Operating lease cost$323,427 $295,111 $216,774 
Short-term lease cost69,823 89,001 21,802 
Variable lease cost53,709 44,237 58,283 
Sublease income(2,959)(4,492)(5,394)
Total operating lease cost$444,000 $423,857 $291,465 
The following table presents a maturity analysis of expected undiscounted cash flows for operating leases on an annual basis for the next five fiscal years and thereafter as of November 30, 2025:
Fiscal Years Ending November 30,
2026$312,965 
2027251,660 
2028192,770 
2029129,777 
203071,067 
Thereafter86,524 
Total payments1,044,763 
Less: imputed interest*146,580 
Total present value of lease payments$898,183 

*Imputed interest represents the difference between undiscounted cash flows and discounted cash flows.
The following amounts were recorded in the consolidated balance sheets related to the Company’s operating leases:
As of November 30,
Description
Balance Sheet location
20252024
Operating lease ROU assets
Other assets
$857,025 $816,550 
Current operating lease liabilitiesOther accrued liabilities256,739 235,912 
Non-current operating lease liabilitiesOther long-term liabilities641,444 625,888 
The following table presents supplemental cash flow information related to the Company’s operating leases. Cash payments related to variable lease costs and short-term leases are not included in the measurement of operating lease liabilities, and, as such, are excluded from the amounts below:
Fiscal Years Ended November 30,
202520242023
Cash paid for amounts included in the measurement of lease liabilities$345,027 $310,859 $225,142 
Non-cash ROU assets obtained in exchange for lease liabilities264,095 295,894 152,071 
The weighted-average remaining lease term and discount rate as of November 30, 2025 and 2024 were as follows:
As of November 30,
20252024
Weighted-average remaining lease term (years)4.204.50
Weighted-average discount rate6.85 %6.91 %
v3.25.4
INCOME TAXES
12 Months Ended
Nov. 30, 2025
Income Tax Disclosure [Abstract]  
INCOME TAXES
NOTE 12—INCOME TAXES:
The sources of income (loss) before the provision for income taxes are as follows:
Fiscal Years Ended November 30,
202520242023
United States$(775,986)$4,279 $(51,820)
Foreign(406,236)294,995 460,048 
Total income (loss) before income taxes
$(1,182,222)$299,274 $408,228 
Provision for income taxes consists of the following:
Fiscal Years Ended November 30,
202520242023
Current tax provision:
Federal$81,553 $89,987 $78,961 
State28,394 7,734 11,064 
Foreign141,632 185,584 126,072 
$251,579 $283,305 $216,097 
Deferred tax benefit:
Federal$(77,575)$(104,236)$(97,371)
State(9,809)(20,462)(12,850)
Foreign(67,493)(110,550)(11,490)
(154,877)(235,248)(121,711)
Total income tax provision$96,702 $48,057 $94,386 
The following presents the breakdown of net deferred tax liabilities after netting by taxing jurisdiction:
As of November 30,
20252024
Deferred tax assets$317,453 $218,396 
Deferred tax liabilities296,519 312,574 
Total net deferred tax asset (liability)
$20,934 $(94,178)
Net deferred tax liabilities consist of the following:
As of November 30,
20252024
Assets:
Net operating losses
$172,819 $172,182 
Accruals and other reserves
87,492 78,308 
Depreciation and amortization
120,727 107,095 
U.S. interest limitation carry forward
88,219 49,481 
Share-based compensation expense
24,402 17,714 
Deferred revenue
5,764 5,280 
Tax credits
5,516 5,082 
Foreign tax credit
9,610 5,199 
Operating lease liabilities202,480 201,266 
Intercompany loans payable119,678 110,708 
Other
13,548 32,048 
Gross deferred tax assets
850,255 784,363 
Valuation allowance
(147,609)(125,163)
Total deferred tax assets
$702,646 $659,200 
Liabilities:
Intangible assets
$447,819 $529,129 
Unremitted non-US earnings
48,952 42,433 
Operating lease right-of-use assets184,941 181,816 
Total deferred tax liabilities
681,712 753,378 
Net deferred tax asset (liability)
$20,934 $(94,178)
The valuation allowance relates primarily to certain federal, state and foreign net operating loss carry forwards, foreign deferred items and state credits. The Company’s assessment is that it is not more likely than not that these deferred tax assets will be realized.
A reconciliation of the statutory U.S. federal income tax rate to the Company’s effective income tax rate is as follows: 
Fiscal Years Ended November 30,
202520242023
Federal statutory income tax rate21.0 %21.0 %21.0 %
State taxes, net of federal income tax benefit(1.1)%(1.8)%(1.0)%
International rate difference(1.7)%(9.0)%(2.3)%
Withholding taxes(1.6)%3.9 %2.5 %
Uncertain tax benefits0.4 %0.7 %1.3 %
Changes in valuation allowance(1.4)%6.5 %1.7 %
Impact of inclusion of foreign income (1)
(0.1)%0.3 %(4.7)%
Impairment charges
(26.7)%— %— %
Capital loss
— %(12.4)%— %
Other (2)
3.0 %6.9 %4.6 %
Effective income tax rate(8.2)%16.1 %23.1 %
(1)    Represents Subpart F income, Base Erosion and Anti-Abuse Tax (BEAT), and Global Intangible Low-Taxed Income (GILTI) (less Section 250 deduction), net of associated foreign tax credits.
(2)    Includes categories of reconciling items that are not individually equal to or greater than 5% for the fiscal year ended November 30, 2025. Includes the effect of foreign tax rate impact to deferred tax liabilities and costs related to future legal entity restructuring for the fiscal year ended November 30, 2024.
The Company’s U.S. business has sufficient cash flow and liquidity to fund its operating requirements and the Company expects and intends that profits earned outside the United States will be fully utilized and reinvested outside of the United States with the exception of earnings of certain acquired non-U.S. entities. The Company has recorded deferred tax liabilities related to non-U.S. withholding taxes on the earnings of its non-U.S. subsidiaries likely to be repatriated in the future.
As of November 30, 2025, the Company had approximately $3,265,961 of undistributed earnings of its non-U.S. subsidiaries for which it has not provided for non-U.S. withholding taxes and state taxes because such earnings are intended to be reinvested indefinitely in international operations. It is not practicable to determine the amount of applicable taxes that would be due if such earnings were distributed. Accordingly, the Company has not provisioned U.S. state taxes and non-U.S. withholding taxes on the non-U.S. legal entities for which the earnings are permanently reinvested.
As of November 30, 2025, the Company had net operating loss carry forwards of approximately $302,482 and $26,824 for federal and state purposes, respectively. The federal net operating loss carry forward and the state net operating loss carry forwards will begin to expire in the fiscal year ending November 30, 2026. The Company also had approximately $234,062 of foreign net operating loss carry forwards that will also begin to expire in fiscal year ending November 30, 2026 if not used. In addition, the Company has approximately $15,126 of various federal and state income tax credit carry forwards that, if not used, will begin to expire in the fiscal year ending November 30, 2026. Utilization of the acquired loss carry forwards may be limited pursuant to Section 382 of the Internal Revenue Code of 1986.
The Company enjoys tax holidays in certain jurisdictions, primarily Algeria, China, Colombia, Costa Rica, Dominican Republic, El Salvador, Estonia, Guatemala, Honduras, India, Jamaica, Jordan, Latvia, Madagascar, Nicaragua, the Philippines, and Türkiye. The tax holidays provide for lower or zero rates of taxation and require various thresholds of investment and business activities in those jurisdictions. The estimated tax benefits from the above tax holidays for fiscal years 2025, 2024, and 2023 were approximately $12,172, $17,332, and $7,961, respectively.
The aggregate changes in the balances of gross unrecognized tax benefits, excluding accrued interest and penalties, during fiscal years 2025, 2024, and 2023 were as follows:

Balance as of November 30, 2022$70,963 
Additions based on tax positions related to the current year5,819 
Additions based on tax positions related to the prior year / acquisition
6,071 
Lapse of statute of limitations(4,938)
Changes due to translation of foreign currencies
1,407 
Balance as of November 30, 202379,322 
Additions based on tax positions related to the current year11,081 
Additions based on tax positions related to the prior year / acquisition
18,576 
Lapse of statute of limitations(8,071)
Changes due to translation of foreign currencies
(132)
Settlements
(428)
Balance as of November 30, 2024100,348 
Additions based on tax positions related to the current year23,367 
Additions based on tax positions related to the prior year
1,197 
Lapse of statute of limitations(42,095)
Changes due to translation of foreign currencies
(643)
Balance as of November 30, 2025$82,174 
The Company conducts business globally and files income tax returns in various U.S. and non-U.S. jurisdictions. The Company is subject to continuous examination and audits by various tax authorities. Significant audits are underway in the United States and India. The Company is not aware of any material exposures arising from these tax audits or in other jurisdictions not already provided for.
Although timing of the resolution of audits and/or appeals is highly uncertain, the Company believes it is reasonably possible that the total amount of unrecognized tax benefits as of November 30, 2025 could decrease between $10,610 and $14,053 in the next twelve months. The Company is no longer subject to U.S. federal income tax audit for returns covering years through fiscal year 2021. The Company is no longer subject to non-U.S. or U.S. state income tax audits for returns covering years through fiscal year 2008 and fiscal year 2020, respectively.
The liability for unrecognized tax benefits, including interest and penalties, was $95,034 and $112,961 at November 30, 2025 and November 30, 2024, respectively, and is included in other long-term liabilities in the consolidated balance sheets. As of November 30, 2025 and 2024, $88,130 and $60,512 of the total unrecognized tax benefits, net of federal benefit, would affect the effective tax rate, if realized. The Company’s policy is to include interest and penalties related to income taxes, including unrecognized tax benefits, within the provision for income taxes. As of November 30, 2025 and 2024, the Company had accrued $12,860 and $12,613, respectively, in income taxes payable related to accrued interest and penalties.
v3.25.4
COMMITMENTS AND CONTINGENCIES
12 Months Ended
Nov. 30, 2025
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES
NOTE 13—COMMITMENTS AND CONTINGENCIES:
From time to time, the Company receives notices from third parties, including customers and suppliers, seeking indemnification, payment of money, or other actions in connection with claims made against them. Also, from time to time, the Company has been involved in various bankruptcy preference actions where the Company was a supplier to the companies now in bankruptcy. In addition, the Company is subject to various other claims, both asserted and unasserted, that arise in the ordinary course of business. The Company evaluates these claims and records the related liabilities. It is possible that the liabilities ultimately incurred by the Company could differ from the amounts recorded.
The Company does not believe that the above commitments and contingencies will have a material adverse effect on the Company’s results of operations, financial position or cash flows.
v3.25.4
EARNINGS PER SHARE
12 Months Ended
Nov. 30, 2025
Earnings Per Share [Abstract]  
EARNINGS PER SHARE
NOTE 14—EARNINGS (LOSS) PER SHARE:
Basic and diluted earnings (loss) per common share (“EPS”) are computed using the two-class method, which is an earnings allocation formula that determines EPS for each class of common stock and participating security.
Fiscal Years Ended November 30,
202520242023
Basic earnings (loss) per common share:
Net income (loss)$(1,278,924)$251,217 $313,842 
Less: net income allocated to participating securities(1)
(4,103)(9,504)(6,001)
Net income (loss) attributable to common stockholders$(1,283,027)$241,713 $307,841 
Weighted-average number of common shares - basic63,012 64,977 53,801 
Basic earnings (loss) per common share$(20.36)$3.72 $5.72 
Diluted earnings (loss) per common share:
Net income (loss)$(1,278,924)$251,217 $313,842 
Less: net income allocated to participating securities(1)
(4,103)(9,490)(5,978)
Net income (loss) attributable to common stockholders$(1,283,027)$241,727 $307,864 
Weighted-average number of common shares - basic63,012 64,977 53,801 
Effect of dilutive securities:
Stock options and certain restricted stock units(2)
— 97 209 
Weighted-average number of common shares - diluted63,012 65,074 54,010 
Diluted earnings (loss) per common share$(20.36)$3.71 $5.70 
(1)    Restricted stock awards and certain restricted stock units granted to employees by the Company are considered participating securities. For the fiscal year ended November 30, 2025, participating securities did not participate in net losses prior to dividends. As a result, the allocation in fiscal 2025 represents dividends paid to participating securities.
(2)    As a result of the Company’s net loss for the fiscal year ended November 30, 2025, the effect of stock options and other certain restricted stock units awards would be antidilutive. As a result, they have been excluded from the diluted EPS calculation for the fiscal year ended November 30, 2025.
v3.25.4
STOCKHOLDERS’ EQUITY
12 Months Ended
Nov. 30, 2025
Equity [Abstract]  
STOCKHOLDERS’ EQUITY
NOTE 15—STOCKHOLDERS’ EQUITY:
Share repurchase program
In September 2021, the Company’s board of directors authorized the repurchase of up to $500,000 of the outstanding shares of Concentrix common stock from time to time as market and business conditions warrant, including through open market purchases or Rule 10b5-1 trading plans. In January 2025, the Company’s board of directors extended the share repurchase program by authorizing an increase of the amount remaining for share repurchases under the existing share repurchase authorization to $600,000. The repurchase program has no termination date and may be suspended or discontinued at any time.
During the fiscal years ended November 30, 2025 and 2024 under the share repurchase program, the Company repurchased 3,557 and 2,201 shares, respectively, of its common stock for an aggregate purchase price of $168,708 and $136,096, respectively. The share repurchases were made on the open market and the shares repurchased by the Company are held in treasury for general corporate purposes. At November 30, 2025, approximately $439,468 remained available for share repurchases under the existing authorization from the Company’s board of directors.
During December 2025, the Company repurchased 256 shares of Concentrix common stock under the repurchase program for an aggregate purchase price of $9,911.

Dividends
During fiscal years 2025 and 2024, the Company paid the following dividends per share approved by the Company’s board of directors:
Announcement DateRecord DatePer Share Dividend AmountPayment Date
January 24, 2024February 5, 2024$0.3025February 15, 2024
March 26, 2024April 26, 2024$0.3025May 7, 2024
June 26, 2024July 26, 2024$0.3025August 6, 2024
September 25, 2024October 25, 2024$0.33275November 5, 2024
January 15, 2025January 31, 2025$0.33275February 11, 2025
March 26, 2025April 25, 2025$0.33275May 6, 2025
June 26, 2025July 25, 2025$0.33275August 5, 2025
September 25, 2025October 24, 2025$0.36November 4, 2025
On January 13, 2026, the Company announced a cash dividend of $0.36 per share to stockholders of record as of January 30, 2026, payable on February 10, 2026.
v3.25.4
Segment Reporting
12 Months Ended
Nov. 30, 2025
Segment Reporting [Abstract]  
Segment Reporting Disclosure
NOTE 16—SEGMENT REPORTING:
The Company operates as one operating segment. The Company's CODM is its President and Chief Executive Officer, who reviews financial information presented on a consolidated basis. The CODM uses consolidated net income (loss) and operating income (loss) to assess financial performance, allocate resources, and make key operating decisions. The following table presents selected financial information, including significant segment expenses, with respect to the Company’s single operating segment for the fiscal years ended November 30, 2025, 2024 and 2023:
Fiscal Years Ended November 30,
202520242023
Revenue$9,825,771 $9,618,900 $7,114,706 
Cost of revenue (1)
6,359,357 6,150,666 4,535,003 
Selling, general and administrative expenses (2)
1,997,095 1,913,309 1,397,914 
Acquisition-related, integration and restructuring expenses
101,468 156,771 69,674 
Share-based compensation expense97,875 95,922 62,493 
Amortization of intangible assets434,332 458,925 214,832 
Impairment charges1,527,726 — — 
Depreciation expense226,101 246,920 173,463 
Operating income (loss)
(918,183)596,387 661,327 
Interest expense and finance charges, net
290,349 321,828 201,004 
Other expense (income), net
(26,310)(24,715)52,095 
Provision for income taxes
96,702 48,057 94,386 
Net income (loss)
$(1,278,924)$251,217 $313,842 
(1) Exclusive of depreciation expense and acquisition-related, integration and restructuring expenses.
(2) Exclusive of depreciation expense, amortization of intangible assets, acquisition-related, integration and restructuring expenses, and share-based compensation expense.
For fiscal years 2025 and 2024, acquisition-related, integration and restructuring expenses, primarily included integration costs associated with our combination with Webhelp and restructuring expenses. These costs primarily included severance and employee-related costs, costs associated with facilities consolidation, including lease terminations to integrate the businesses, and information technology system consolidation costs. For fiscal year 2023, acquisition-related, integration and restructuring expenses primarily consisted of acquisition-related and integration costs associated with our combination with Webhelp, including legal and professional services.
v3.25.4
SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS
12 Months Ended
Nov. 30, 2025
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS
SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS
For the Fiscal Years Ended November 30, 2025, 2024 and 2023
(in thousands)
Additions/Deductions
Balances at
Beginning of
Fiscal Year
Charged to Revenue
and Expense, net
Additions
from
Acquisitions
Reclassifications
and
Write-offs
Balances at
End of
Fiscal Year
Fiscal Year Ended November 30, 2025
Allowance for deferred tax assets$125,163 $19,084 $— $3,362 $147,609 
Fiscal Year Ended November 30, 2024
Allowance for deferred tax assets$117,679 $40,340 $— $(32,856)$125,163 
Fiscal Year Ended November 30, 2023
Allowance for deferred tax assets$103,169 $4,823 $11,760 $(2,073)$117,679 
v3.25.4
Insider Trading Arrangements
12 Months Ended
Nov. 30, 2025
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.25.4
Insider Trading Policies and Procedures
12 Months Ended
Nov. 30, 2025
Insider Trading Policies and Procedures [Line Items]  
Insider Trading Policies and Procedures Adopted true
v3.25.4
Cybersecurity Risk Management and Strategy Disclosure
12 Months Ended
Nov. 30, 2025
Cybersecurity Risk Management, Strategy, and Governance [Line Items]  
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
As a global technology and services leader, our business is heavily dependent upon information technology networks and systems. Protecting our systems, data, and information, as well as the information and data of our game-changers, clients, and partners, is a key priority.
We have established and maintain a corporate-wide information security management system and an integrated risk management framework with practices that are derived from industry standards, including ISO 31000, ISO 27001, HITRUST, PCI DSS, and the National Institute of Standards and Technology (“NIST”) Cybersecurity Framework, and data privacy regulations, including the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) and the General Data Protection Regulation (“GDPR”). The data security controls from these standards
and regulations are evaluated as a component of our risk management framework, based on the needs of our business and our clients, the nature of our industry, and applicable regulations.
We are one of the few companies globally recognized for our AI governance, privacy and security standards by receiving the ISO/IIEC 42001:2023 Artificial Intelligence Management System certification for our iX suite of products, together with meeting the ISO 31700:2023 Privacy by Design and HITRUST AI requirements.
Risk Management and Strategy
We have implemented and maintain an Information Security Management System (“ISMS”) that covers information security, data protection, cybersecurity, application security, and other areas as necessary. As a part of our ISMS, we:
•evaluate our security risk strategy on an ongoing basis to facilitate our response to the changing cybersecurity threat landscape and build a culture of security within Concentrix;
•allocate and evaluate available resources, including technology, infrastructure, and personnel, to support information security initiatives;
•regularly identify security risks and prepare and continuously update mitigation and response plans, including with respect to risks related to the use of our third party service providers;
•report, investigate, and respond to suspected or confirmed information security risks; and
•maintain a business continuity management process to counter potential interruptions to business activities and a data privacy program to protect personal and sensitive information.
We regularly evaluate the ISMS for compliance with applicable regulatory, legislative, and contractual requirements, as well as recent trends and developments in security.
Our management team gathers information to support our efforts to prevent, detect, mitigate, and remediate cybersecurity risks and incidents from various sources, including reports from internal security personnel, threat intelligence, and other information obtained from governmental, public, or private sources, including external consultants engaged by us, and alerts and reports produced by the information security tools we utilize. Our Cyber Defense Operations Center (the “CDOC”) is a security operations center that operates 24 hours a day, seven days a week and is our first line of defense against cybersecurity threats. The CDOC continually monitors our information technology security infrastructure for anomalous behavior and other indications of potential threats to protect our data and systems.
We regularly conduct internal and external audits, reviews, assessments, and evaluations to evaluate our compliance posture and the effectiveness of our physical, technical, and organizational measures for protecting us and our systems. Elements of our cybersecurity program are also periodically audited as part of external certification audits. Third-party managed security providers and cybersecurity experts provide us with 24x7 monitoring, threat hunting, risk assessments, penetration testing, and attack surface management to support our Cyber Security Framework. Key findings from cybersecurity audits and third-party risk assessments are summarized and communicated to our senior leadership and the Audit Committee, and remediation actions are implemented to enhance our overall cybersecurity program. We contractually require our vendors to comply with cybersecurity and data privacy requirements, and we perform risk assessments of vendors, including their ability to protect data from unauthorized access.
To facilitate the success of our risk management framework, multidisciplinary teams throughout the Company, including members of the legal department, operations, and senior management, are deployed to support risk mitigation and our response to threats and potential cybersecurity incidents. We also regularly conduct training and education to upgrade our game-changers’ knowledge of security risks and vulnerabilities. In fiscal year 2025, our game-changers completed mandatory security awareness training resulting in a company-wide pass percentage of approximately 95%. In March 2025, we held a Cyber Fraud Awareness Month, which promoted best practices and vigilance in protecting information and data to prevent cyber-attacks, and educated game-changers on how to identify sophisticated social engineering attacks, and report phishing or suspicious messages through our dedicated reporting channel.
We are currently not aware of any cybersecurity incidents or threats that have materially impacted us or our business, financial condition, and results of operations. However, we and our clients routinely face risks of cybersecurity incidents, and there can be no assurance that our security efforts and measures, and those of our third-party providers, will prevent or mitigate a cybersecurity threat or incident that could adversely affect our business. For a discussion of these risks and others that we face, see “Risk Factors” in this Annual Report on Form 10-K.
Cybersecurity Risk Management Processes Integrated [Flag] true
Cybersecurity Risk Management Processes Integrated [Text Block]
We have established and maintain a corporate-wide information security management system and an integrated risk management framework with practices that are derived from industry standards, including ISO 31000, ISO 27001, HITRUST, PCI DSS, and the National Institute of Standards and Technology (“NIST”) Cybersecurity Framework, and data privacy regulations, including the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) and the General Data Protection Regulation (“GDPR”). The data security controls from these standards
and regulations are evaluated as a component of our risk management framework, based on the needs of our business and our clients, the nature of our industry, and applicable regulations.
We are one of the few companies globally recognized for our AI governance, privacy and security standards by receiving the ISO/IIEC 42001:2023 Artificial Intelligence Management System certification for our iX suite of products, together with meeting the ISO 31700:2023 Privacy by Design and HITRUST AI requirements.
Cybersecurity Risk Management Third Party Engaged [Flag] true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] false
Cybersecurity Risk Board of Directors Oversight [Text Block]
Our board of directors, directly and indirectly through its committees, has oversight responsibility for our risk management process, including risks related to cybersecurity and artificial intelligence. Our board of directors has delegated to the Audit Committee oversight responsibility for the Company’s risk assessment and management activities, including with respect to information technology, cybersecurity, and privacy.
As part of our integrated enterprise risk management program, management reports periodically to the Audit Committee on its assessment of our risks and risk management practices, including with respect to ongoing or new cyber and information security risks. Management also reports quarterly to the Audit Committee and annually to the full board of directors on the status of our cybersecurity program, which includes key cybersecurity controls, audits, and compliance, and on any significant projects or areas of focus for the cybersecurity team.
Our cybersecurity risk management framework is implemented by our global security team, which is led by our EVP, Information Technology and Global Security, our SVP, Information Systems and Global Security, and our GVP, Governance, Risk, and Compliance. As the leaders of our global security efforts, these roles and their teams support the establishment and maintenance of our corporate-wide information security program to protect our information assets and to oversee our cybersecurity and insider risk and compliance teams. Our SVP, Information Systems and Global Security, and our GVP, Governance, Risk, and Compliance report to our EVP, Information Technology and Global Security, and our EVP, Information Technology and Global Security reports to our Chief Executive Officer.
Our EVP, Information Technology and Global Security has over 40 years of global information technology leadership experience, including hands-on management and technology innovation experience. He provides strategic direction for the design, implementation strategy, and Governance of Concentrix Global Infrastructure, Information Security and Application development. Our SVP, Information Systems and Global Security has an undergraduate degree in Information Technology and over 25 years of global experience in cybersecurity strategy and risk management in various leadership roles at large companies and within government, with extensive experience in the development of and enforcement of security policies, protection of sensitive data, responding to cyber and fraud incidents, and integrating security across operations. Our SVP, IT Infrastructure has over 30 years of experience in managing a large, geographically dispersed team that designs, plans, implements, and maintains a complex IT infrastructure and operations. He has also played a critical role in the development of security technologies at Concentrix. Our GVP, Governance, Risk, and Compliance has over 23 years of global experience in information security with specialization in risk management, security tools and technologies, compliance, and privacy. His experience in information security spans advisory and consulting, policy, processes and standards, engineering, and operational support for clients and the internal organization.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Our board of directors has delegated to the Audit Committee oversight responsibility for the Company’s risk assessment and management activities, including with respect to information technology, cybersecurity, and privacy.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] As part of our integrated enterprise risk management program, management reports periodically to the Audit Committee on its assessment of our risks and risk management practices, including with respect to ongoing or new cyber and information security risks. Management also reports quarterly to the Audit Committee and annually to the full board of directors on the status of our cybersecurity program, which includes key cybersecurity controls, audits, and compliance, and on any significant projects or areas of focus for the cybersecurity team.
Cybersecurity Risk Role of Management [Text Block]
As part of our integrated enterprise risk management program, management reports periodically to the Audit Committee on its assessment of our risks and risk management practices, including with respect to ongoing or new cyber and information security risks. Management also reports quarterly to the Audit Committee and annually to the full board of directors on the status of our cybersecurity program, which includes key cybersecurity controls, audits, and compliance, and on any significant projects or areas of focus for the cybersecurity team.
Our cybersecurity risk management framework is implemented by our global security team, which is led by our EVP, Information Technology and Global Security, our SVP, Information Systems and Global Security, and our GVP, Governance, Risk, and Compliance. As the leaders of our global security efforts, these roles and their teams support the establishment and maintenance of our corporate-wide information security program to protect our information assets and to oversee our cybersecurity and insider risk and compliance teams. Our SVP, Information Systems and Global Security, and our GVP, Governance, Risk, and Compliance report to our EVP, Information Technology and Global Security, and our EVP, Information Technology and Global Security reports to our Chief Executive Officer.
Cybersecurity Risk Management Positions or Committees Responsible [Flag] true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block] Our board of directors, directly and indirectly through its committees, has oversight responsibility for our risk management process, including risks related to cybersecurity and artificial intelligence. Our board of directors has delegated to the Audit Committee oversight responsibility for the Company’s risk assessment and management activities, including with respect to information technology, cybersecurity, and privacy.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]
Our EVP, Information Technology and Global Security has over 40 years of global information technology leadership experience, including hands-on management and technology innovation experience. He provides strategic direction for the design, implementation strategy, and Governance of Concentrix Global Infrastructure, Information Security and Application development. Our SVP, Information Systems and Global Security has an undergraduate degree in Information Technology and over 25 years of global experience in cybersecurity strategy and risk management in various leadership roles at large companies and within government, with extensive experience in the development of and enforcement of security policies, protection of sensitive data, responding to cyber and fraud incidents, and integrating security across operations. Our SVP, IT Infrastructure has over 30 years of experience in managing a large, geographically dispersed team that designs, plans, implements, and maintains a complex IT infrastructure and operations. He has also played a critical role in the development of security technologies at Concentrix. Our GVP, Governance, Risk, and Compliance has over 23 years of global experience in information security with specialization in risk management, security tools and technologies, compliance, and privacy. His experience in information security spans advisory and consulting, policy, processes and standards, engineering, and operational support for clients and the internal organization.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] As part of our integrated enterprise risk management program, management reports periodically to the Audit Committee on its assessment of our risks and risk management practices, including with respect to ongoing or new cyber and information security risks. Management also reports quarterly to the Audit Committee and annually to the full board of directors on the status of our cybersecurity program, which includes key cybersecurity controls, audits, and compliance, and on any significant projects or areas of focus for the cybersecurity team.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] true
v3.25.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
12 Months Ended
Nov. 30, 2025
Accounting Policies [Abstract]  
Basis of presentation (including principles of consolidation)
Basis of presentation (including principles of consolidation)
The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and include the accounts of the Company, its majority-owned subsidiaries and entities over which the Company has control. All intercompany balances and transactions have been eliminated in consolidation.
Use of estimates
Use of estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expense during the reporting period. The Company evaluates these estimates on a regular basis and bases them on historical experience and on various assumptions that the Company believes are reasonable. Actual results could differ from the estimates.
Segment reporting
Segment reporting
Concentrix’ operations are based on an integrated global delivery model whereby services under a client contract in one location may be provided from delivery centers located in one or more different countries, with a significant portion of the Company’s workforce located in the Philippines and India. Given the homogeneity of end-to-end solutions and technology and the integrated delivery model, the Company operates in a single operating segment, based on how the chief operating decision maker (“CODM”) views and evaluates the Company’s operations in making operational and strategic decisions and assessments of financial performance (including for purposes of allocating resources and assessing performance). The Company’s President and Chief Executive Officer has been identified as the CODM.
Cash equivalents
Cash equivalents
The Company considers all highly liquid debt instruments purchased with an original maturity or remaining maturity at the date of purchase of three months or less to be cash equivalents. Cash equivalents consist principally of money market deposit accounts that are stated at cost, which approximates fair value. The Company is exposed to
credit risk in the event of default by financial institutions to the extent that cash balances with financial institutions are in excess of amounts that are insured.
Accounts receivable and allowance for doubtful accounts
Accounts receivable and allowance for credit losses
Accounts receivable are comprised primarily of amounts owed to the Company by clients and are presented net of an allowance for credit losses. The allowance for credit losses is an estimate to cover the losses resulting from uncertainty regarding collections from customers to make payments for outstanding balances. In estimating the required allowance, the Company considers the overall quality and aging of the accounts receivable and credit evaluations of its clients’ financial condition. The Company also evaluates the collectability of accounts receivable based on specific client circumstances, current economic trends, historical experience with collections and the value and adequacy of any collateral received from clients.
Unbilled receivables
Unbilled receivables
For the majority of service contracts, the Company performs the services prior to billing the client, and this amount is captured as an unbilled receivable included in accounts receivable, net on the consolidated balance sheet. Billing usually occurs in the month after the Company performs the services or in accordance with the specific contractual provisions.
Derivative financial instruments
Derivative financial instruments
The Company accounts for its derivative instruments as either assets or liabilities and carries them at fair value.
For derivative instruments that hedge the exposure to variability in expected future cash flows that are designated as cash flow hedges, the gain or loss on the derivative instrument is reported as a component of “Accumulated other comprehensive income (loss),” in stockholders’ equity and reclassified into earnings in the same line associated with the forecasted transactions, in the same period or periods during which the hedged transaction affects earnings. To receive hedge accounting treatment, cash flow hedges must be highly effective in offsetting changes to expected future cash flows on hedged transactions.
For derivative instruments that are not designated as cash flow hedges, gains and losses on derivative instruments are reported in the consolidated statements of operations in the current period.
Software costs
Software costs
The Company develops software platforms for internal use. The Company capitalizes costs incurred to develop software subsequent to the software product reaching the application development stage. The Company also
capitalizes the costs incurred to extend the life of existing software, or the cost of significant enhancements that are added to the features of existing software. The capitalized development costs primarily comprise payroll costs and related software costs. Capitalized costs are amortized over the economic life of the software using the straight-line method.
Property and equipment
Property and equipment
Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method based upon the shorter of the estimated useful lives of the assets, or the lease term of the respective assets, if applicable. Maintenance and repairs are charged to expense as incurred, and improvements are capitalized. When assets are retired or otherwise disposed of, the cost and accumulated depreciation and amortization are removed from the accounts and any resulting gain or loss is reflected in operations in the period realized.
Leases
Leases
The Company enters into leases as a lessee for property and equipment in the ordinary course of business. When procuring services, or upon entering into a contract with its clients, the Company determines whether an arrangement contains a lease at its inception. As part of that evaluation, the Company considers whether there is an implicitly or explicitly identified asset in the arrangement and whether the Company, as the lessee, or the client, if the Company is the lessor, has the right to control the use of that asset. When the Company is the lessee, all leases with a term of more than 12 months are recognized as right-of-use (“ROU”) assets and associated lease liabilities in the consolidated balance sheet. Lease liabilities are measured at the lease commencement date and determined using the present value of the lease payments not yet paid, at the Company’s incremental borrowing rate, which approximates the rate at which the Company would borrow on a secured basis in the country where the lease was executed. The interest rate implicit in the lease is generally not determinable in the transactions where the Company is the lessee. The ROU asset equals the lease liability adjusted for any initial direct costs, prepaid rent and lease incentives. The Company’s variable lease payments generally relate to payments tied to various indexes, non-lease components and payments above a contractual minimum fixed amount.
Operating leases are included in other assets, net, other accrued liabilities and other long-term liabilities in the consolidated balance sheet. Substantially all of the Company’s leases are classified as operating leases, and lease expense is recorded on a straight-line basis over the lease term. The Company recognizes options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. The Company made a policy election to not recognize leases with a lease term of 12 months or less in the consolidated balance sheet. Lease expenses are recorded within selling, general, and administrative expenses in the consolidated statements of operations. Operating lease payments are presented within “Cash flows from operating activities” in the consolidated statements of cash flows.
For all asset classes, the Company has elected the lessee practical expedient to combine lease and non-lease components (e.g., maintenance services) and account for the consolidated unit as a single lease component. Variable lease payments are recognized in the periods in which the obligations for those payments are incurred. The Company’s lease agreements do not contain any material residual guarantees or material restrictive covenants.
Goodwill and intangible assets
Goodwill and intangible assets
The Company tests goodwill for impairment annually at the reporting unit level on the first day of the fiscal fourth quarter or more frequently if events or changes in circumstances indicate that it may be impaired. For purposes of the goodwill impairment test, the Company can elect to perform a quantitative or qualitative analysis. If the qualitative analysis is elected, goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less
than its carrying value. The factors that are considered in the qualitative analysis include: macroeconomic conditions; industry and market considerations; cost factors such as increases in labor, or other costs that would have a negative effect on earnings and cash flows; and other relevant entity-specific events and information.
If the Company elects to perform or is required to perform a quantitative analysis, then the reporting unit’s carrying value is compared to its fair value. As part of this analysis, the Company reconciles the fair value of its reporting unit to its market capitalization. Additionally, under a quantitative assessment, the fair value of the Company’s single reporting unit is estimated using an income approach and a market approach with equal weighting. The income approach applies a fair value methodology to the Company’s reporting unit based on a discounted cash flow analysis. A number of significant judgments are involved in the application of the discounted cash flow analysis, including estimation of future cash flows, which is dependent on internally developed forecasts, including future levels of revenue and earnings growth, estimation of the long-term rate of growth for the Company’s business, and determination of a discount rate. The market approach is performed using the guideline public company method which involves calculating valuation multiples based on financial data from comparable publicly traded companies and considerations of recent transactions in the market and industry. Goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value and the excess is recognized as an impairment loss. See Note 5—Goodwill and Intangible Assets for more information.
Intangible assets consist of customer relationships, technology, trade names and non-compete agreements. Amortization is based on the pattern over which the economic benefits of the intangible assets will be consumed or, when the consumption pattern is not apparent, by using the straight-line method over the following useful lives:
Impairment of long-lived assets
Impairment of long-lived assets
The Company reviews the recoverability of its long-lived assets, such as intangible assets subject to amortization, property and equipment and certain other assets, including lease right-of-use assets, when events or changes in circumstances occur that indicate the carrying value of the asset or asset group may not be recoverable. The assessment of possible impairment is based on the Company’s ability to recover the carrying value of the asset or asset group from the expected future pre-tax cash flows, undiscounted and without interest charges, of the related operations. If these cash flows are less than the carrying value of such assets, an impairment loss is recognized for the difference between estimated fair value and carrying value.
Held for sale
In November 2025, the Company entered into a definitive agreement to sell one of its subsidiaries. The Company completed the sale in December 2025. The Company appropriately classified assets and liabilities related to the subsidiary as current assets and liabilities held for sale on its consolidated balance sheet as of November 30, 2025. The assets and liabilities and related transaction were not material. The loss on the sale was not material.
Concentration of credit risk
Concentration of credit risk
Financial instruments that potentially subject the Company to significant concentration of credit risk consist principally of cash and cash equivalents, accounts receivable and derivative instruments.
The Company’s cash and cash equivalents and derivative instruments are transacted and maintained with financial institutions with high credit standing, and their compositions and maturities are regularly monitored by management. Through November 30, 2025, the Company has not experienced any credit losses on such deposits and derivative instruments.
Accounts receivable comprise amounts due from clients. The Company performs ongoing credit evaluations of its clients’ financial condition and limits the amount of credit extended when deemed necessary, but generally requires no collateral. The Company also maintains allowances for credit losses. In estimating the required
allowances, the Company takes into consideration the overall quality and aging of its receivable portfolio and specifically identified client risks.
In fiscal years 2025, 2024, and 2023, no client accounted for more than 10% of the Company’s consolidated revenue.
As of November 30, 2025 and 2024, no client comprised more than 10% of the Company’s total accounts receivable balance.
Revenue recognition
Revenue recognition
The Company generates revenue primarily from the provision of integrated, end-to-end solutions and technology, including CX process optimization to its clients. The Company recognizes revenue from services contracts over time as the promised services are delivered to clients for an amount that reflects the consideration to which the Company is entitled in exchange for those services. The Company recognizes revenue over time as the client simultaneously receives and consumes the benefits provided by the Company as the Company performs the services. The Company accounts for a contract with a client when it has written approval, the contract is committed, the rights of the parties, including payment terms, are identified, the contract has commercial substance and consideration is probable of collection. Revenue is presented net of taxes collected from clients and remitted to government authorities. The Company generally invoices a client after performance of services, or in accordance with specific contractual provisions. Payments are due as per contract terms and do not contain a significant financing component.
The Company determines whether the services performed during the initial phases of an arrangement, such as setup activities, are distinct. In most cases, the arrangement is a single performance obligation comprised of a series of distinct services that are substantially the same and that have the same pattern of transfer (i.e., distinct days of service).
Service contracts are most significantly based on a fixed unit-price per transaction or other objective measure of output. Revenue on unit-price transactions is recognized over time using an objective measure of output such as staffing hours or the number of transactions processed by service advisors. Client contract terms can range from less than one year to more than five years.
Certain client contracts include incentive payments from the client upon achieving certain agreed-upon service levels and performance metrics or service level agreements that could result in credits or refunds to the client. Revenue relating to such arrangements is accounted for as variable consideration when the likely amount of revenue to be recognized can be estimated to the extent that it is probable that a significant reversal of any incremental revenue will not occur.
Cost of revenue
Cost of revenue
Recurring direct operating costs for services are recognized as incurred. Cost of services revenue consists primarily of personnel costs and transition and initial set-up costs.
Selling, general and administrative expenses
Selling, general and administrative expenses
Selling, general and administrative expenses are charged to income as incurred. Expenses of promoting and selling products and services are classified as selling expense and include such items as compensation, sales commissions and travel. General and administrative expenses include such items as compensation, cost of delivery centers, legal and professional costs, office supplies, non-income taxes, insurance and utility expenses. In addition, selling, general and administrative expenses include other operating items such as allowances for credit losses, depreciation and amortization of intangible assets.
Advertising
Advertising
Costs related to advertising and service promotion expenditures are charged to “Selling, general and administrative expenses” as incurred. To date, net costs related to advertising and promotion expenditures have not been material.
Income taxes
Income taxes
The asset and liability method is used in accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for the expected tax consequences of temporary differences between the tax bases of assets and liabilities and their reported amounts in the financial statements using enacted tax rates and laws that will be in effect when the difference is expected to reverse. Tax on global low-taxed intangible income is accounted for as a current expense in the period in which the income is includable in a tax return using the “period cost” method. Valuation allowances are provided against deferred tax assets that are not likely to be realized.
The Company recognizes tax benefits from uncertain tax positions only if that tax position is more likely than not to be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. The Company recognizes interest and penalties related to unrecognized tax benefits in the provisions for income taxes.
Foreign currency translations
Foreign currency translations
The functional currencies of the legal entities’ financial statements included in these consolidated financial statements are the local currencies of the legal entities and are translated into United States (“U.S.”) dollars for consolidation as follows: assets and liabilities at the exchange rate as of the balance sheet date, equity at the historical rates of exchange, and income and expense amounts at the average exchange rate for the month. Translation adjustments resulting from the translation of the legal entities’ accounts are included in “Accumulated other comprehensive income (loss).” Transactions denominated in currencies other than the applicable functional currency are converted to the functional currency at the exchange rate on the transaction date. At period end, monetary assets and liabilities are remeasured to the functional currency using exchange rates in effect at the balance sheet date. Non-monetary assets and liabilities are remeasured at historical exchange rates. Gains and losses resulting from foreign currency transactions are included within “Other expense (income), net.”
Other comprehensive income
Other comprehensive income (loss)
The primary components of other comprehensive income (loss) for the Company include foreign currency translation adjustments arising from the Company’s foreign legal entities, unrealized gains and losses on qualifying hedges, and changes in unrecognized pension and post-retirement benefits.
Share-based compensation
Share-based compensation
Share-based compensation cost for stock options, restricted stock awards and restricted stock units is determined based on the fair value at the measurement date. The Company recognizes share-based compensation cost as expense for these awards ratably on a straight-line basis over the requisite service period. Share-based compensation for performance-based restricted stock units is measured based on fair value at the initial measurement date and is adjusted each reporting period, as necessary, to reflect changes in management’s assessment of the probability that performance conditions will be satisfied. The Company recognizes share-based compensation cost associated with its performance-based restricted stock units over the requisite service period if it is probable that the performance conditions will be satisfied. Share-based compensation cost for equity awards that include a market performance condition are determined using a Monte Carlo simulation valuation model and expense is recognized for these awards ratably on a straight-line basis over the requisite service period. The Company accounts for expense reductions that result from the forfeiture of unvested awards in the period that the forfeitures occur.
Pension and post-retirement benefits
Pension and post-retirement benefits
The funded status of the Company’s pension and other post-retirement benefit plans is recognized in the consolidated balance sheets. The funded status is measured as the difference between the fair value of plan assets and the benefit obligation at November 30, the measurement date. For defined benefit pension plans, the benefit obligation is the projected benefit obligation (“PBO”) and, for the other post-retirement benefit plans, the benefit obligation is the accumulated post-retirement benefit obligation (“APBO”). The PBO represents the actuarial present value of benefits expected to be paid upon retirement. For active plans, the present value reflects estimated future compensation levels. The APBO represents the actuarial present value of post-retirement benefits attributed to employee services already rendered. The fair value of plan assets represents the current market value of assets held by an irrevocable trust fund for the sole benefit of participants. The measurement of the benefit obligation is based
on the Company’s estimates and actuarial valuations. These valuations reflect the terms of the plans and use participant-specific information such as compensation, age and years of service, as well as certain key assumptions that require significant judgment, including, but not limited to, estimates of discount rates, expected return on plan assets, inflation, rate of compensation increases, interest crediting rates and mortality rates. The assumptions used are reviewed on an annual basis.
Earnings per common share
Earnings (loss) per common share
Basic and diluted earnings (loss) per common share are calculated using the two-class method. The two-class method is an earnings allocation proportional to the respective ownership among holders of common stock and participating securities. The Company’s restricted stock awards and, effective in the fourth quarter of fiscal year 2023, restricted stock units are considered participating securities because holders have a non-forfeitable right to receive dividends. Basic earnings per common share is computed by dividing net income attributable to the Company’s common stockholders by the weighted-average common shares outstanding during the period. Diluted earnings per common share also considers the dilutive effect of in-the-money stock options and non-participating securities, calculated using the treasury stock method.
Treasury stock
Treasury stock
Repurchases of shares of common stock are accounted for at cost and are included as a component of stockholders’ equity in the consolidated balance sheets.
Accounting pronouncements adopted and recently issued accounting pronouncements not yet adopted
Accounting pronouncements recently issued
In November 2023, the Financial Accounting Standards Board (the “FASB”) issued accounting standards update (“ASU”) 2023-07, which enhances the disclosures required for reportable segments in annual and interim consolidated financial statements. The Company adopted this ASU during the fiscal year ended November 30, 2025. See Note 16—Segment Reporting for more information.
In December 2023, the FASB issued ASU 2023-09, which requires enhanced income tax disclosures, including disaggregation of information in the rate reconciliation table and disaggregated information related to income taxes paid. The amendments in ASU 2023-09 are effective for the Company for the fiscal year ending November 30, 2026. The Company is currently evaluating the impact that this update will have on its disclosures in the consolidated financial statements.
In November 2024, the FASB issued ASU 2024-03, which requires the disaggregation of certain expenses in the notes to the financial statements, to provide enhanced transparency into the expense captions presented on the face of the income statement. ASU 2024-03 is effective for the Company for annual reporting periods beginning with the fiscal year ending November 30, 2028 and for interim periods beginning in fiscal year 2029. Early adoption is permitted. The amendments in this ASU may be applied either prospectively or retrospectively. The Company is currently evaluating the impact that this update will have on its disclosures in the consolidated financial statements.
In September 2025, the FASB issued ASU 2025-06, which amends the guidance in ASC 350-40, Intangibles -Goodwill and Other - Internal-Use Software. The amendments modernize the recognition and disclosure framework for internal-use software costs, removing the previous “development stage” model and introducing a more judgment-based approach. ASU 2025-06 is effective for the Company for annual reporting periods beginning with the fiscal year ending November 30, 2029 and for interim reporting periods beginning in that fiscal year. The Company is currently evaluating the impact that this update will have on the consolidated financial statements.

No other new accounting pronouncements recently adopted or issued had or are expected to have a material impact on the consolidated financial statements.
v3.25.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Nov. 30, 2025
Accounting Policies [Abstract]  
Property, Plant and Equipment Useful Life The ranges of estimated useful lives for property and equipment categories are as follows:
Equipment and furniture
3 - 10 years
Software
3 - 7 years
Leasehold improvements
2 - 15 years
Buildings and building improvements
10 - 39 years
Property and equipment, net:
The following table summarizes the carrying amounts and related accumulated depreciation for property and equipment as of November 30, 2025 and 2024:
As of November 30,
20252024
Land$28,391 $28,235 
Equipment, computers, and software
969,841 853,558 
Furniture and fixtures172,154 151,477 
Buildings, building improvements, and leasehold improvements
704,074 617,880 
Construction-in-progress39,098 44,566 
Total property and equipment, gross$1,913,558 $1,695,716 
Less: Accumulated depreciation(1,178,008)(981,199)
Property and equipment, net$735,550 $714,517 
Shown below are the countries where 10% or more and other significant concentrations of the Company’s property and equipment, net are located as of November 30, 2025 and 2024:
As of November 30,
20252024
Property and equipment, net:
Philippines$105,475 $82,864 
United States
93,773 118,732 
India
57,585 49,339 
France
56,386 59,645 
Others422,331 403,937 
Total$735,550 $714,517 
Schedule of Intangible Assets Useful Life
Customer relationships
10 - 15 years
Technology5 years
Trade names
3 - 5 years
Non-compete agreements3 years
As of November 30, 2025 and 2024, the Company’s other intangible assets consisted of the following:
As of November 30, 2025As of November 30, 2024
Gross
amounts
Accumulated
amortization
Net
amounts
Gross
amounts
Accumulated
amortization
Net
amounts
Customer relationships$3,736,591 $(1,822,119)$1,914,472 $3,594,694 $(1,399,588)$2,195,106 
Technology79,603 (64,089)15,514 79,645 (50,119)29,526 
Trade names123,484 (93,132)30,352 113,758 (51,503)62,255 
Non-compete agreements2,200 (2,200)— 2,200 (2,147)53 
$3,941,878 $(1,981,540)$1,960,338 $3,790,297 $(1,503,357)$2,286,940 
v3.25.4
SHARE-BASED COMPENSATION (Tables)
12 Months Ended
Nov. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Share-based Payment Arrangement, Option, Activity
A summary of the changes in the employee stock options during fiscal years 2023, 2024, and 2025 is presented below.
Options Outstanding
Number of shares
(in thousands)
Weighted-
average exercise
price per share
Balance as of November 30, 2022395$52.60 
Options granted— — 
Options exercised(100)45.50 
Options cancelled
(1)30.70 
Balance as of November 30, 202329454.45 
Options granted— — 
Options exercised(56)42.60
Balance as of November 30, 202423857.21 
Options granted— — 
Options exercised(18)44.58
Options cancelled
(2)55.12
Balance as of November 30, 2025218$58.28 
Schedule of Nonvested Restricted Stock Units Activity
A summary of the changes in the non-vested restricted stock awards, restricted stock units, and performance-based stock units (exclusive of performance-based awards with market conditions as described further below) during fiscal years 2023, 2024 and 2025 is presented below.
Number of shares
(in thousands)
Weighted-average,
grant-date
fair value per share
Non-vested as of November 30, 20221,395 $124.69 
Awards granted60 135.01 
Units granted (1)
1,828 74.64 
Performance-based units vested in excess of target (2)
17 159.97 
Awards and units vested(513)122.76 
Awards and units cancelled/forfeited(114)138.88 
Non-vested as of November 30, 20232,673 92.80 
Units granted (1)
2,824 52.94 
Awards and units vested(849)92.02 
Awards and units cancelled/forfeited(337)84.94 
Non-vested as of November 30, 20244,311 68.35 
Units granted (1)
1,817 47.81 
Awards and units vested(1,374)72.75 
Awards and units cancelled/forfeited(474)68.82 
Non-vested as of November 30, 20254,280 $58.18 
(1)For performance-based restricted stock units, the target number of shares that can be awarded upon full vesting of the grants is included.
(2)Amounts represent performance-based awards that vested in excess of the target number of shares for the fiscal year 2021 performance-based grants.
In January 2025, the Company granted performance-based restricted stock units under the 2020 Plan that will vest, if at all, upon the achievement of certain total shareholder return goals during the three-year period ending January 25, 2028. These performance-based restricted stock units are market condition awards and had a grant date
weighted-average fair value of $41.28 per share, valued using a Monte-Carlo simulation model. Below is a summary of the changes in these awards during fiscal year 2025.
Number of shares
(in thousands)
Weighted-average,
grant-date
fair value per share
Non-vested as of November 30, 2024
— $— 
Units granted
326 41.28 
Units cancelled/forfeited
(21)41.28 
Non-vested as of November 30, 2025
305 $41.28 
In October 2025, the Company granted cash-settled restricted stock units under the Concentrix Stock Incentive Plan. These units will be settled in cash and are accounted for as liability-type awards. The expense is recognized over the requisite service period with remeasurement at the end of each reporting period at fair value until settlement. The requisite service period is based on the vesting provisions of the awards which generally occur in three equal annual installments beginning one year after the grant date. Below is a summary of the changes in these units during fiscal year 2025.
Number of shares
(in thousands)
Weighted-average,
grant-date
fair value per share
Non-vested as of November 30, 2024— $— 
Units granted 622 46.93 
Units cancelled/forfeited(2)46.93 
Non-vested as of November 30, 2025
620 $46.93 
As of November 30, 2025, there was $191,887 of total unamortized share-based compensation expense related to non-vested restricted stock awards, restricted stock units and performance-based restricted stock units granted under the Concentrix Stock Incentive Plan. That cost is expected to be recognized over an estimated weighted-average amortization period of 2.14 years.
v3.25.4
BALANCE SHEET COMPONENTS (Tables)
12 Months Ended
Nov. 30, 2025
Balance Sheet Related Disclosures [Abstract]  
Schedule of Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents, cash held for sale and restricted cash reported within the consolidated balance sheets that sum to the total of the same amounts shown in the consolidated statements of cash flows:
As of November 30,
20252024
Cash and cash equivalents$327,347 $240,571 
Cash held for sale
2,057 — 
Restricted cash included in other current assets191,723 189,033 
Cash, cash equivalents, cash held for sale and restricted cash
$521,127 $429,604 
Schedule of Restricted Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents, cash held for sale and restricted cash reported within the consolidated balance sheets that sum to the total of the same amounts shown in the consolidated statements of cash flows:
As of November 30,
20252024
Cash and cash equivalents$327,347 $240,571 
Cash held for sale
2,057 — 
Restricted cash included in other current assets191,723 189,033 
Cash, cash equivalents, cash held for sale and restricted cash
$521,127 $429,604 
Schedule of Accounts Receivable
Accounts receivable, net:
Accounts receivable, net is comprised of the following as of November 30, 2025 and 2024:
As of November 30,
20252024
Billed accounts receivable$1,102,601 $1,080,778 
Unbilled accounts receivable913,863 860,266 
Less: Allowance for credit losses
(17,443)(14,307)
Accounts receivable, net$1,999,021 $1,926,737 
Schedule of Allowance for Doubtful Trade Receivables
Allowance for credit losses:
Presented below is a progression of the allowance for credit losses:
Fiscal Years Ended November 30,
202520242023
Balance at beginning of period$14,307 $12,533 $4,797 
Net additions
5,738 7,057 10,236 
Write-offs
(2,602)(5,283)(2,500)
Balance at end of period$17,443 $14,307 $12,533 
Property, Plant and Equipment The ranges of estimated useful lives for property and equipment categories are as follows:
Equipment and furniture
3 - 10 years
Software
3 - 7 years
Leasehold improvements
2 - 15 years
Buildings and building improvements
10 - 39 years
Property and equipment, net:
The following table summarizes the carrying amounts and related accumulated depreciation for property and equipment as of November 30, 2025 and 2024:
As of November 30,
20252024
Land$28,391 $28,235 
Equipment, computers, and software
969,841 853,558 
Furniture and fixtures172,154 151,477 
Buildings, building improvements, and leasehold improvements
704,074 617,880 
Construction-in-progress39,098 44,566 
Total property and equipment, gross$1,913,558 $1,695,716 
Less: Accumulated depreciation(1,178,008)(981,199)
Property and equipment, net$735,550 $714,517 
Shown below are the countries where 10% or more and other significant concentrations of the Company’s property and equipment, net are located as of November 30, 2025 and 2024:
As of November 30,
20252024
Property and equipment, net:
Philippines$105,475 $82,864 
United States
93,773 118,732 
India
57,585 49,339 
France
56,386 59,645 
Others422,331 403,937 
Total$735,550 $714,517 
Schedule of Accumulated Other Comprehensive Income (Loss)
The components of accumulated other comprehensive loss (“AOCL”), net of taxes, were as follows:
Unrecognized
gains (losses) on
defined benefit
plan, net
of taxes
Unrealized gains
(losses)
on
hedges, net of
taxes
Foreign currency
translation
adjustment and other,
net of taxes
Total
Balances at November 30, 2023$(11,271)$4,489 $(184,945)$(191,727)
Other comprehensive income (loss) before reclassification5,988 (34,029)(198,204)(226,245)
Reclassification of losses from other comprehensive income (loss)
— 3,659 — 3,659 
Balances at November 30, 2024$(5,283)$(25,881)$(383,149)$(414,313)
Other comprehensive income (loss) before reclassification3,702 (3,578)154,909 155,033 
Reclassification of losses from other comprehensive income (loss)
— 6,818 — 6,818 
Balances at November 30, 2025$(1,581)$(22,641)$(228,240)$(252,462)
v3.25.4
GOODWILL AND INTANGIBLE ASSETS (Tables)
12 Months Ended
Nov. 30, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
Below is a progression of goodwill for fiscal years 2025 and 2024:
Fiscal Years Ended November 30,
20252024
Balance at beginning of year$4,986,967 $5,078,668 
Acquisitions17,370 2,000 
Acquisition measurement period adjustments— 60,630 
Assets held for sale(2,570)— 
Impairment charge(1,523,266)— 
Foreign currency translation193,245 (154,331)
Balance at end of year$3,671,746 $4,986,967 

The Company is required to provide additional disclosures about fair value measurements as part of the consolidated financial statements for each major category of assets and liabilities measured at fair value on a non-recurring basis (including impairment assessments). Goodwill was valued using Level 3 inputs, which are unobservable by nature, and included internal estimates of future cash flows (income approach). Significant increases (decreases) in any of those unobservable inputs in isolation would result in a significantly higher (lower) fair value measurement.
Schedule of Intangible Assets
Customer relationships
10 - 15 years
Technology5 years
Trade names
3 - 5 years
Non-compete agreements3 years
As of November 30, 2025 and 2024, the Company’s other intangible assets consisted of the following:
As of November 30, 2025As of November 30, 2024
Gross
amounts
Accumulated
amortization
Net
amounts
Gross
amounts
Accumulated
amortization
Net
amounts
Customer relationships$3,736,591 $(1,822,119)$1,914,472 $3,594,694 $(1,399,588)$2,195,106 
Technology79,603 (64,089)15,514 79,645 (50,119)29,526 
Trade names123,484 (93,132)30,352 113,758 (51,503)62,255 
Non-compete agreements2,200 (2,200)— 2,200 (2,147)53 
$3,941,878 $(1,981,540)$1,960,338 $3,790,297 $(1,503,357)$2,286,940 
Schedule of Intangible Assets, Future Amortization Expense
Amortization expense for intangible assets was $434,332, $458,925, and $214,832 for the fiscal years ended November 30, 2025, 2024 and 2023, respectively, and the related estimated expense for the five subsequent fiscal years and thereafter is as follows:
Fiscal Years Ending November 30,Amortization Expense
2026$393,559 
2027297,133 
2028251,871 
2029209,650 
2030177,687 
Thereafter630,438 
Total$1,960,338 
v3.25.4
DERIVATIVE INSTRUMENTS (Tables)
12 Months Ended
Nov. 30, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
The fair values of the Company’s derivative instruments are disclosed in Note 7—Fair Value Measurements and summarized in the table below:
Value as of
Balance Sheet Line ItemNovember 30, 2025November 30, 2024
Derivative instruments not designated as hedging instruments:
Foreign exchange forward contracts (notional value)$— $458,482 
Other current assets
— 13,935 
Other accrued liabilities
— 167 
Derivative instruments designated as fair value hedges:
Cross-currency interest rate swaps (notional value)
$1,112,706 $471,604 
Other assets5,343 — 
Other current liabilities and other long-term liabilities
49,319 7,468 
Derivative instruments designated as cash flow hedges:
Interest rate swaps (notional value)
$750,000 $— 
Other long-term liabilities
3,357 — 
Foreign exchange forward contracts (notional value)$1,049,896 $1,049,787 
Other current assets and other assets
914 578 
Other accrued liabilities and other long-term liabilities
21,424 22,155 
Derivative Instruments, Gain (Loss)
The following table shows the location of the gains and losses, before taxes, of the Company’s derivative instruments designated as cash flow hedges, fair value hedges, and not designated as hedging instruments in other comprehensive income (“OCI”), and the consolidated statements of operations for the periods presented:
Fiscal Years Ended November 30,
Locations of gain (loss) in statement of operations
202520242023
Derivative instruments designated as cash flow and fair value hedges:
Gains (losses) recognized in OCI:
Foreign exchange forward contracts
$(8,072)$(38,459)$19,199 
Cross-currency interest rate swaps
5,800 (5,084)(3,651)
Interest rate swaps
(3,357)— — 
Total$(5,629)$(43,543)$15,548 
Gains (losses) reclassified from AOCL into income:
Foreign exchange forward contracts
Gain (loss) reclassified from AOCL into income
Revenue for services
$— $— $222 
Gain (loss) reclassified from AOCL into income
Cost of revenue
(6,484)(4,028)(13,864)
Gain (loss) reclassified from AOCL into income
Selling, general and administrative expenses
(2,656)(861)(4,745)
Total$(9,140)$(4,889)$(18,387)
Derivative instruments not designated as hedging instruments:
Gain (loss) recognized from foreign exchange forward contracts, net(1)
Other expense (income), net
$6,429 $9,940 $(13,007)
Gain (loss) recognized from foreign exchange call options contracts, net
Other expense (income), net— — (14,629)
Total
$6,429 $9,940 $(27,636)
(1)    The gains and losses largely offset the currency gains and losses that resulted from changes in the assets and liabilities denominated in nonfunctional currencies.
v3.25.4
FAIR VALUE MEASUREMENTS (Tables)
12 Months Ended
Nov. 30, 2025
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following table summarizes the valuation of the Company’s investments and financial instruments that are measured at fair value on a recurring basis:
As of November 30, 2025As of November 30, 2024
Fair value measurement categoryFair value measurement category
TotalLevel 1Level 2Level 3TotalLevel 1Level 2Level 3
Assets measured at fair value:
Cash and cash equivalents, including cash held for sale
$329,404 $329,404 $— $— $240,571 $240,571 $— $— 
Restricted cash
191,723 191,723 — — 189,033 189,033 — — 
Forward foreign currency exchange contracts914 — 914 — 14,513 — 14,513 — 
Cross-currency interest rate swaps5,343 — 5,343 — — — — — 
Liabilities measured at fair value:
Forward foreign currency exchange contracts21,424 — 21,424 — 22,322 — 22,322 — 
Cross-currency interest rate swaps
49,319 — 49,319 — 7,468 — 7,468 — 
Interest rate swaps
3,357 — 3,357 — — — — — 
Acquisition contingent consideration
7,866 — — 7,866 13,373 — — 13,373 
Liabilities measured at other than fair value:
Long term debt (senior notes)
Fair value
2,184,727 — 2,184,727 — 2,202,221 — 2,202,221 — 
Carrying amount
2,139,537 — — — 2,135,576 — — — 
v3.25.4
BORROWINGS (Tables)
12 Months Ended
Nov. 30, 2025
Debt Disclosure [Abstract]  
Schedule of Debt
Borrowings consist of the following:
As of November 30,
20252024
Credit Facility - current portion of term loans component$65,625 $— 
Other loans— 2,522 
Current portion of long-term debt$65,625 $2,522 
6.650% Senior Notes due 2026
$800,000 $800,000 
6.600% Senior Notes due 2028
800,000 800,000 
6.850% Senior Notes due 2033
550,000 550,000 
Credit Facility - term loans component1,900,000 1,500,000 
Securitization Facility537,000 371,000 
Sellers’ Note— 740,466 
Other loans— 3,643 
Long-term debt, before unamortized debt discount and issuance costs4,587,000 4,765,109 
Less: unamortized debt discount and issuance costs(14,111)(32,053)
Long-term debt, net$4,572,889 $4,733,056 
Schedule of Maturities of Long-term Debt
As of November 30, 2025, future principal payments under the above loans for the subsequent fiscal years are as follows:
Amount
Fiscal Years Ending November 30,
2026 (1)
$865,625 
20271,087,000 
20281,718,750 
202925,000 
2030406,250 
Thereafter550,000 
Total$4,652,625 
v3.25.4
REVENUE (Tables)
12 Months Ended
Nov. 30, 2025
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
The following table presents the Company’s revenue disaggregated by primary industry verticals:
Fiscal Years Ended November 30,
202520242023
Industry vertical:
Technology and consumer electronics$2,666,072 $2,674,040 $2,205,834 
Retail, travel and e-commerce
2,433,885 2,361,866 1,448,666 
Communications and media1,592,373 1,527,922 1,117,694 
Banking, financial services and insurance1,536,223 1,455,641 1,091,853 
Healthcare725,283 727,389 696,266 
Other871,935 872,042 554,393 
Total$9,825,771 $9,618,900 $7,114,706 
The following table presents the Company’s revenue by geographical locations where the Company’s services are delivered. Shown below are the countries that account for the Company’s revenue for the periods presented:
Fiscal Years Ended November 30,
202520242023
Revenue by geography:
Philippines$1,594,559 $1,596,578 $1,585,878 
India
1,126,061 1,054,460 898,250 
United States
1,051,700 1,110,763 1,304,797 
Great Britain356,490 394,945 205,437 
Germany334,293 388,005 232,729 
Canada302,085 307,590 317,410 
Others5,060,583 4,766,559 2,570,205 
Total$9,825,771 $9,618,900 $7,114,706 
v3.25.4
Compensation Related Costs, Retirement Benefits (Tables)
12 Months Ended
Nov. 30, 2025
Retirement Benefits [Abstract]  
Schedule of Defined Benefit Plans Disclosures
Components of pension cost for the Company’s defined benefit plans are as follows:
Fiscal Years Ended November 30,
202520242023
Service costs$12,289 $9,033 $6,937 
Interest costs on projected benefit obligation10,379 10,893 10,306 
Expected return on plan assets(6,918)(5,295)(6,208)
Amortization and deferrals, net1,696 1,457 98 
Settlement charges— 9 195 
Curtailment gain
(881)— — 
Total pension costs$16,565 $16,097 $11,328 
Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan
The funded status of the Company’s defined benefit plans is summarized below:
Fiscal Years Ended November 30,
20252024
Change in Benefit Obligation:
Benefit obligation at beginning of year$213,865 $208,565 
Service costs
12,289 9,033 
Interest costs
10,379 10,893 
Actuarial losses
584 6,017 
Benefits paid
(20,094)(17,161)
Settlements
— (490)
Curtailments
(1,784)— 
Foreign currency adjustments
(1,284)(2,992)
Projected obligation at end of year$213,955 $213,865 
Change in Plan Assets:
Fair value of plan assets at beginning of year$135,923 $126,752 
Actual return on assets
8,395 17,251 
Settlements
— (83)
Employer contributions
4,058 4,442 
Benefits paid
(14,815)(12,279)
Foreign currency adjustments
(670)(160)
Fair value of plan assets at end of year$132,891 $135,923 
Funded Status of Plans:
Unfunded status$81,064 $77,942 
Schedule of Amounts Recognized in Balance Sheet
Amounts recognized in the consolidated balance sheet and recorded within other accrued liabilities and other long-term liabilities as of November 30, 2025 and 2024 consist of the following:
As of November 30,
20252024
Current liability$16,623 $16,694 
Non-current liability64,441 61,248 
Total$81,064 $77,942 
Schedule Of Defined Benefit Plan Weighted Average Rates Used In Determining Benefit Obligations And Pension Costs
The following weighted-average rates were used in determining the benefit obligations as of November 30, 2025 and 2024:
As of November 30,
20252024
Discount rate
3.6% - 6.1%
3.2% - 6.7%
Interest crediting rate for cash balance plan4.0 %4.0 %
Expected rate of future compensation growth
1.5% - 8.0%
2.5% - 7.0%
The following weighted-average rates were used in determining the pension costs for the fiscal years ended November 30, 2025 and 2024:
Fiscal Years Ended November 30,
20252024
Discount rate
3.2% - 6.7%
4.0% - 7.5%
Interest crediting rate for cash balance plan4.0 %4.0 %
Expected return on plan assets
1.0% - 7.0%
3.6% - 7.1%
Expected rate of future compensation growth
2.5% - 7.5%
1.8% - 8.0%
Schedule of Allocation of Plan Assets The following table sets forth by level within the fair value hierarchy, total plan assets at fair value as of November 30, 2025 and 2024, including the cash balance plan and other funded benefit plans:
InvestmentsAs of November 30, 2025As of Quoted Prices in Active Markets for Identical Assets
(Level 1)
As of Significant Other Observable Inputs (Level 2)As of Significant Unobservable Inputs (Level 3)
Cash and cash equivalents$3,682 $3,682 $— $— 
Common/collective trusts:
Fixed income86,623 — 86,623 — 
U.S. large cap13,642 — 13,642 — 
U.S. small cap3,489 — 3,489 — 
International equity13,825 — 13,825 — 
Governmental bonds6,873 — 6,873 — 
Corporate bonds4,757 — 4,757 — 
Total investments$132,891 $3,682 $129,209 $— 
InvestmentsAs of November 30, 2024As of Quoted Prices in Active Markets for Identical Assets
(Level 1)
As of Significant Other Observable Inputs (Level 2)As of Significant Unobservable Inputs (Level 3)
Cash and cash equivalents$3,606 $3,606 $— $— 
Common/collective trusts:
Fixed income59,928 — 59,928 — 
U.S. large cap25,924 — 25,924 — 
U.S. small cap7,662 — 7,662 — 
International equity27,168 — 27,168 — 
Governmental bonds8,501 — 8,501 — 
Corporate bonds3,134 — 3,134 — 
Total investments$135,923 $3,606 $132,317 $— 
Schedule of Expected Benefit Payments
The following table details expected benefit payments for the cash balance plan and other defined benefit plans:
Fiscal Years Ending November 30,
2026$30,790 
202727,236 
202825,420 
202923,419 
203022,260 
Thereafter98,213 
Total$227,338 
v3.25.4
LEASES (Tables)
12 Months Ended
Nov. 30, 2025
Leases [Abstract]  
Schedule of Lease Cost
The following table presents the various components of operating lease costs:
Fiscal Years Ended November 30,
202520242023
Operating lease cost$323,427 $295,111 $216,774 
Short-term lease cost69,823 89,001 21,802 
Variable lease cost53,709 44,237 58,283 
Sublease income(2,959)(4,492)(5,394)
Total operating lease cost$444,000 $423,857 $291,465 
The weighted-average remaining lease term and discount rate as of November 30, 2025 and 2024 were as follows:
As of November 30,
20252024
Weighted-average remaining lease term (years)4.204.50
Weighted-average discount rate6.85 %6.91 %
Operating Lease Liability Maturity Schedule
The following table presents a maturity analysis of expected undiscounted cash flows for operating leases on an annual basis for the next five fiscal years and thereafter as of November 30, 2025:
Fiscal Years Ending November 30,
2026$312,965 
2027251,660 
2028192,770 
2029129,777 
203071,067 
Thereafter86,524 
Total payments1,044,763 
Less: imputed interest*146,580 
Total present value of lease payments$898,183 

*Imputed interest represents the difference between undiscounted cash flows and discounted cash flows.
Schedule of Amounts Recorded In Consolidated Balance Sheet Related to Operating Leases
The following amounts were recorded in the consolidated balance sheets related to the Company’s operating leases:
As of November 30,
Description
Balance Sheet location
20252024
Operating lease ROU assets
Other assets
$857,025 $816,550 
Current operating lease liabilitiesOther accrued liabilities256,739 235,912 
Non-current operating lease liabilitiesOther long-term liabilities641,444 625,888 
Schedule of Supplemental Cash Flow Information Related to Operating Leases
The following table presents supplemental cash flow information related to the Company’s operating leases. Cash payments related to variable lease costs and short-term leases are not included in the measurement of operating lease liabilities, and, as such, are excluded from the amounts below:
Fiscal Years Ended November 30,
202520242023
Cash paid for amounts included in the measurement of lease liabilities$345,027 $310,859 $225,142 
Non-cash ROU assets obtained in exchange for lease liabilities264,095 295,894 152,071 
v3.25.4
INCOME TAXES (Tables)
12 Months Ended
Nov. 30, 2025
Income Tax Disclosure [Abstract]  
Schedule of Income before Income Tax, Domestic and Foreign
The sources of income (loss) before the provision for income taxes are as follows:
Fiscal Years Ended November 30,
202520242023
United States$(775,986)$4,279 $(51,820)
Foreign(406,236)294,995 460,048 
Total income (loss) before income taxes
$(1,182,222)$299,274 $408,228 
Schedule of Components of Income Tax Expense (Benefit)
Provision for income taxes consists of the following:
Fiscal Years Ended November 30,
202520242023
Current tax provision:
Federal$81,553 $89,987 $78,961 
State28,394 7,734 11,064 
Foreign141,632 185,584 126,072 
$251,579 $283,305 $216,097 
Deferred tax benefit:
Federal$(77,575)$(104,236)$(97,371)
State(9,809)(20,462)(12,850)
Foreign(67,493)(110,550)(11,490)
(154,877)(235,248)(121,711)
Total income tax provision$96,702 $48,057 $94,386 
Schedule of Deferred Tax Assets and Liabilities
The following presents the breakdown of net deferred tax liabilities after netting by taxing jurisdiction:
As of November 30,
20252024
Deferred tax assets$317,453 $218,396 
Deferred tax liabilities296,519 312,574 
Total net deferred tax asset (liability)
$20,934 $(94,178)
Net deferred tax liabilities consist of the following:
As of November 30,
20252024
Assets:
Net operating losses
$172,819 $172,182 
Accruals and other reserves
87,492 78,308 
Depreciation and amortization
120,727 107,095 
U.S. interest limitation carry forward
88,219 49,481 
Share-based compensation expense
24,402 17,714 
Deferred revenue
5,764 5,280 
Tax credits
5,516 5,082 
Foreign tax credit
9,610 5,199 
Operating lease liabilities202,480 201,266 
Intercompany loans payable119,678 110,708 
Other
13,548 32,048 
Gross deferred tax assets
850,255 784,363 
Valuation allowance
(147,609)(125,163)
Total deferred tax assets
$702,646 $659,200 
Liabilities:
Intangible assets
$447,819 $529,129 
Unremitted non-US earnings
48,952 42,433 
Operating lease right-of-use assets184,941 181,816 
Total deferred tax liabilities
681,712 753,378 
Net deferred tax asset (liability)
$20,934 $(94,178)
Schedule of Effective Income Tax Rate Reconciliation
A reconciliation of the statutory U.S. federal income tax rate to the Company’s effective income tax rate is as follows: 
Fiscal Years Ended November 30,
202520242023
Federal statutory income tax rate21.0 %21.0 %21.0 %
State taxes, net of federal income tax benefit(1.1)%(1.8)%(1.0)%
International rate difference(1.7)%(9.0)%(2.3)%
Withholding taxes(1.6)%3.9 %2.5 %
Uncertain tax benefits0.4 %0.7 %1.3 %
Changes in valuation allowance(1.4)%6.5 %1.7 %
Impact of inclusion of foreign income (1)
(0.1)%0.3 %(4.7)%
Impairment charges
(26.7)%— %— %
Capital loss
— %(12.4)%— %
Other (2)
3.0 %6.9 %4.6 %
Effective income tax rate(8.2)%16.1 %23.1 %
(1)    Represents Subpart F income, Base Erosion and Anti-Abuse Tax (BEAT), and Global Intangible Low-Taxed Income (GILTI) (less Section 250 deduction), net of associated foreign tax credits.
(2)    Includes categories of reconciling items that are not individually equal to or greater than 5% for the fiscal year ended November 30, 2025. Includes the effect of foreign tax rate impact to deferred tax liabilities and costs related to future legal entity restructuring for the fiscal year ended November 30, 2024.
Schedule of Unrecognized Tax Benefits Roll Forward
The aggregate changes in the balances of gross unrecognized tax benefits, excluding accrued interest and penalties, during fiscal years 2025, 2024, and 2023 were as follows:

Balance as of November 30, 2022$70,963 
Additions based on tax positions related to the current year5,819 
Additions based on tax positions related to the prior year / acquisition
6,071 
Lapse of statute of limitations(4,938)
Changes due to translation of foreign currencies
1,407 
Balance as of November 30, 202379,322 
Additions based on tax positions related to the current year11,081 
Additions based on tax positions related to the prior year / acquisition
18,576 
Lapse of statute of limitations(8,071)
Changes due to translation of foreign currencies
(132)
Settlements
(428)
Balance as of November 30, 2024100,348 
Additions based on tax positions related to the current year23,367 
Additions based on tax positions related to the prior year
1,197 
Lapse of statute of limitations(42,095)
Changes due to translation of foreign currencies
(643)
Balance as of November 30, 2025$82,174 
v3.25.4
EARNINGS PER SHARE (Tables)
12 Months Ended
Nov. 30, 2025
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share
Fiscal Years Ended November 30,
202520242023
Basic earnings (loss) per common share:
Net income (loss)$(1,278,924)$251,217 $313,842 
Less: net income allocated to participating securities(1)
(4,103)(9,504)(6,001)
Net income (loss) attributable to common stockholders$(1,283,027)$241,713 $307,841 
Weighted-average number of common shares - basic63,012 64,977 53,801 
Basic earnings (loss) per common share$(20.36)$3.72 $5.72 
Diluted earnings (loss) per common share:
Net income (loss)$(1,278,924)$251,217 $313,842 
Less: net income allocated to participating securities(1)
(4,103)(9,490)(5,978)
Net income (loss) attributable to common stockholders$(1,283,027)$241,727 $307,864 
Weighted-average number of common shares - basic63,012 64,977 53,801 
Effect of dilutive securities:
Stock options and certain restricted stock units(2)
— 97 209 
Weighted-average number of common shares - diluted63,012 65,074 54,010 
Diluted earnings (loss) per common share$(20.36)$3.71 $5.70 
(1)    Restricted stock awards and certain restricted stock units granted to employees by the Company are considered participating securities. For the fiscal year ended November 30, 2025, participating securities did not participate in net losses prior to dividends. As a result, the allocation in fiscal 2025 represents dividends paid to participating securities.
(2)    As a result of the Company’s net loss for the fiscal year ended November 30, 2025, the effect of stock options and other certain restricted stock units awards would be antidilutive. As a result, they have been excluded from the diluted EPS calculation for the fiscal year ended November 30, 2025.
v3.25.4
Equity (Tables)
12 Months Ended
Nov. 30, 2025
Equity [Abstract]  
Dividends Declared
During fiscal years 2025 and 2024, the Company paid the following dividends per share approved by the Company’s board of directors:
Announcement DateRecord DatePer Share Dividend AmountPayment Date
January 24, 2024February 5, 2024$0.3025February 15, 2024
March 26, 2024April 26, 2024$0.3025May 7, 2024
June 26, 2024July 26, 2024$0.3025August 6, 2024
September 25, 2024October 25, 2024$0.33275November 5, 2024
January 15, 2025January 31, 2025$0.33275February 11, 2025
March 26, 2025April 25, 2025$0.33275May 6, 2025
June 26, 2025July 25, 2025$0.33275August 5, 2025
September 25, 2025October 24, 2025$0.36November 4, 2025
On January 13, 2026, the Company announced a cash dividend of $0.36 per share to stockholders of record as of January 30, 2026, payable on February 10, 2026.
v3.25.4
Segment Reporting (Tables)
12 Months Ended
Nov. 30, 2025
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment The following table presents selected financial information, including significant segment expenses, with respect to the Company’s single operating segment for the fiscal years ended November 30, 2025, 2024 and 2023:
Fiscal Years Ended November 30,
202520242023
Revenue$9,825,771 $9,618,900 $7,114,706 
Cost of revenue (1)
6,359,357 6,150,666 4,535,003 
Selling, general and administrative expenses (2)
1,997,095 1,913,309 1,397,914 
Acquisition-related, integration and restructuring expenses
101,468 156,771 69,674 
Share-based compensation expense97,875 95,922 62,493 
Amortization of intangible assets434,332 458,925 214,832 
Impairment charges1,527,726 — — 
Depreciation expense226,101 246,920 173,463 
Operating income (loss)
(918,183)596,387 661,327 
Interest expense and finance charges, net
290,349 321,828 201,004 
Other expense (income), net
(26,310)(24,715)52,095 
Provision for income taxes
96,702 48,057 94,386 
Net income (loss)
$(1,278,924)$251,217 $313,842 
(1) Exclusive of depreciation expense and acquisition-related, integration and restructuring expenses.
(2) Exclusive of depreciation expense, amortization of intangible assets, acquisition-related, integration and restructuring expenses, and share-based compensation expense.
v3.25.4
BACKGROUND AND BASIS OF PRESENTATION (Details)
$ in Thousands
12 Months Ended
Sep. 25, 2023
USD ($)
Nov. 30, 2025
USD ($)
market
Nov. 30, 2024
USD ($)
Nov. 30, 2023
USD ($)
Business Combination [Line Items]        
Primary industry verticals | market   5    
Payments to Acquire Businesses, Net of Cash Acquired   $ 15,887 $ 5,504 $ 1,914,079
Webhelp        
Business Combination [Line Items]        
Payments to Acquire Businesses, Net of Cash Acquired $ 3,800,000      
Cash Acquired from Acquisition 500,000      
Cash paid for acquisition $ 2,400,000      
v3.25.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property, Plant and Equipment Useful Life (Details)
Nov. 30, 2025
Equipment and furniture | Minimum  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment useful life 3 years
Equipment and furniture | Maximum  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment useful life 10 years
Software | Minimum  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment useful life 3 years
Software | Maximum  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment useful life 7 years
Leasehold improvements | Minimum  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment useful life 2 years
Leasehold improvements | Maximum  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment useful life 15 years
Buildings, building improvements, and leasehold improvements | Minimum  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment useful life 10 years
Buildings, building improvements, and leasehold improvements | Maximum  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment useful life 39 years
v3.25.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Intangible Assets Useful Life (Details)
Nov. 30, 2025
Technology  
Finite-Lived Intangible Assets [Line Items]  
Intangible assets useful life 5 years
Non-compete Covenants  
Finite-Lived Intangible Assets [Line Items]  
Intangible assets useful life 3 years
Minimum | Customer relationships  
Finite-Lived Intangible Assets [Line Items]  
Intangible assets useful life 10 years
Minimum | Trade names  
Finite-Lived Intangible Assets [Line Items]  
Intangible assets useful life 3 years
Maximum | Customer relationships  
Finite-Lived Intangible Assets [Line Items]  
Intangible assets useful life 15 years
Maximum | Trade names  
Finite-Lived Intangible Assets [Line Items]  
Intangible assets useful life 5 years
v3.25.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) - USD ($)
$ in Thousands
12 Months Ended
Nov. 30, 2025
Nov. 30, 2024
Nov. 30, 2023
Concentration Risk [Line Items]      
Accounts Receivable Factoring, Amounts Sold $ 1,300,000 $ 1,400,000 $ 300,000
Accounts Receivable Factoring, Amount Outstanding $ 119 $ 162  
v3.25.4
SHARE-BASED COMPENSATION - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Apr. 30, 2024
Nov. 30, 2025
Nov. 30, 2024
Oct. 28, 2024
Dec. 31, 2023
Nov. 30, 2023
Dec. 31, 2022
Nov. 30, 2022
Dec. 31, 2021
Nov. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Common stock reserved for issuance (in shares)         664,000   520,000   523,000 4,000,000
Options outstanding (in shares)   218,000 238,000     294,000   395,000    
Weighted average life   3 years 7 days                
Aggregate pre-tax intrinsic value   $ 0                
Amended and Restated 2020 Stock Incentive Plan                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Common stock authorized for issuance (in shares)       3,000,000            
Employee Stock                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Common stock authorized for issuance (in shares)                   1,000,000
Term period   10 years                
Vesting period   5 years                
Restricted Stock Awards, Restricted Stock Units and Performance-Based Restricted Stock Units                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Unamortized share-based compensation expense   $ 191,887                
Estimated weighted-average amortization period   2 years 1 month 20 days                
Restricted Stock Awards, Restricted Stock Units and Performance-Based Restricted Stock Units | Minimum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Vesting period   3 years                
Restricted Stock Awards, Restricted Stock Units and Performance-Based Restricted Stock Units | Maximum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Vesting period   4 years                
Performance-based Restricted Stock Units                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage   12.00%                
Performance-based Restricted Stock Units | Amended and Restated 2020 Stock Incentive Plan                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Term period   3 years                
Stock granted (in shares)   326,000                
Awards and units granted (in dollars per share) $ 41.28 $ 41.28                
v3.25.4
SHARE-BASED COMPENSATION - Stock Options Summary (Details) - $ / shares
shares in Thousands
12 Months Ended
Nov. 30, 2025
Nov. 30, 2024
Nov. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]      
Beginning balance (in shares) 238 294 395
Options granted (in shares) 0 0 0
Options exercised (in dollars per share) $ 44.58 $ 42.60 $ 45.50
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations 2   1
Options exercised (in shares) (18) (56) (100)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price $ 55.12   $ 30.70
Ending balance (in shares) 218 238 294
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]      
Beginning balance (in dollars per share) $ 57.21 $ 54.45 $ 52.60
Ending balance (in dollars per share) $ 58.28 $ 57.21 $ 54.45
v3.25.4
SHARE-BASED COMPENSATION - Restricted Stock Awards Summary (Details) - $ / shares
shares in Thousands
1 Months Ended 12 Months Ended
Apr. 30, 2024
Nov. 30, 2025
Nov. 30, 2024
Nov. 30, 2023
Nov. 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]          
Options granted (in shares)   0 0 0  
Options granted (in dollars per share)   $ 0 $ 0 $ 0  
Options exercised (in shares)   (18) (56) (100)  
Options exercised (in dollars per share)   $ 44.58 $ 42.60 $ 45.50  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price   $ 55.12   $ 30.70  
Options outstanding (in shares)   218 238 294 395
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price   $ 58.28 $ 57.21 $ 54.45 $ 52.60
Restricted Stock Awards, Restricted Stock Units and Performance-Based Restricted Stock Units          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]          
Non-vested, beginning balance (in dollars per share)   $ 68.35 $ 92.80 $ 124.69  
Awards and units vested (in shares)   (1,374) (849) (513)  
Awards and units vested (in dollars per share)   $ 72.75 $ 92.02 $ 122.76  
Awards and units cancelled/forfeited (in shares)   (474) (337) (114)  
Awards and units cancelled/forfeited (in dollars per share)   $ 68.82 $ 84.94 $ 138.88  
Non-vested, ending balance (in dollars per share)   $ 58.18 $ 68.35 $ 92.80  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number   4,280 4,311 2,673 1,395
Restricted Stock          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]          
Awards and units granted (in dollars per share)       $ 135.01  
Stock granted (in shares)       60  
Restricted Stock | Amended and Restated 2020 Stock Incentive Plan          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]          
Non-vested, beginning balance (in dollars per share)   $ 0      
Awards and units granted (in dollars per share)   $ 46.93      
Awards and units cancelled/forfeited (in shares)   (2)      
Awards and units cancelled/forfeited (in dollars per share)   $ 46.93      
Non-vested, ending balance (in dollars per share)   $ 46.93 $ 0    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number   620 0    
Stock granted (in shares)   622      
Restricted Stock Units (RSUs)          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]          
Awards and units granted (in dollars per share)   $ 47.81 $ 52.94 $ 74.64  
Stock granted (in shares)   1,817 2,824 1,828  
Performance-based units in excess of target          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]          
Awards and units granted (in dollars per share)       $ 159.97  
Stock granted (in shares)       17  
Performance-based Restricted Stock Units | Amended and Restated 2020 Stock Incentive Plan          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]          
Non-vested, beginning balance (in dollars per share)   $ 0      
Awards and units granted (in dollars per share) $ 41.28 $ 41.28      
Awards and units cancelled/forfeited (in shares)   (21)      
Awards and units cancelled/forfeited (in dollars per share)   $ 41.28      
Non-vested, ending balance (in dollars per share)   $ 41.28 $ 0    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number   305 0    
Stock granted (in shares)   326      
v3.25.4
BALANCE SHEET COMPONENTS - Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)
$ in Thousands
Nov. 30, 2025
Nov. 30, 2024
Nov. 30, 2023
Nov. 30, 2022
Balance Sheet Related Disclosures [Abstract]        
Cash and cash equivalents $ 327,347 $ 240,571    
Cash held for sale 2,057 0    
Restricted cash included in other current assets 191,723 189,033    
Cash, cash equivalents, cash held for sale and restricted cash 521,127 429,604 $ 516,487 $ 157,463
Funds Held for Clients $ 187,139 $ 179,949    
v3.25.4
BALANCE SHEET COMPONENTS - Accounts Receivable, Net (Details) - USD ($)
$ in Thousands
Nov. 30, 2025
Nov. 30, 2024
Nov. 30, 2023
Nov. 30, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Less: Allowance for credit losses $ (17,443) $ (14,307) $ (12,533) $ (4,797)
Accounts receivable, net 1,999,021 1,926,737    
Billed accounts receivable        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Accounts receivable, gross 1,102,601 1,080,778    
Unbilled accounts receivable        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Accounts receivable, gross $ 913,863 $ 860,266    
v3.25.4
BALANCE SHEET COMPONENTS - Allowance for Doubtful Trade Receivables (Details) - USD ($)
$ in Thousands
12 Months Ended
Nov. 30, 2025
Nov. 30, 2024
Nov. 30, 2023
Accounts Receivable, Allowance for Credit Loss [Roll Forward]      
Beginning Balance $ 14,307 $ 12,533 $ 4,797
Net additions (reductions) 5,738 7,057 10,236
Accounts Receivable, Allowance for Credit Loss, Writeoff (2,602) (5,283) (2,500)
Ending Balance $ 17,443 $ 14,307 $ 12,533
v3.25.4
BALANCE SHEET COMPONENTS - Property and Equipment, Net (Details) - USD ($)
$ in Thousands
Nov. 30, 2025
Nov. 30, 2024
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross $ 1,913,558 $ 1,695,716
Less: Accumulated depreciation (1,178,008) (981,199)
Property and equipment, net 735,550 714,517
India    
Property, Plant and Equipment [Line Items]    
Property and equipment, net 105,475 82,864
Philippines    
Property, Plant and Equipment [Line Items]    
Property and equipment, net 93,773 118,732
United States    
Property, Plant and Equipment [Line Items]    
Property and equipment, net 56,386 59,645
Others    
Property, Plant and Equipment [Line Items]    
Property and equipment, net 422,331 403,937
FRANCE    
Property, Plant and Equipment [Line Items]    
Property and equipment, net 57,585 49,339
Land    
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross 28,391 28,235
Equipment, computers, and software    
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross 969,841 853,558
Equipment and furniture    
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross 172,154 151,477
Buildings, building improvements, and leasehold improvements    
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross 704,074 617,880
Construction-in-progress    
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross $ 39,098 $ 44,566
v3.25.4
BALANCE SHEET COMPONENTS - Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Thousands
12 Months Ended
Nov. 30, 2025
Nov. 30, 2024
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning Balance $ 4,039,724 $ 4,143,294
Other comprehensive income (loss) before reclassification 155,033 (226,245)
Reclassification of losses from other comprehensive income (loss) 6,818 (3,659)
Ending Balance 2,744,345 4,039,724
Accumulated other comprehensive income (loss)    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning Balance (414,313) (191,727)
Ending Balance (252,462) (414,313)
Unrecognized gains (losses) on defined benefit plan, net of taxes    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning Balance (5,283) (11,271)
Other comprehensive income (loss) before reclassification 3,702 5,988
Reclassification of losses from other comprehensive income (loss) 0 0
Ending Balance (1,581) (5,283)
Unrealized gains (losses) on hedges, net of taxes    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning Balance (25,881) 4,489
Other comprehensive income (loss) before reclassification (3,578) (34,029)
Reclassification of losses from other comprehensive income (loss) 6,818 (3,659)
Ending Balance (22,641) (25,881)
Foreign currency translation adjustment and other, net of taxes    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning Balance (383,149) (184,945)
Other comprehensive income (loss) before reclassification 154,909 (198,204)
Reclassification of losses from other comprehensive income (loss) 0 0
Ending Balance $ (228,240) $ (383,149)
v3.25.4
GOODWILL AND INTANGIBLE ASSETS - Goodwill Rollforward (Details) - USD ($)
$ in Thousands
12 Months Ended
Nov. 30, 2025
Nov. 30, 2024
Nov. 30, 2023
Goodwill [Roll Forward]      
Balance at beginning of year $ 4,986,967 $ 5,078,668  
Acquisitions 17,370 2,000  
Foreign currency translation 193,245 (154,331)  
Balance at end of year 3,671,746 4,986,967  
Goodwill, Measurement Period Adjustment 0 60,630  
Disposal Group, Including Discontinued Operation, Goodwill, Current (2,570)   $ 0
Goodwill, Impairment Loss $ (1,523,266) $ 0  
v3.25.4
GOODWILL AND INTANGIBLE ASSETS - Schedule of Intangible Assets (Details) - USD ($)
Nov. 30, 2025
Nov. 30, 2024
Finite-Lived Intangible Assets [Line Items]    
Gross amounts $ 3,941,878,000 $ 3,790,297,000
Accumulated amortization (1,981,540,000) (1,503,357,000)
Net amounts 1,960,338,000 2,286,940,000
Customer relationships    
Finite-Lived Intangible Assets [Line Items]    
Gross amounts 3,736,591,000 3,594,694,000
Accumulated amortization (1,822,119,000) (1,399,588,000)
Net amounts 1,914,472,000 2,195,106,000
Technology    
Finite-Lived Intangible Assets [Line Items]    
Gross amounts 79,603,000 79,645,000
Accumulated amortization (64,089,000) (50,119,000)
Net amounts 15,514,000 29,526,000
Trade names    
Finite-Lived Intangible Assets [Line Items]    
Gross amounts 123,484,000 113,758,000
Accumulated amortization (93,132,000) (51,503,000)
Net amounts 30,352,000 62,255,000
Noncompete Agreements    
Finite-Lived Intangible Assets [Line Items]    
Gross amounts 2,200,000 2,200,000
Accumulated amortization (2,200,000) (2,147,000)
Net amounts $ 0 $ 53,000
v3.25.4
GOODWILL AND INTANGIBLE ASSETS - Narrative (Details) - USD ($)
$ in Thousands
12 Months Ended
Nov. 30, 2025
Nov. 30, 2024
Nov. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]      
Amortization $ 434,332 $ 458,925 $ 214,832
Remaining amortization period 12 years    
Goodwill, Impairment Loss, Statement of Income or Comprehensive Income [Extensible Enumeration] Impairment charges    
v3.25.4
GOODWILL AND INTANGIBLE ASSETS - Intangible Assets Future Amortization Expense (Details) - USD ($)
Nov. 30, 2025
Nov. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]    
2026 $ 393,559,000  
2027 297,133,000  
2028 251,871,000  
2029 209,650,000  
2030 177,687,000  
Thereafter 630,438,000  
Net amounts $ 1,960,338,000 $ 2,286,940,000
v3.25.4
DERIVATIVE INSTRUMENTS - Narrative (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Sep. 25, 2023
Sep. 30, 2025
Nov. 30, 2025
Nov. 30, 2024
Aug. 02, 2023
Derivative [Line Items]          
Existing net losses expected to be reclassified     $ 14,504    
Term Loan          
Derivative [Line Items]          
Issuance of delayed draw term loan   $ 750      
6.650% Senior Notes due 2026          
Derivative [Line Items]          
Converted debt $ 250,000        
Interest rate 6.65%   6.65%   6.65%
Weighted average interest rate 5.12%        
6.600% Senior Notes due 2028          
Derivative [Line Items]          
Converted debt $ 250        
Interest rate 6.66%   6.60%   6.60%
Weighted average interest rate 5.18%        
Three Year Term Loan          
Derivative [Line Items]          
Weighted average interest rate 3.43%        
Derivative term   3 years      
Five Year Term Loan          
Derivative [Line Items]          
Weighted average interest rate 3.69%        
Derivative term   5 years      
Cross Currency Interest Rate Contract | Not Designated as Hedging Instrument          
Derivative [Line Items]          
Notional value $ 500,000 $ 750      
Cross Currency Interest Rate Contract | Designated as Hedging Instrument          
Derivative [Line Items]          
Notional value $ 500   $ 1,112,706 $ 471,604  
v3.25.4
DERIVATIVE INSTRUMENTS - Fair Value of Derivative Instruments in Balance Sheets (Details) - USD ($)
$ in Thousands
Nov. 30, 2025
Sep. 30, 2025
Nov. 30, 2024
Sep. 25, 2023
Foreign Exchange Forward | Not Designated as Hedging Instrument        
Derivative instruments not designated as hedging instruments:        
Notional value $ 0   $ 458,482  
Derivative instruments designated as cash flow hedges:        
Notional value 0   458,482  
Foreign Exchange Forward | Not Designated as Hedging Instrument | Other current assets        
Derivative instruments not designated as hedging instruments:        
Forward foreign currency exchange contracts 0   13,935  
Derivative instruments designated as cash flow hedges:        
Forward foreign currency exchange contracts 0   13,935  
Foreign Exchange Forward | Not Designated as Hedging Instrument | Other accrued liabilities        
Derivative instruments not designated as hedging instruments:        
Forward foreign currency exchange contracts 0   167  
Derivative instruments designated as cash flow hedges:        
Forward foreign currency exchange contracts 0   167  
Foreign Exchange Forward | Designated as Hedging Instrument        
Derivative instruments not designated as hedging instruments:        
Notional value 1,049,896   1,049,787  
Derivative instruments designated as cash flow hedges:        
Notional value 1,049,896   1,049,787  
Foreign Exchange Forward | Designated as Hedging Instrument | Other current assets and other assets        
Derivative instruments not designated as hedging instruments:        
Forward foreign currency exchange contracts 914   578  
Derivative instruments designated as cash flow hedges:        
Forward foreign currency exchange contracts 914   578  
Foreign Exchange Forward | Designated as Hedging Instrument | Other accrued liabilities and other long-term liabilities        
Derivative instruments not designated as hedging instruments:        
Forward foreign currency exchange contracts 21,424   22,155  
Derivative instruments designated as cash flow hedges:        
Forward foreign currency exchange contracts 21,424   22,155  
Cross Currency Interest Rate Contract | Not Designated as Hedging Instrument        
Derivative instruments not designated as hedging instruments:        
Notional value   $ 750   $ 500,000
Derivative instruments designated as cash flow hedges:        
Notional value   $ 750   500,000
Cross Currency Interest Rate Contract | Designated as Hedging Instrument        
Derivative instruments not designated as hedging instruments:        
Notional value 1,112,706   471,604 500
Derivative instruments designated as cash flow hedges:        
Notional value 1,112,706   471,604 $ 500
Cross Currency Interest Rate Contract | Designated as Hedging Instrument | Other current liabilities and other long-term liabilities        
Derivative instruments not designated as hedging instruments:        
Forward foreign currency exchange contracts 49,319   7,468  
Derivative instruments designated as cash flow hedges:        
Forward foreign currency exchange contracts 49,319   7,468  
Cross Currency Interest Rate Contract | Designated as Hedging Instrument | Other Noncurrent Assets        
Derivative instruments not designated as hedging instruments:        
Forward foreign currency exchange contracts 5,343   0  
Derivative instruments designated as cash flow hedges:        
Forward foreign currency exchange contracts 5,343   0  
Interest Rate Swap | Designated as Hedging Instrument        
Derivative instruments not designated as hedging instruments:        
Notional value 750,000   0  
Derivative instruments designated as cash flow hedges:        
Notional value 750,000   0  
Interest Rate Swap | Designated as Hedging Instrument | Other current liabilities and other long-term liabilities        
Derivative instruments not designated as hedging instruments:        
Forward foreign currency exchange contracts 3,357   0  
Derivative instruments designated as cash flow hedges:        
Forward foreign currency exchange contracts $ 3,357   $ 0  
v3.25.4
DERIVATIVE INSTRUMENTS - Effect of Derivative Instruments on AOCI and Statements of Operations (Details) - USD ($)
$ in Thousands
12 Months Ended
Nov. 30, 2025
Nov. 30, 2024
Nov. 30, 2023
Designated as Hedging Instrument      
Derivative [Line Items]      
(Losses) gains recognized in OCI $ (5,629) $ (43,543) $ 15,548
Not Designated as Hedging Instrument      
Derivative [Line Items]      
(Loss) gain recognized from foreign exchange forward contracts, net 6,429 9,940 (27,636)
Foreign Exchange Forward | Designated as Hedging Instrument      
Derivative [Line Items]      
(Losses) gains recognized in OCI (8,072) (38,459) 19,199
Gains reclassified from AOCI into income (9,140) (4,889) (18,387)
Foreign Exchange Forward | Revenue for services | Designated as Hedging Instrument      
Derivative [Line Items]      
Gains reclassified from AOCI into income 0 0 222
Foreign Exchange Forward | Cost of revenue | Designated as Hedging Instrument      
Derivative [Line Items]      
Gains reclassified from AOCI into income (6,484) (4,028) (13,864)
Foreign Exchange Forward | Selling, general and administrative expenses | Designated as Hedging Instrument      
Derivative [Line Items]      
Gains reclassified from AOCI into income (2,656) (861) (4,745)
Foreign Exchange Forward | Other expense (income), net | Not Designated as Hedging Instrument      
Derivative [Line Items]      
(Loss) gain recognized from foreign exchange forward contracts, net 6,429 9,940 (13,007)
Cross Currency Interest Rate Contract | Designated as Hedging Instrument      
Derivative [Line Items]      
(Losses) gains recognized in OCI 5,800 (5,084) (3,651)
Foreign Exchange Option | Other expense (income), net | Not Designated as Hedging Instrument      
Derivative [Line Items]      
(Loss) gain recognized from foreign exchange forward contracts, net 0 0 (14,629)
Interest Rate Swap | Designated as Hedging Instrument      
Derivative [Line Items]      
(Losses) gains recognized in OCI $ (3,357) $ 0 $ 0
v3.25.4
FAIR VALUE MEASUREMENTS (Details) - USD ($)
$ in Thousands
Nov. 30, 2025
Nov. 30, 2024
Liabilities measured at fair value:    
Long-Term Debt $ 4,572,889 $ 4,733,056
Fair Value, Recurring    
Assets measured at fair value:    
Cash and cash equivalents, including cash held for sale 329,404 240,571
Liabilities measured at fair value:    
Long-Term Debt, Fair Value 2,184,727 2,202,221
Long-Term Debt 2,139,537 2,135,576
Other Assets, Fair Value Disclosure 191,723 189,033
Fair Value, Recurring | Foreign Exchange Forward    
Assets measured at fair value:    
Forward foreign currency exchange contracts 914 14,513
Liabilities measured at fair value:    
Forward foreign currency exchange contracts 21,424 22,322
Fair Value, Recurring | Cross Currency Interest Rate Contract    
Assets measured at fair value:    
Forward foreign currency exchange contracts 5,343 0
Liabilities measured at fair value:    
Forward foreign currency exchange contracts 49,319 7,468
Fair Value, Recurring | Contingent Consideration    
Liabilities measured at fair value:    
Forward foreign currency exchange contracts 7,866 13,373
Fair Value, Recurring | Interest Rate Swap    
Liabilities measured at fair value:    
Forward foreign currency exchange contracts 3,357 0
Fair Value, Recurring | Level 1    
Assets measured at fair value:    
Cash and cash equivalents, including cash held for sale 329,404 240,571
Liabilities measured at fair value:    
Long-Term Debt, Fair Value 0 0
Long-Term Debt 0 0
Other Assets, Fair Value Disclosure 191,723 189,033
Fair Value, Recurring | Level 1 | Foreign Exchange Forward    
Assets measured at fair value:    
Forward foreign currency exchange contracts 0 0
Liabilities measured at fair value:    
Forward foreign currency exchange contracts 0 0
Fair Value, Recurring | Level 1 | Cross Currency Interest Rate Contract    
Assets measured at fair value:    
Forward foreign currency exchange contracts 0 0
Liabilities measured at fair value:    
Forward foreign currency exchange contracts 0 0
Fair Value, Recurring | Level 1 | Contingent Consideration    
Liabilities measured at fair value:    
Forward foreign currency exchange contracts 0 0
Fair Value, Recurring | Level 1 | Interest Rate Swap    
Liabilities measured at fair value:    
Forward foreign currency exchange contracts 0 0
Fair Value, Recurring | Level 2    
Assets measured at fair value:    
Cash and cash equivalents, including cash held for sale 0 0
Liabilities measured at fair value:    
Long-Term Debt, Fair Value 2,184,727 2,202,221
Long-Term Debt 0 0
Other Assets, Fair Value Disclosure 0 0
Fair Value, Recurring | Level 2 | Foreign Exchange Forward    
Assets measured at fair value:    
Forward foreign currency exchange contracts 914 14,513
Liabilities measured at fair value:    
Forward foreign currency exchange contracts 21,424 22,322
Fair Value, Recurring | Level 2 | Cross Currency Interest Rate Contract    
Assets measured at fair value:    
Forward foreign currency exchange contracts 5,343 0
Liabilities measured at fair value:    
Forward foreign currency exchange contracts 49,319 7,468
Fair Value, Recurring | Level 2 | Contingent Consideration    
Liabilities measured at fair value:    
Forward foreign currency exchange contracts 0 0
Fair Value, Recurring | Level 2 | Interest Rate Swap    
Liabilities measured at fair value:    
Forward foreign currency exchange contracts 3,357 0
Fair Value, Recurring | Level 3    
Assets measured at fair value:    
Cash and cash equivalents, including cash held for sale 0 0
Liabilities measured at fair value:    
Long-Term Debt, Fair Value 0 0
Long-Term Debt 0 0
Other Assets, Fair Value Disclosure 0 0
Fair Value, Recurring | Level 3 | Foreign Exchange Forward    
Assets measured at fair value:    
Forward foreign currency exchange contracts 0 0
Liabilities measured at fair value:    
Forward foreign currency exchange contracts 0 0
Fair Value, Recurring | Level 3 | Cross Currency Interest Rate Contract    
Assets measured at fair value:    
Forward foreign currency exchange contracts 0 0
Liabilities measured at fair value:    
Forward foreign currency exchange contracts 0 0
Fair Value, Recurring | Level 3 | Contingent Consideration    
Liabilities measured at fair value:    
Forward foreign currency exchange contracts 7,866 13,373
Fair Value, Recurring | Level 3 | Interest Rate Swap    
Liabilities measured at fair value:    
Forward foreign currency exchange contracts $ 0 $ 0
v3.25.4
BORROWINGS - Schedule of Debt (Details) - USD ($)
$ in Thousands
Nov. 30, 2025
Nov. 30, 2024
Sep. 25, 2023
Aug. 02, 2023
Debt Instrument [Line Items]        
Other Loans Payable, Current $ 0 $ 2,522    
Other Long-Term Debt, Current 65,625 2,522    
Notes Payable 0 740,466    
Other Loans Payable 0 3,643    
Total 4,587,000 4,765,109    
Less: unamortized debt discount and issuance costs (14,111) (32,053)    
Long-term debt, net 4,572,889 4,733,056    
Securitization Facility        
Debt Instrument [Line Items]        
Credit Facility - term loans component $ 537,000 371,000    
6.650% Senior Notes due 2026        
Debt Instrument [Line Items]        
Interest rate 6.65%   6.65% 6.65%
Senior Notes $ 800,000 800,000   $ 800,000
6.600% Senior Notes due 2028        
Debt Instrument [Line Items]        
Interest rate 6.60%   6.66% 6.60%
Senior Notes $ 800,000 800,000   $ 800,000
6.850% Senior Notes due 2033        
Debt Instrument [Line Items]        
Interest rate 6.85%     6.85%
Senior Notes $ 550,000 550,000   $ 550,000
Senior Secured Credit Facility | Term Loan        
Debt Instrument [Line Items]        
Credit Facility - term loans component 1,900,000 1,500,000    
Line of Credit, Current $ 65,625 $ 0    
v3.25.4
BORROWINGS - Narrative (Details)
3 Months Ended 12 Months Ended
Apr. 11, 2025
USD ($)
Jan. 14, 2025
USD ($)
Apr. 25, 2024
USD ($)
Sep. 25, 2023
EUR (€)
Apr. 21, 2023
USD ($)
Dec. 27, 2021
Nov. 30, 2025
USD ($)
Nov. 30, 2025
USD ($)
Nov. 30, 2024
USD ($)
Nov. 30, 2023
USD ($)
Sep. 25, 2023
USD ($)
Sep. 25, 2023
EUR (€)
Aug. 02, 2023
USD ($)
Webhelp                          
Debt Instrument [Line Items]                          
Interest rate                     2.00% 2.00%  
Business Acquisition, Note Payable Consideration | €       € 700,000,000                  
Business Acquisition, Note Payable Discount | €                       € 31,500,000  
Debt Instrument, Imputed Annual Interest Rate                     4.36% 4.36%  
Business Acquisition, Note Payable Discounted Value                     $ 711,830,000 € 668,500,000  
Revolver                          
Debt Instrument [Line Items]                          
Repayments of the Prior Credit Facility - Term Loan               $ 238,500,000 $ 0 $ 0      
Term Loan                          
Debt Instrument [Line Items]                          
Repayments of the Prior Credit Facility - Term Loan               0 0 $ 25,000,000      
Securitization Facility                          
Debt Instrument [Line Items]                          
Credit facility, maximum borrowing capacity   $ 700,000,000 $ 600,000                    
Credit Facility - term loans component             $ 537,000,000 537,000,000 371,000,000        
Securitization Facility | Commercial Paper Rate                          
Debt Instrument [Line Items]                          
Basis spread on variable rate   0.75% 0.80%                    
Securitization Facility | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate                          
Debt Instrument [Line Items]                          
Basis spread on variable rate   0.90%                      
Debt Instrument, Basis Spread on Variable Rate, Adjustment   0.10%                      
6.650% Senior Notes due 2026                          
Debt Instrument [Line Items]                          
Senior Notes             $ 800,000,000 $ 800,000,000 800,000,000       $ 800,000,000
Interest rate             6.65% 6.65%     6.65% 6.65% 6.65%
6.600% Senior Notes due 2028                          
Debt Instrument [Line Items]                          
Senior Notes             $ 800,000,000 $ 800,000,000 800,000,000       $ 800,000,000
Interest rate             6.60% 6.60%     6.66% 6.66% 6.60%
6.850% Senior Notes due 2033                          
Debt Instrument [Line Items]                          
Senior Notes             $ 550,000,000 $ 550,000,000 550,000,000       $ 550,000,000
Interest rate             6.85% 6.85%         6.85%
Senior Secured Credit Facility                          
Debt Instrument [Line Items]                          
Consolidated leverage ratio 3.75                        
Consolidated interest coverage ratio 3.00                        
Senior Secured Credit Facility | Certain Period Following Certain Qualified Acquisition                          
Debt Instrument [Line Items]                          
Consolidated leverage ratio 4.25                        
Senior Secured Credit Facility | Base Rate Loans                          
Debt Instrument [Line Items]                          
Basis spread on variable rate 1.00%                        
Interest rate floor 1.00%                        
Senior Secured Credit Facility | Revolver                          
Debt Instrument [Line Items]                          
Credit facility, maximum borrowing capacity $ 1,100,000,000                        
Amount outstanding             $ 0 $ 0 0        
Increase in credit facility         $ 500,000,000                
Senior Secured Credit Facility | Term Loan                          
Debt Instrument [Line Items]                          
Quarterly installment payment             9,375,000            
Credit facility, maximum borrowing capacity 750,000                        
Amount outstanding             1,965,625,000 1,965,625,000 1,500,000,000        
Credit Facility - term loans component             $ 1,900,000,000 1,900,000,000 $ 1,500,000,000        
Repayments of the Prior Credit Facility - Term Loan               $ 275,000,000          
Senior Secured Credit Facility | New Term Loan Member                          
Debt Instrument [Line Items]                          
Credit facility, maximum borrowing capacity 750,000                        
Senior Secured Credit Facility | 3-Year DD Term Loan                          
Debt Instrument [Line Items]                          
Credit facility, maximum borrowing capacity 250,000                        
Senior Secured Credit Facility | 5-Year DD Term Loan                          
Debt Instrument [Line Items]                          
Credit facility, maximum borrowing capacity $ 500,000                        
Senior Secured Credit Facility | Prior Credit Facility - Term Loan                          
Debt Instrument [Line Items]                          
Debt Instrument, Periodic Payment, Percentage of Existing Principal Balance 1.25%                        
Senior Secured Credit Facility | Federal Funds Rate                          
Debt Instrument [Line Items]                          
Debt Instrument, Basis Spread on Variable Rate, Adjustment 0.50%                        
Senior Secured Credit Facility | Federal Funds Rate | Not SOFR Rate Loans                          
Debt Instrument [Line Items]                          
Basis spread on variable rate           0.50%              
Senior Secured Credit Facility | Secured Overnight Financing Rate (SOFR)                          
Debt Instrument [Line Items]                          
Debt Instrument, Basis Spread on Variable Rate, Adjustment 0.10%                        
Debt Instrument, Interest Rate, Effective Percentage, Minimum 0.00%                        
Senior Secured Credit Facility | Secured Overnight Financing Rate (SOFR) | Minimum | Revolver                          
Debt Instrument [Line Items]                          
Debt Instrument, Basis Spread on Variable Rate, Adjustment 0.875%                        
Senior Secured Credit Facility | Secured Overnight Financing Rate (SOFR) | Minimum | 3-Year DD Term Loan                          
Debt Instrument [Line Items]                          
Debt Instrument, Basis Spread on Variable Rate, Adjustment 1.00%                        
Senior Secured Credit Facility | Secured Overnight Financing Rate (SOFR) | Minimum | 5-Year DD Term Loan                          
Debt Instrument [Line Items]                          
Debt Instrument, Basis Spread on Variable Rate, Adjustment 1.10%                        
Senior Secured Credit Facility | Secured Overnight Financing Rate (SOFR) | Minimum | Prior Credit Facility - Term Loan                          
Debt Instrument [Line Items]                          
Debt Instrument, Basis Spread on Variable Rate, Adjustment 1.125%                        
Senior Secured Credit Facility | Secured Overnight Financing Rate (SOFR) | Maximum | Revolver                          
Debt Instrument [Line Items]                          
Debt Instrument, Basis Spread on Variable Rate, Adjustment 1.50%                        
Senior Secured Credit Facility | Secured Overnight Financing Rate (SOFR) | Maximum | 3-Year DD Term Loan                          
Debt Instrument [Line Items]                          
Debt Instrument, Basis Spread on Variable Rate, Adjustment 1.50%                        
Senior Secured Credit Facility | Secured Overnight Financing Rate (SOFR) | Maximum | 5-Year DD Term Loan                          
Debt Instrument [Line Items]                          
Debt Instrument, Basis Spread on Variable Rate, Adjustment 1.60%                        
Senior Secured Credit Facility | Secured Overnight Financing Rate (SOFR) | Maximum | Prior Credit Facility - Term Loan                          
Debt Instrument [Line Items]                          
Debt Instrument, Basis Spread on Variable Rate, Adjustment 2.00%                        
Senior Secured Credit Facility | Base Rate | Minimum | 3-Year DD Term Loan                          
Debt Instrument [Line Items]                          
Debt Instrument, Basis Spread on Variable Rate, Adjustment 0.00%                        
Senior Secured Credit Facility | Base Rate | Minimum | 5-Year DD Term Loan                          
Debt Instrument [Line Items]                          
Debt Instrument, Basis Spread on Variable Rate, Adjustment 0.10%                        
Senior Secured Credit Facility | Base Rate | Minimum | Prior Credit Facility - Term Loan                          
Debt Instrument [Line Items]                          
Debt Instrument, Basis Spread on Variable Rate, Adjustment 0.125%                        
Senior Secured Credit Facility | Base Rate | Maximum | 3-Year DD Term Loan                          
Debt Instrument [Line Items]                          
Debt Instrument, Basis Spread on Variable Rate, Adjustment 0.50%                        
Senior Secured Credit Facility | Base Rate | Maximum | 5-Year DD Term Loan                          
Debt Instrument [Line Items]                          
Debt Instrument, Basis Spread on Variable Rate, Adjustment 0.60%                        
Senior Secured Credit Facility | Base Rate | Maximum | Prior Credit Facility - Term Loan                          
Debt Instrument [Line Items]                          
Debt Instrument, Basis Spread on Variable Rate, Adjustment 1.00%                        
v3.25.4
BORROWINGS - Long Term Debt Maturity (Details)
$ in Thousands
Nov. 30, 2025
USD ($)
Debt Disclosure [Abstract]  
2026 $ 865,625
2027 1,087,000
2028 1,718,750
2029 25,000
2030 406,250
Thereafter 550,000
Total $ 4,652,625
v3.25.4
REVENUE (Details) - USD ($)
$ in Thousands
12 Months Ended
Nov. 30, 2025
Nov. 30, 2024
Nov. 30, 2023
Disaggregation of Revenue [Line Items]      
Revenue $ 9,825,771 $ 9,618,900 $ 7,114,706
Technology and consumer electronics      
Disaggregation of Revenue [Line Items]      
Revenue 2,666,072 2,674,040 2,205,834
Retail, travel and e-commerce      
Disaggregation of Revenue [Line Items]      
Revenue 2,433,885 2,361,866 1,448,666
Communications and media      
Disaggregation of Revenue [Line Items]      
Revenue 1,592,373 1,527,922 1,117,694
Banking, financial services and insurance      
Disaggregation of Revenue [Line Items]      
Revenue 1,536,223 1,455,641 1,091,853
Other      
Disaggregation of Revenue [Line Items]      
Revenue 871,935 872,042 554,393
Healthcare      
Disaggregation of Revenue [Line Items]      
Revenue 725,283 727,389 696,266
Philippines      
Disaggregation of Revenue [Line Items]      
Revenue 1,594,559 1,596,578 1,585,878
India      
Disaggregation of Revenue [Line Items]      
Revenue 1,126,061 1,054,460 898,250
United States      
Disaggregation of Revenue [Line Items]      
Revenue 1,051,700 1,110,763 1,304,797
Canada      
Disaggregation of Revenue [Line Items]      
Revenue 302,085 307,590 317,410
Germany      
Disaggregation of Revenue [Line Items]      
Revenue 334,293 388,005 232,729
Great Britain      
Disaggregation of Revenue [Line Items]      
Revenue 356,490 394,945 205,437
Others      
Disaggregation of Revenue [Line Items]      
Revenue $ 5,060,583 $ 4,766,559 $ 2,570,205
v3.25.4
PENSION AND EMPLOYEE BENEFITS PLANS - Narrative (Details) - USD ($)
$ in Thousands
12 Months Ended
Nov. 30, 2025
Nov. 30, 2024
Nov. 30, 2023
Defined Benefit Plan Disclosure [Line Items]      
Contributed amount $ 127,611 $ 105,087 $ 89,767
Net benefit costs 16,565 $ 16,097 $ 11,328
Employer contributions $ 3,877    
Defined Benefit Plan, Equity Securities      
Defined Benefit Plan Disclosure [Line Items]      
Investment plan asset category percentage 26.00% 26.00%  
Targeted allocation percentage 25.00% 25.00%  
Fixed income      
Defined Benefit Plan Disclosure [Line Items]      
Investment plan asset category percentage 74.00% 74.00%  
Targeted allocation percentage 75.00% 75.00%  
Foreign Plan      
Defined Benefit Plan Disclosure [Line Items]      
Projected benefit obligation percentage 42.00% 40.00%  
v3.25.4
PENSION AND EMPLOYEE BENEFITS PLANS - Pension Cost (Details) - USD ($)
$ in Thousands
12 Months Ended
Nov. 30, 2025
Nov. 30, 2024
Nov. 30, 2023
Retirement Benefits [Abstract]      
Service costs $ 12,289 $ 9,033 $ 6,937
Interest costs $ 10,379 $ 10,893 $ 10,306
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration] Other Operating Income (Expense), Net Other Operating Income (Expense), Net Other Operating Income (Expense), Net
Expected return on plan assets $ (6,918) $ (5,295) $ (6,208)
Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Expected Return (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Other Operating Income (Expense), Net Other Operating Income (Expense), Net Other Operating Income (Expense), Net
Amortization and deferrals, net $ 1,696 $ 1,457 $ 98
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Amortization of Prior Service Cost (Credit), Statement of Income or Comprehensive Income [Extensible Enumeration] Other Operating Income (Expense), Net Other Operating Income (Expense), Net Other Operating Income (Expense), Net
Settlements $ 0 $ 9 $ 195
Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Settlement Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Other Operating Income (Expense), Net Other Operating Income (Expense), Net Other Operating Income (Expense), Net
Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Curtailment Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Other Operating Income (Expense), Net Other Operating Income (Expense), Net Other Operating Income (Expense), Net
Curtailment gain $ (881) $ 0 $ 0
Total pension costs $ 16,565 $ 16,097 $ 11,328
v3.25.4
PENSION AND EMPLOYEE BENEFITS PLANS - Employee Benefit Plan (Details) - USD ($)
$ in Thousands
12 Months Ended
Nov. 30, 2025
Nov. 30, 2024
Nov. 30, 2023
Change in Benefit Obligation:      
Service costs $ 12,289 $ 9,033 $ 6,937
Interest costs 10,379 10,893 10,306
Settlements 0 9 195
Curtailments 1,784 0  
Change in Plan Assets:      
Beginning balance 135,923    
Ending balance 132,891 135,923  
Pension Plan      
Change in Benefit Obligation:      
Beginning balance 213,865 208,565  
Service costs 12,289 9,033  
Interest costs 10,379 10,893  
Actuarial losses 584 6,017  
Benefits paid (20,094) (17,161)  
Settlements 0 (490)  
Defined Benefit Plan, Settlement and Curtailment [Abstract]      
Foreign currency adjustments (1,284) (2,992)  
Ending balance 213,955 213,865 208,565
Change in Plan Assets:      
Beginning balance 135,923 126,752  
Actual return on assets 8,395 17,251  
Settlements 0 (83)  
Employer contributions 4,058 4,442  
Benefits paid (14,815) (12,279)  
Foreign currency adjustments (670) (160)  
Ending balance 132,891 135,923 $ 126,752
Funded Status of Plans:      
Unfunded status $ 81,064 $ 77,942  
v3.25.4
PENSION AND EMPLOYEE BENEFITS PLANS - Defined Benefit Plan Liability (Details) - USD ($)
$ in Thousands
Nov. 30, 2025
Nov. 30, 2024
Defined Benefit Plan Disclosure [Line Items]    
Defined Benefit Plan, Accumulated Benefit Obligation $ 192,950 $ 213,461
Pension Plan    
Defined Benefit Plan Disclosure [Line Items]    
Current liability 16,623 16,694
Non-current liability 64,441 61,248
Total $ 81,064 $ 77,942
v3.25.4
PENSION AND EMPLOYEE BENEFITS PLANS - Weighted-Average Rates (Details) - Pension Plan
12 Months Ended
Nov. 30, 2025
Nov. 30, 2024
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]    
Interest crediting rate for cash balance plan 4.00% 4.00%
Interest crediting rate for cash balance plan 4.00% 4.00%
Minimum    
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]    
Discount rate 3.60% 3.20%
Expected rate of future compensation growth 1.50% 2.50%
Discount rate 3.20% 4.00%
Expected return on plan assets 1.00% 3.60%
Expected rate of future compensation growth 2.50% 1.80%
Maximum    
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]    
Discount rate 6.10% 6.70%
Expected rate of future compensation growth 8.00% 7.00%
Discount rate 6.70% 7.50%
Expected return on plan assets 7.00% 7.10%
Expected rate of future compensation growth 7.50% 8.00%
v3.25.4
PENSION AND EMPLOYEE BENEFITS PLANS - Fair Value of Plan Assets (Details) - USD ($)
$ in Thousands
Nov. 30, 2025
Nov. 30, 2024
Defined Benefit Plan Disclosure [Line Items]    
Total investments $ 132,891 $ 135,923
Level 1    
Defined Benefit Plan Disclosure [Line Items]    
Total investments 3,682 3,606
Level 2    
Defined Benefit Plan Disclosure [Line Items]    
Total investments 129,209 132,317
Level 3    
Defined Benefit Plan Disclosure [Line Items]    
Total investments 0 0
Cash and cash equivalents    
Defined Benefit Plan Disclosure [Line Items]    
Total investments 3,682 3,606
Cash and cash equivalents | Level 1    
Defined Benefit Plan Disclosure [Line Items]    
Total investments 3,682 3,606
Cash and cash equivalents | Level 2    
Defined Benefit Plan Disclosure [Line Items]    
Total investments 0 0
Cash and cash equivalents | Level 3    
Defined Benefit Plan Disclosure [Line Items]    
Total investments 0 0
Fixed income    
Defined Benefit Plan Disclosure [Line Items]    
Total investments 86,623 59,928
Fixed income | Level 1    
Defined Benefit Plan Disclosure [Line Items]    
Total investments 0 0
Fixed income | Level 2    
Defined Benefit Plan Disclosure [Line Items]    
Total investments 86,623 59,928
Fixed income | Level 3    
Defined Benefit Plan Disclosure [Line Items]    
Total investments 0 0
U.S. large cap    
Defined Benefit Plan Disclosure [Line Items]    
Total investments 13,642 25,924
U.S. large cap | Level 1    
Defined Benefit Plan Disclosure [Line Items]    
Total investments 0 0
U.S. large cap | Level 2    
Defined Benefit Plan Disclosure [Line Items]    
Total investments 13,642 25,924
U.S. large cap | Level 3    
Defined Benefit Plan Disclosure [Line Items]    
Total investments 0 0
U.S. small cap    
Defined Benefit Plan Disclosure [Line Items]    
Total investments 3,489 7,662
U.S. small cap | Level 1    
Defined Benefit Plan Disclosure [Line Items]    
Total investments 0 0
U.S. small cap | Level 2    
Defined Benefit Plan Disclosure [Line Items]    
Total investments 3,489 7,662
U.S. small cap | Level 3    
Defined Benefit Plan Disclosure [Line Items]    
Total investments 0 0
International equity    
Defined Benefit Plan Disclosure [Line Items]    
Total investments 13,825 27,168
International equity | Level 1    
Defined Benefit Plan Disclosure [Line Items]    
Total investments 0 0
International equity | Level 2    
Defined Benefit Plan Disclosure [Line Items]    
Total investments 13,825 27,168
International equity | Level 3    
Defined Benefit Plan Disclosure [Line Items]    
Total investments 0 0
Governmental bonds    
Defined Benefit Plan Disclosure [Line Items]    
Total investments 6,873 8,501
Governmental bonds | Level 1    
Defined Benefit Plan Disclosure [Line Items]    
Total investments 0 0
Governmental bonds | Level 2    
Defined Benefit Plan Disclosure [Line Items]    
Total investments 6,873 8,501
Governmental bonds | Level 3    
Defined Benefit Plan Disclosure [Line Items]    
Total investments 0 0
Corporate bonds    
Defined Benefit Plan Disclosure [Line Items]    
Total investments 4,757 3,134
Corporate bonds | Level 1    
Defined Benefit Plan Disclosure [Line Items]    
Total investments 0 0
Corporate bonds | Level 2    
Defined Benefit Plan Disclosure [Line Items]    
Total investments 4,757 3,134
Corporate bonds | Level 3    
Defined Benefit Plan Disclosure [Line Items]    
Total investments $ 0 $ 0
v3.25.4
PENSION AND EMPLOYEE BENEFITS PLANS - Expected Benefit Payments (Details)
$ in Thousands
Nov. 30, 2025
USD ($)
Retirement Benefits [Abstract]  
2026 $ 30,790
2027 27,236
2028 25,420
2029 23,419
2030 22,260
Thereafter 98,213
Total $ 227,338
v3.25.4
LEASES - Lease Cost (Details) - USD ($)
$ in Thousands
12 Months Ended
Nov. 30, 2025
Nov. 30, 2024
Nov. 30, 2023
Leases [Abstract]      
Operating lease cost $ 323,427 $ 295,111 $ 216,774
Short-term lease cost 69,823 89,001 21,802
Variable lease cost 53,709 44,237 58,283
Sublease income (2,959) (4,492) (5,394)
Total operating lease cost $ 444,000 $ 423,857 $ 291,465
v3.25.4
LEASES - Operating Lease Liability Maturity (Details)
$ in Thousands
Nov. 30, 2025
USD ($)
Leases [Abstract]  
2026 $ 312,965
2027 251,660
2028 192,770
2029 129,777
2030 71,067
Thereafter 86,524
Total payments 1,044,763
Less: imputed interest 146,580
Total present value of lease payments $ 898,183
v3.25.4
LEASES - Operating Lease ROU Assets and Liabilities (Details) - USD ($)
$ in Thousands
Nov. 30, 2025
Nov. 30, 2024
Leases [Abstract]    
Operating lease ROU assets $ 857,025 $ 816,550
Current operating lease liabilities 256,739 235,912
Non-current operating lease liabilities $ 641,444 $ 625,888
Operating lease, right-of-use asset, statement of financial position Other assets Other assets
Operating lease, liability, current, statement of financial position Other accrued liabilities Other accrued liabilities
Operating Lease, liability, noncurrent, statement of financial position Other long-term liabilities Other long-term liabilities
v3.25.4
LEASES - Operating Lease Supplemental Cash Flow Information (Details) - USD ($)
$ in Thousands
12 Months Ended
Nov. 30, 2025
Nov. 30, 2024
Nov. 30, 2023
Leases [Abstract]      
Cash paid for amounts included in the measurement of lease liabilities $ 345,027 $ 310,859 $ 225,142
Non-cash ROU assets obtained in exchange for lease liabilities $ 264,095 $ 295,894 $ 152,071
v3.25.4
LEASES - Operating Lease Weighted Average Remaining Lease Term and Discount Rate (Details)
Nov. 30, 2025
Nov. 30, 2024
Leases [Abstract]    
Weighted-average remaining lease term (years) 4 years 2 months 12 days 4 years 6 months
Weighted-average discount rate 6.85% 6.91%
v3.25.4
INCOME TAXES - Income Before Income Tax (Details) - USD ($)
$ in Thousands
12 Months Ended
Nov. 30, 2025
Nov. 30, 2024
Nov. 30, 2023
Income Tax Disclosure [Abstract]      
United States $ (775,986) $ 4,279 $ (51,820)
Foreign (406,236) 294,995 460,048
Total $ (1,182,222) $ 299,274 $ 408,228
v3.25.4
INCOME TAXES - Provision for Income Taxes (Details) - USD ($)
$ in Thousands
12 Months Ended
Nov. 30, 2025
Nov. 30, 2024
Nov. 30, 2023
Current tax provision:      
Federal $ 81,553 $ 89,987 $ 78,961
State 28,394 7,734 11,064
Foreign 141,632 185,584 126,072
Current tax provision (benefit) 251,579 283,305 216,097
Deferred tax benefit:      
Federal (77,575) (104,236) (97,371)
State (9,809) (20,462) (12,850)
Foreign (67,493) (110,550) (11,490)
Deferred tax provision (benefit) (154,877) (235,248) (121,711)
Total income tax provision $ 96,702 $ 48,057 $ 94,386
v3.25.4
INCOME TAXES - Narrative (Details) - USD ($)
$ in Thousands
12 Months Ended
Nov. 30, 2025
Nov. 30, 2024
Nov. 30, 2023
Nov. 30, 2022
Investments, Owned, Federal Income Tax Note [Line Items]        
Current tax provision (benefit) $ 251,579 $ 283,305 $ 216,097  
Deferred income taxes (154,877) (235,248) (121,711)  
Undistributed earnings of non-U.S. subsidiaries 3,265,961      
Credit carry forwards 15,126      
Estimated tax benefits from tax holidays 12,172 17,332 7,961  
Unrecognized tax benefits 82,174 100,348 $ 79,322 $ 70,963
Unrecognized tax benefits that would affect income tax expense if recognized 88,130 60,512    
Income taxes payable related to accrued interest and penalties 12,860 12,613    
Other current liabilities and other long-term liabilities        
Investments, Owned, Federal Income Tax Note [Line Items]        
Unrecognized tax benefits 95,034 $ 112,961    
Minimum        
Investments, Owned, Federal Income Tax Note [Line Items]        
Unrecognized tax benefits, possible decrease amount 10,610      
Maximum        
Investments, Owned, Federal Income Tax Note [Line Items]        
Unrecognized tax benefits, possible decrease amount 14,053      
Domestic Tax Jurisdiction        
Investments, Owned, Federal Income Tax Note [Line Items]        
Operating loss carry forwards 302,482      
State and Local Jurisdiction        
Investments, Owned, Federal Income Tax Note [Line Items]        
Operating loss carry forwards 26,824      
Foreign Tax Jurisdiction        
Investments, Owned, Federal Income Tax Note [Line Items]        
Operating loss carry forwards $ 234,062      
v3.25.4
INCOME TAXES - Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Nov. 30, 2025
Nov. 30, 2024
Income Tax Disclosure [Abstract]    
Deferred tax assets $ 317,453 $ 218,396
Deferred tax liabilities 296,519 312,574
Total net deferred tax asset (liability) $ 20,934  
Total net deferred tax asset (liability)   $ (94,178)
v3.25.4
INCOME TAXES - Deferred Tax Assets, Net (Details) - USD ($)
$ in Thousands
Nov. 30, 2025
Nov. 30, 2024
Assets:    
Net operating losses $ 172,819 $ 172,182
Accruals and other reserves 87,492 78,308
Depreciation and amortization 120,727 107,095
U.S. interest limitation carry forward 88,219 49,481
Share-based compensation expense 24,402 17,714
Deferred revenue 5,764 5,280
Tax credits 5,516 5,082
Foreign tax credit 9,610 5,199
Operating lease liabilities 202,480 201,266
Intercompany loans payable 119,678 110,708
Other 13,548 32,048
Gross deferred tax assets 850,255 784,363
Valuation allowance (147,609) (125,163)
Total deferred tax assets 702,646 659,200
Liabilities:    
Intangible assets 447,819 529,129
Unremitted non-US earnings 48,952 42,433
Operating lease right-of-use assets 184,941 181,816
Total deferred tax liabilities 681,712 753,378
Total net deferred tax asset (liability) $ 20,934  
Total net deferred tax asset (liability)   $ (94,178)
v3.25.4
INCOME TAXES - Income Tax Rate Reconciliation (Details)
12 Months Ended
Nov. 30, 2025
Nov. 30, 2024
Nov. 30, 2023
Income Tax Disclosure [Abstract]      
Federal statutory income tax rate 21.00% 21.00% 21.00%
State taxes, net of federal income tax benefit (1.10%) (1.80%) (1.00%)
International rate difference (1.70%) (9.00%) (2.30%)
Withholding taxes (1.60%) 3.90% 2.50%
Uncertain tax benefits 0.40% 0.70% 1.30%
Changes in valuation allowance (1.40%) 6.50% 1.70%
Impact of inclusion of foreign income (1) (0.10%) 0.30% (4.70%)
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent (26.70%)    
Effective Income Tax Rate Reconciliation, Capital Gains losses   (12.40%)  
Other 3.00% 6.90% 4.60%
Effective income tax rate (8.20%) 16.10% 23.10%
v3.25.4
INCOME TAXES - Unrecognized Tax Benefits (Details) - USD ($)
$ in Thousands
12 Months Ended
Nov. 30, 2025
Nov. 30, 2024
Nov. 30, 2023
Unrecognized Tax Benefits [Roll Forward]      
Beginning balance $ 100,348 $ 79,322 $ 70,963
Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 23,367 11,081 5,819
Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions 1,197 18,576 6,071
Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities   (428)  
Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations (42,095) (8,071) (4,938)
Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation (643) (132)  
Unrecognized Tax Benefits, Increase Resulting from Foreign Currency Translation     1,407
Ending balance $ 82,174 $ 100,348 $ 79,322
v3.25.4
EARNINGS PER SHARE - Computation of Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Nov. 30, 2025
Nov. 30, 2024
Nov. 30, 2023
Basic earnings (loss) per common share:      
Net income (loss) $ (1,278,924) $ 251,217 $ 313,842
Less: net income allocated to participating securities (4,103) (9,504) (6,001)
Net income (loss) attributable to common stockholders $ (1,283,027) $ 241,713 $ 307,841
Weighted-average number of common shares - basic (in shares) 63,012 64,977 53,801
Basic earnings per common share (in dollars per share) $ (20.36) $ 3.72 $ 5.72
Diluted earnings (loss) per common share:      
Net income (loss) $ (1,278,924) $ 251,217 $ 313,842
Less: net income allocated to participating securities (4,103) (9,490) (5,978)
Net income (loss) attributable to common stockholders $ (1,283,027) $ 241,727 $ 307,864
Weighted-average number of common shares - basic (in shares) 63,012 64,977 53,801
Effect of dilutive securities:      
Stock options and restricted stock units (in shares) 0 97 209
Weighted-average number of common shares - diluted (in shares) 63,012 65,074 54,010
Diluted earnings per common share (in dollars per share) $ (20.36) $ 3.71 $ 5.70
v3.25.4
STOCKHOLDERS’ EQUITY (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Jan. 13, 2026
Sep. 25, 2024
Jun. 26, 2024
Mar. 26, 2024
Jan. 24, 2024
Sep. 27, 2023
Jun. 28, 2023
Mar. 29, 2023
Jan. 19, 2023
Dec. 31, 2025
Nov. 30, 2025
Nov. 30, 2024
Jan. 01, 2025
Sep. 30, 2021
Equity [Abstract]                            
Authorized repurchase amount                         $ 600,000 $ 500,000
Shares repurchased                     3,557,000 2,201,000    
Aggregate purchase price                     $ 168,708 $ 136,096    
Share Repurchase Program, Remaining Authorized, Amount                     $ 439,468      
Common Stock, Dividends, Per Share, Cash Paid   $ 0.36 $ 0.33275 $ 0.33275 $ 0.33275 $ 0.33275 $ 0.3025 $ 0.3025 $ 0.3025          
Subsequent Event [Line Items]                            
Shares repurchased                     3,557,000 2,201,000    
Aggregate purchase price                     $ 168,708 $ 136,096    
Authorized repurchase amount                         $ 600,000 $ 500,000
Subsequent Event                            
Equity [Abstract]                            
Shares repurchased                   256,000        
Aggregate purchase price                   $ 9,911        
Subsequent Event [Line Items]                            
Declared quarterly dividend (in dollars per share) $ 0.36                          
Shares repurchased                   256,000        
Aggregate purchase price                   $ 9,911        
v3.25.4
Segment Reporting (Details)
$ in Thousands
12 Months Ended
Nov. 30, 2025
USD ($)
segments
Nov. 30, 2024
USD ($)
Nov. 30, 2023
USD ($)
Segment Reporting [Abstract]      
Number of Operating Segments | segments 1    
Number of Reportable Segments | segments 1    
Segment Reporting Information [Line Items]      
Revenue $ 9,825,771 $ 9,618,900 $ 7,114,706
Cost of revenue 6,390,760 6,170,013 4,536,771
Selling, general and administrative expenses 2,825,468 2,852,500 1,916,608
Total share-based compensation 97,875 95,922 62,493
Amortization 434,332 458,925 214,832
Impairment charges 1,527,726 0 0
Depreciation 226,101 246,920 173,463
Operating Income (Loss) (918,183) 596,387 661,327
Interest expense and finance charges, net 290,349 321,828 201,004
Other Operating Income (Expense), Net 26,310 24,715 (52,095)
Provision for income taxes 96,702 48,057 94,386
Net income (loss) (1,278,924) 251,217 313,842
Reportable Segment      
Segment Reporting Information [Line Items]      
Revenue 9,825,771 9,618,900 7,114,706
Cost of revenue 6,359,357 6,150,666 4,535,003
Selling, general and administrative expenses 1,997,095 1,913,309 1,397,914
Acquisitions 101,468    
Business Combination, Integration-Related Cost, Expense   156,771 69,674
Total share-based compensation 97,875 95,922 62,493
Amortization 434,332 458,925 214,832
Impairment charges 1,527,726 0 0
Depreciation 226,101 246,920  
Other Depreciation and Amortization     173,463
Operating Income (Loss) (918,183) 596,387 661,327
Interest expense and finance charges, net 290,349 321,828 201,004
Other Operating Income (Expense), Net (26,310) (24,715) 52,095
Provision for income taxes 96,702 48,057 94,386
Net income (loss) $ (1,278,924) $ 251,217 $ 313,842
v3.25.4
SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS (Details) - USD ($)
$ in Thousands
12 Months Ended
Nov. 30, 2025
Nov. 30, 2024
Nov. 30, 2023
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balances at Beginning of Fiscal Year $ 125,163 $ 117,679 $ 103,169
Charged to Revenue and Expense, net 19,084 40,340 4,823
Additions from Acquisitions 0 0 11,760
Reclassifications and Write-offs 3,362 (32,856) (2,073)
Balances at End of Fiscal Year $ 147,609 $ 125,163 $ 117,679